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Summary 
Background: The neglected tropical diseases (NTDs) comprise of a group of infections, that 
primarily occur in impoverished communities and may impair the course and outcome of 
pregnancy, childhood growth, intellectual development, education and worker productivity. 
Long-term chronic infection may result in disfigurement and stigmatization. Hence, the NTDs 
may exacerbate poverty, but because there are only limited commercial opportunities, the 
fight against these conditions has been widely neglected. Amongst others, helminth infections 
such as schistosomiasis (e.g., due to Schistosoma haematobium and S. mansoni), soil-
transmitted helminthiasis (e.g., due to Ascaris lumbricoides, Trichuris trichiura and 
hookworm) and food-borne trematodiasis (e.g., due to Clonorchis sinensis, Opisthorchis 
viverrini, Fasciola spp. and Paragonimus spp.) belong to the NTDs. 
For better quantifying the health burden caused by diseases, injuries and risk factors, in 
the 1990s, the World Health Organization (WHO) and the World Bank developed the 
disability-adjusted life year (DALY) metrics, as a scalable, time-based measure. DALYs 
combine years of life lost and years lived with disability in a single metrics and should help to 
better prioritize public health activities. In 2007, a comprehensive revision of all global 
burden estimates was launched, which also aimed at the inclusion of not yet assessed 
conditions such as food-borne trematodiasis. 
The increasing popularity of DALYs and burden of disease estimates sparked also 
renewed interest in the underlying epidemiological parameters. For instance, it became clear 
that for the NTDs, which mainly cause morbidity rather than mortality, the assessment of the 
average disability incurred by a diseased individual is crucial for correctly compiling data to 
global burden estimates. Interestingly, anamnestic questionnaires to assess morbidity due to 
helminth infections had been used before in attempts to better gauge helminth control efforts. 
Goal and specific objectives: The overarching goal of this PhD thesis was to develop, 
validate, and apply tools for assessing the morbidity and burden caused by NTDs at different 
geographical scales. The following three specific objectives were pursued in order to achieve 
this goal. First, to participate in the global burden of diseases, injuries and risk factors study 
2010 and assess – for the first time – the global burden of food-borne trematodiasis. Second, 
to generate new evidence on the disability incurred by individuals infected with schistosomes 
and/or soil-transmitted helminths in field-based epidemiological investigations in rural Côte 
d’Ivoire and compare the results with the most recent disability weights of the global burden 
of disease study. Third, to explore the potential of simple and low-cost anamnestic 
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questionnaire tools for the assessment of morbidity due to schistosomiasis and soil-
transmitted helminthiasis in the recently established Taabo health demographic surveillance 
site (Taabo HDSS) in Côte d’Ivoire in order to identify high-risk groups and guide control 
measures. 
Methods: To tackle the first objective, a systematic review was conducted and the current 
knowledge about the manifestation, diagnosis, management and epidemiology of food-borne 
trematodiasis summarized. The global burden of food-borne trematodiasis was then assessed 
according to the latest global burden of diseases study guidelines. 
Regarding the second objective, a first cross-sectional survey was carried out with 156 
schoolchildren in south Côte d’Ivoire in early 2010. Children were parasitologically tested for 
helminth and Plasmodium spp. infections, clinically examined, interviewed with a quality of 
life questionnaire and invited to participate in a maximal multistage 20 m shuttle run test. A 
second cross-sectional survey was conducted in the recently established Taabo HDSS in 
south-central Côte d’Ivoire in mid-2010. Overall, 187 adults were parasitologically tested for 
helminth and Plasmodium spp. infections and interviewed with a quality of life questionnaire. 
In the analysis of each survey, the different test results were juxtaposed to each other. 
For the third objective, 187 adults participating in the second annual parasitological 
surveys of the Taabo HDSS in 2010, and 146 children and 439 adults participating in the third 
annual parasitological survey in 2011 were interviewed with anamnestic questionnaires. The 
questionnaires contained questions about risk factors, signs and symptoms that are often 
associated with schistosomiasis and soil-transmitted helminthiasis. The questionnaire results 
were compared with the participants’ parasitological results in order to evaluate the diagnostic 
properties (sensitivity, specificity, positive and negative predictive values) of single responses 
and response combinations. 
Results: The estimates on the global burden of human food-borne trematodiasis indicate that 
56.2 million people were infected with food-borne trematodes worldwide in 2005, 7.9 million 
suffered from severe sequelae and 7,158 died due to cholangiocarcinoma and cerebral 
infection. These figures result in a global burden of 665,352 DALYs for the year 2005. 
With regard to individuals’ disability measurements, no effect of schistosomiasis and soil-
transmitted helminthiasis on schoolchildren’s physical fitness could be identified, irrespective 
of whether objectively measured shuttle run test results or questionnaire results on self-
reported physical fitness were considered. However, statistically significant correlations 
between the children’s shuttle run test and questionnaire results were found. In the second 
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survey, adults infected with S. mansoni or T. trichiura reported a significantly lower quality 
of life (-16.4%; p = 0.011 and -12.6%; p = 0.035, respectively). 
The results on specificity, sensitivity, positive and negative predictive values of the risk 
factors, signs and symptoms considered in the anamnestic questionnaire in the 2010 study 
revealed neither a promising diagnostic single indicator nor an appropriate combination. In-
depth analyses of data collected during the larger survey done in 2011 are underway. 
Conclusions: Despite disclosing many unsolved issues about the global burden of disease 
concept, knowledge gaps about food-borne trematodiasis and deliberately making 
conservative estimates, the identified disease burden reveals food-borne trematodiasis as an 
important cluster of neglected diseases. Particularly in the most endemic areas, efforts to 
control human food-borne trematodiases are essential. 
The results on individuals’ disability incurred by schistosomiasis and soil-transmitted 
helminthiasis are ambiguous. However, the significant correlation between objectively 
measured and self-reported physical fitness of schoolchildren is a promising indication for the 
more general use of quality of life questionnaires. Indeed, the figures on adults’ reduced 
quality of life indicate a stronger negative effect of these parasitic infections than currently 
assumed in most burden of disease compilations. The need for further innovation, validation 
and application of systematic, truly interdisciplinary, field-based, epidemiological approaches 
to gather additional evidence has been emphasized and a potential way forward outlined. 
As the whole project on the potential of further refined anamnestic questionnaires to 
guide schistosomiasis and soil-transmitted helminthiasis control efforts is still in an early 
exploration phase, findings presented in this PhD thesis are rather suggestive and should be 
interpreted with caution. Of note, if it may become possible to elicit effects of NTDs with 
carefully adapted and applied quality of life questionnaires, it is conceivable that disease-
associated risk factors, signs and symptoms allow for the development of anamnestic 
questionnaires. The potential benefits of such anamnestic questionnaire tools warrant further 
efforts, optimally within the frame of more comprehensive research collaborations aiming at 
the elaboration of integrative diagnosis and treatment algorithms. Detailed suggestions for 
future studies have been provided. 
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Zusammenfassung 
Hintergrund: Die sogenannten vernachlässigten Tropenkrankheiten bestehen aus einer 
Gruppe von Infektionen, die vor allem in verarmten Gemeinschaften hoch endemisch sind, 
und können das Wachstum von Kindern, die intellektuelle Entwicklung, die schulische 
Leistung und die Arbeitsproduktivität beeinträchtigen. Zudem können sie zu Entstellungen 
und Stigmatisierung führen. Folglich sind auch die vernachlässigten Tropenkrankheiten selbst 
armutsfördernd, aber weil kommerziellen Möglichkeiten zu deren Bekämpfung sehr 
beschränkt sind, wurden sie bisher weitestgehend nicht beachtet. Nebst anderen Krankheiten, 
gehören Infektionen mit Würmern der Spezies Schistosoma haematobium, S. mansoni, 
Ascaris lumbricoides, Trichuris trichiura, Hakenwürmer (Ancylostoma duodenale und 
Necator americanus) und durch Nahrungsmittel übertragene Trematodeninfektionen zu den 
vernachlässigten Tropenkrankheiten. 
Um die durch Krankheiten, Verletzungen und Risikofaktoren verursachte Krankheitslast 
besser zu bemessen, entwickelte die Weltgesundheitsorganisation (WHO) zusammen mit der 
Weltbank gegen Ende des 20. Jahrhunderts die sogenannten „behinderungsbereinigten 
Lebensjahre“ (disability-adjusted life years; DALYs) als eine neue, skalierbare, zeitbasierte 
Masseinheit. Diese DALYs kombinieren verlorene Lebensjahre aufgrund eines vorzeitigen 
Todes mit Lebensjahren gelebt mit einer Beeinträchtigung in einer einzigen Zahl, was der 
besseren Prioritätensetzung im Gesundheitswesen helfen soll. Im Jahr 2007 wurde eine 
komplette und systematische Revision von allen Schätzungen zu globalen Krankheitslasten 
lanciert. Diese Revision soll auch bisher noch nicht erfasste Krankheiten, wie zum Beispiel 
durch Nahrungsmittel übertragene Trematodeninfektionen, berücksichtigen. 
Die zunehmende Popularität von den DALYs und Schätzungen zur Krankheitslast hat 
auch das Interesse an den zu Grunde liegenden epidemiologischen Parametern neu entfacht. 
Zum Beispiel wurde erkannt, dass im Fall der vernachlässigten Tropenkrankheiten, welche 
vor allem zu Morbidität und nicht Mortalität führen, die Erfassung der durchschnittlichen 
Beeinträchtigung eines Patienten entscheidend ist um die geschätzte Krankheitslast korrekte 
aufsummieren zu können. Interessanterweise wurden anamnestische Fragebogen zur 
Erfassung der durch Wurmerkrankungen verursachten Morbidität schon früher eingesetzt, 
allerdings mit dem Ziel deren Kontrolle besser zu lenken. 
Ziel: Das Hauptziel dieser Dissertation war die Entwicklung, Validierung und Anwendung 
von Instrumenten zur Erfassung der durch verschiedene vernachlässigte Tropenkrankheiten 
auf verschiedenen geographischen Ebenen verursachten Morbidität und Krankheitslast. Dazu 
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wurden die folgenden drei Teilziele verfolgt: Erstens sollte im Rahmen der umfassenden 
Revision von allen globalen Krankheitslastschätzungen zum ersten Mal überhaupt die globale 
Krankheitslast von durch Nahrungsmittel übertragene Trematodeninfektionen erfasst werden. 
Zweitens sollten in epidemiologischen Feldstudien neue Anhaltspunkte in Bezug auf die 
individuelle Beeinträchtigung von Patienten mit Schistosomiasis (S. haematobium und 
S. mansoni) und/oder durch Bodenkontakt übertragene Würmern (A. lumbricoides, 
T. trichiura, Hakenwürmer) erarbeitet werden und die Resultate mit den aktuellsten 
Kennziffern zur durchschnittlichen Beeinträchtigung in der globalen Krankheitslaststudie 
verglichen werden. Drittens sollten einfache und billige anamnestischen Fragebogen, welche 
die von Schistosomiasis und von durch Bodenkontakt übertragenen Würmern verursachte 
Morbidität erfassen, insbesondere auf ihr Potenzial bei der Identifikation von 
Hochrisikogruppen und der Lenkung von Kontrollmassnahmen im Feld untersucht werden. 
Methoden: Um das erste Teilziel anzugehen, wurde mittels eines breitgefächerten, 
systematischen Literaturreviews das derzeitige Wissen zu Manifestationen, Diagnostik, 
Behandlung und Epidemiologie von durch Nahrungsmittel übertragene 
Trematodeninfektionen zusammengetragen. Anschliessend wurde basierend auf den neusten 
Richtlinien die globale Krankheitslast von durch Nahrungsmittel übertragene 
Trematodeninfektionen erarbeitet. 
Mit Bezug auf das zweite Teilziel wurde anfangs 2010 eine erste Querschnittsstudie mit 
156 Schulkindern im Süden der Côte d’Ivoire durchgeführt. Kinder wurden parasitologisch 
auf S. haematobium, S. mansoni, A. lumbricoides, T. trichiura, Hakenwürmer und 
Plasmodium spp. getestet, klinisch untersucht, mit einem Teil eines Lebensqualitäts-
Fragebogens befragt und eingeladen ein einem maximalen, mehrstufigen 20 m Pendellauftest 
teilzunehmen. Eine zweite Querschnittsstudie wurde Mitte 2010 im neu geschaffenen 
gesundheits-demographischen Beobachtungssystems (health demographic surveillance site; 
HDSS) in Taabo in Süd-Zentral-Côte d’Ivoire durchgeführt. 187 Erwachsene wurden 
parasitologisch auf die die selben Parasiten untersucht und mit einem kompletten Fragebogen 
zur Lebensqualität befragt. In der Analyse von beiden Studien wurden dann die verschiednen 
Testresultate einander gegenübergestellt. 
Für das dritte Teilziel wurden 187 Erwachsene, die 2010 an der zweiten jährlichen 
parasitologischen Untersuchung des Taabo HDSS teilnahmen, und 146 Kinder und 439 
Erwachsene, die 2011 an der dritten jährlichen parasitologischen Untersuchung des Taabo 
HDSS teilnahmen, mit anamnestischen Fragebogen befragt. Die Fragebogen enthielten 
Fragen zu Risikofaktoren, Anzeichen und Symptomen die oft mit Schistosomiasis und durch 
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Bodenkontakt übertragenen Würmern einhergehen. Die Fragebogenresultate wurden mit den 
parasitologischen Ergebnissen des Teilnehmers verglichen um die diagnostischen Fähigkeiten 
(Sensitivität, Spezifität, positiver und negativer Vorhersagewert) von einzelnen Antworten 
und Antwortkombinationen zu evaluieren. 
Ergebnisse: Die Schätzungen zur globalen Krankheitslast von durch Nahrungsmittel 
übertragene Trematodeninfektionen implizieren, dass im Jahr 2005 56.2 Millionen Menschen 
weltweit infiziert waren, dass 7.9 Millionen an ernsthaften Komplikationen litten und dass 
7'158 Menschen durch Cholangiokarzinome und cerebrale Infektionen starben. Diese Zahlen 
resultieren schliesslich in einer globalen Krankheitslast von 665'352 DALYs fürs Jahr 2005. 
Mit Bezug auf die Messung der individuellen Beeinträchtigung konnte weder in den 
objektiv gemessenen Ergebnissen des maximalen, mehrstufigen 20 m Pendellauftest noch in 
den Resultaten der selbstausgefüllten Lebensqualitäts-Fragebogens ein Effekte von 
Schistosomiasis oder von durch Bodenkontakt übertragenen Würmern auf die physische 
Fitness der Schulkinder festgestellt werden. Dafür wurde eine statistisch signifikante 
Korrelation zwischen den Resultaten des Pendellauftest und des Fragebogens gefunden. In der 
zweiten Studie erzielten die mit S. mansoni oder T. trichiura infizierten Erwachsenen eine 
signifikant tiefere Lebensqualität (-16.4%; p = 0.011 und -12.6%; p = 0.035). 
Die Resultate betreffend Sensitivität, Spezifität, positiven und negativen 
Vorhersagewerten der im anamnestischen Fragebogen der Pilotstudie von 2010 
berücksichtigen Risikofaktoren, Anzeichen und Symptome enthüllten weder einen 
vielversprechenden Einzelindikator, noch eine vielversprechenden Indikatorenkombination. 
Die weitere Auswertung der Daten von der grösseren Studie von 2011 ist noch ausstehend. 
Schlussfolgerung: Obschon einige noch offenen Probleme zum Konzept der globalen 
Krankheitslaststudien und Wissenslücken in Bezug auf durch Nahrungsmittel übertragene 
Trematoden aufgezeigt wurden und obschon bewusst zurückhaltende Schätzungen gemacht 
wurden, belegt die identifizierte Krankheitslast, dass durch Nahrungsmittel übertragene 
Trematodeninfektionen eine wichtige Gruppe von vernachlässigten Tropenkrankheiten 
darstellen. Insbesondere in den hochendemischen Regionen sind Anstrengungen zur Kontrolle 
von durch Nahrungsmittel übertragenen Trematoden unumgänglich. 
Die Resultate zur individuellen Beeinträchtigung aufgrund von Schistosomiasis und durch 
Bodenkontakt übertragenen Würmern sind nicht eindeutig. Die signifikante Korrelation 
zwischen objektiv gemessener und selbstberichteter physischen Fitness von Schulkindern ist 
ein vielversprechender Hinweis für die allgemeinere Anwendbarkeit von Lebensqualität-
Fragebogen. Und tatsächlich deuten die Zahlen zur reduzierten Lebensqualität von 
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Erwachsenen einen stärkeren negativen Effekt der Parasiteninfektionen als derzeit in den 
meisten Zusammenstellungen zur Krankheitslast angenommen wird. Die Notwendigkeit zur 
weiteren Innovation, Validation und Anwendung von systematischeren, holistischeren, 
wirklich interdisziplinären, feldbasierten, epidemiologischen Ansätzen um weitere 
Anhaltspunkte zu sammeln wird betont und mögliche nächste Schritte werden skizziert. 
Das Projekt über die Möglichkeiten von weiter verfeinerten anamnestischen Fragebogen 
in der Lenkung der Kontrolle von Schistosomiasis und durch Bodenkontakt übertragenen 
Wurminfektionen ist noch in einem sehr frühen Innovationsstadium. Deshalb sind alle 
bisherigen Ergebnisse mit Vorsicht und als weitere Anregungen zu interpretieren. Wichtig zu 
Bedenken in diesem Zusammenhang: Wenn es möglich werden sollte die Effekte von 
vernachlässigten Tropenkrankheiten mit sorgfältig adaptierten und angewendeten 
Lebensqualitäts-Fragebogen zu eruieren, so scheint es auch vorstellbar, das 
krankheitsbezogene Risikofaktoren, Anzeichen und Symptome die Entwicklung von 
anamnestischen Fragebogen erlauben. Der mögliche Nutzen von solchen anamnestischen 
Fragebogen rechtfertigt weitere Anstrengungen. Optimalerweise sind diese Anstrengungen in 
breitere Forschungszusammenarbeiten eingebunden mit dem Ziel umfassendere Diagnsotik- 
und Behandlungs-Algorithmen zu erarbeiten. Detailierte Anregungen für weitere Studien sind 
in dieser Dissertation erwähnt. 
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Résumé 
Contexte: Les maladies tropicales négligées (MTNs) comprennent un groupe d'infections, qui 
se produisent principalement dans les communautés pauvres et peuvent altérer le cours et 
l'issue d’une grossesse, la croissance durant l’enfance, le développement intellectuel, 
l'éducation et la productivité du travailleur. Une infection chronique à long terme peut 
entraîner une défiguration et la stigmatisation. D’où, les MTNs peuvent exacerber la pauvreté, 
et pourtant parce qu'il y a des opportunités commerciales limitées liées à celle-ci, la lutte 
contre elles reste largement négligée. Entre autres, les helminthiases telles que la 
schistosomiase (par exemple, causée par Schistosoma haematobium et S. mansoni), les 
géohelminthiases (par exemple, causée par Ascaris lumbricoides, Trichuris trichiura et les 
ankylostomes) et les trematodiases d'origine alimentaire (par exemple, causée par Clonorchis 
sinensis, Opisthorchis viverrini, Fasciola spp. et Paragonimus spp.) appartiennent au groupe 
des MTNs. 
Dans les années 1990, pour mieux quantifier le fardeau attribué aux différentes maladies, 
infirmités et facteurs de risque, l'Organisation Mondiale de la Santé (OMS) et la Banque 
Mondiale ont élaboré un outil de mesure désigné sous le vocable «années de vie ajustées sur 
l’incapacité (AVAI). Les AVAI combinent les années de vie perdues pour cause de décès 
prématuré et les années vécues avec une invalidité en une seule mesure avec le but d’aider à 
mieux prioriser les activités de santé publique. En 2007, une révision complète de toutes les 
estimations du fardeau global attribué aux différentes maladies, infirmités et facteurs de risque 
a été lancée. Elle visait également à l'inclusion de pathologies non encore évaluées tels que les 
trematodiases d'origine alimentaire. 
La popularité croissante des AVAI et des estimations du fardeau des maladies a suscité 
également un regain d'intérêt dans les paramètres épidémiologiques sous-jacents. Par exemple 
pour les MTNs, qui causent la morbidité plutôt que la mortalité, il est devenu évident que 
l'évaluation de la moyenne d’invalidité encourue par un patient est cruciale pour compiler 
correctement les données du fardeau global. Il est intéressant de noter l’usage dans un passé 
récent de questionnaires anamnestiques pour évaluer la morbidité causée par les helminthiases 
afin de mieux calibrer les efforts de lutte contre les helminthes. 
Objectifs: L'objectif principal de cette thèse était de développer, valider et appliquer des outils 
d'évaluation de la morbidité et du fardeau causé par les MTNs à différentes échelles 
géographiques. Dans but de réaliser cet objectif principale, les trois objectifs spécifiques ci-
après ont été poursuivis: (i) participer à l’estimation du fardeau global attribué aux différentes 
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maladies, infirmités et facteurs de risque et évaluer – pour la toute première fois – le fardeau 
global des trematodiases d'origine alimentaire, (ii) mener des enquêtes épidémiologiques en 
zone rural de Côte d'Ivoire pour générer de nouvelles évidences sur l’incapacité subie par les 
individus infectés par des schistosomes et/ou des géohelminthes et comparer ces résultats à 
des données récentes utilisées dans l’estimation du fardeau global, (iii) explorer le potentiel 
des questionnaires anamnestiques simples et à bas coût pour cerner la morbidité causé par la 
schistosomiase et les géohelminthiases dans le nouveau système de surveillance 
démographique (SSD) de Taabo, Côte d'Ivoire, afin d'identifier les groupes à haut risque et de 
diriger les efforts de lutte contre ces helminthiases. 
Méthodes: Pour réaliser le premier objectif, une revue systématique a été menée afin d’établir 
l’évidence actuelle sur les conséquences, les techniques diagnostiques, les options de 
traitements et l'épidémiologie des trematodiases d'origine alimentaire. Le fardeau mondial des 
trematodiases d'origine alimentaire a ensuite été évalué en référence aux directives de la 
dernière révision du fardeau global. 
Concernant le deuxième objectif, une première enquête transversale a été réalisée avec 
156 écoliers dans le sud de la Côte d'Ivoire au début de 2010. Les enfants ont été examinés au 
moyen d’examens parasitologiques et cliniques, interrogés avec un questionnaire concernant 
la qualité de vie et invités à participer à une course navette de 20 mètres. En été 2010, une 
deuxième enquête transversale a été menée au sein du SSD de Taabo au sud-centre de la Côte 
d'Ivoire. Au total, 187 adultes ont subi des examens parasitologiques pour vérifier la présence 
et l’intensité des infections avec des helminthes et Plasmodium spp. En plus, les adultes ont 
été interrogés à l’aide d‘un questionnaire concernant leur qualité de vie. Les résultats des 
différents enquêtes ont été comparés les uns aux autres. 
Pour le troisième objectif, 187 adultes ont été interrogés par questionnaires anamnestiques 
dans le cadre de la deuxième enquête annuelle du SSD de Taabo en 2010 et 146 enfants et 
439 adultes ont été interrogés par questionnaires anamnestiques pendant la troisième enquête 
annuelle du SSD de Taabo en 2011. Les questionnaires étaient structurés autour des facteurs 
de risque, les signes et les symptômes souvent associés à la schistosomiase et les 
géohelminthiases. Les résultats des questionnaires ont été comparés avec les résultats 
parasitologiques des participants afin d'évaluer le potentiel des questionnaires comme outil 
diagnostiques (sensibilités, spécificités, valeurs prédictives positives et négatives). 
Résultats: L’évaluation du fardeau global attribué aux trematodiases d'origine alimentaire en 
2005 indique que 56.2 millions de personnes ont été infectées, 7.9 millions ont souffert de 
séquelles graves et 7,1 millions sont morts à cause des cholangiocarcinomes et des infections 
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cérébrales. Ces chiffres se traduisent par un fardeau global de 665,352 AVAI pour l'année 
2005. 
Concernant l’invalidité subie par les individus infectés par des schistosomes et/ou des 
géohelminthes, les résultats de la première enquête transversale n’ont révélé aucun effet des 
infections sur la condition physique des écoliers – ni pour les résultats des courses navettes 
(mesure objective) ni pour les résultats des questionnaires (mesure subjective). Mais des 
corrélations statistiquement significatives ont été trouvés entre les résultats des courses 
navettes et les résultats des questionnaires. Dans la deuxième enquête transversale, les adultes 
infectés par S. mansoni ou T. trichiura rapportaient une réduction de la qualité de vie qui était 
statistiquement significatives (-16.4%, p = 0.011 et -12.6%, p = 0.035, respectivement). 
Les résultats concernant, la spécificité, la sensibilité, les valeurs prédictives positives et 
négatives des facteurs de risque, des signes et des symptômes considérés dans le questionnaire 
anamnestique de l’enquête de 2010 n’ont révélé aucun indicateurs prometteurs pour le 
développement des questionnaires anamnestiques, qu’ils soient pris individuellement ou en 
combinaison. L’analyse des données recueillies pendant la plus grande enquête effectuée en 
2011 est encore en cours. 
Conclusion: Malgré les nombreuses questions non résolues sur le concept du fardeau global, 
les lacunes concernant les trematodiases d'origine alimentaire et notre décision de faire des 
estimations avec circonspection, l’évaluation du fardeau global révèle les trematodiases 
d'origine alimentaire comme groupe important parmi les MTNs. Surtout dans les zones de 
haute endémicité, les efforts pour contrôler les trematodiases d'origine alimentaire sont 
essentiels. 
Les résultats sur l’invalidité subie par les individus infectés par des schistosomes et des 
géohelminthes sont ambigus. Mais la corrélation significative entre les mesures objectives et 
les mesures subjectives des aptitudes physiques des écoliers est un indicateur prometteur pour 
l'utilisation de questionnaires sur la qualité de la vie en général. En fait, les chiffres 
concernant la réduction de la qualité de vie des adultes indiquent un effet négatif de ces 
infections parasitaires qui est plus élevée que précédemment estimée dans la compilation du 
fardeau des maladies. La thèse de doctorat souligne la nécessité de poursuivre l'innovation, la 
validation et l'application des approches systématiques et interdisciplinaires, qui se basent sur 
des études de terrain pour recueillir nouvelle évidence sur l’invalidité causée par les 
helminthiases. Une perspective d'avenir est décrite dans la présente thèse. 
Le projet sur le potentiel et l’amélioration des questionnaires anamnestiques pour guider les 
efforts de lutte contre la schistosomiase et les géohelminthiases est encore dans une phase 
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d'exploration. En conséquence, les résultats présentés dans cette thèse sont plutôt suggestifs et 
doivent être interprétés avec prudence. Mais s’il est éventuellement possible d’évaluer les 
effets des MTNs avec des questionnaires de qualité de vie, il est aussi concevable que les 
facteurs de risque, les signes et les symptômes associés aux helminthiases permettent 
l'élaboration d’un questionnaire anamnestique. Les avantages potentiels d’un questionnaire 
anamnestique justifient des efforts additionnels. Idéalement, ces efforts devront se déroulent 
dans le cadre d’une collaboration de recherche plus compréhensive, visant à l'élaboration des 
algorithmes intégratifs pour la diagnose et le traitement des différents syndromes. Des 
suggestions détaillées pour des futures études ont été fournies dans la présente thèse. 
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1. Introduction 
This chapter provides a succinct overview of the life cycle, geographical distribution and 
burden (section 1.1), epidemiology (section 1.2), pathological consequences and clinical 
manifestations (section 1.3), diagnosis (section 1.4), treatment (section 1.5) and control 
(section 1.6) of schistosomiasis and soil-transmitted helminthiasis. These two diseases belong 
to the neglected tropical diseases (NTDs).
1
 Another important cluster of NTDs considered in 
this thesis are food-borne trematodiases. The characteristics of the food-borne trematodiases 
are comprehensively discussed in the first research article (chapter 5), and hence not covered 
here. The final two sections of this introduction highlight the importance of assessing human 
health on a global (section 1.7) and on a local scale (section 1.8). 
 
1.1. Geographical distribution, burden and life cycle of schistosomiasis and soil-
transmitted helminthiasis 
1.1.1. Schistosomiasis 
Schistosomiasis, also known as bilharzia, or blood fluke infection, or snail fever is a parasitic 
disease caused by trematode worms of the genus Schistosoma.
2-5
 The six species Schistosoma 
guineensis, S. haematobium, S. intercalatum, S. japonicum, S. mansoni, and S. mekongi are 
known to infect humans and considered endemic in 76 countries (Figure 1).
2-6
 Most human 
infections with S. haematobium and S. mansoni occur in sub-Saharan Africa, but both species 
are also present on the Arabian Peninsula and S. mansoni remains endemic in parts of Latin 
America and the Caribbean.
2-5
 S. guineensis and S. intercalatum are only of regional 
importance in Central Africa.
4-6
 S. japonicum is found in East and Southeast Asia and 
S. mekongi exist only along the Mekong River.
2-5
 
Currently, 779 million people are believed to be at risk of schistosomiasis worldwide and 
207 million infected with schistosomes.
7
 120 million people may suffer from clinical 
manifestations and 15,000-280,000 may die due to schistosomiasis each year.
8,9
 The global 
burden of schistosomiasis has been estimated at 1.7-4.5 million disability-adjusted life years 
(DALYs),
8,9
 but based on revised disability assessments, estimates of up to 70 million 
DALYs have been put forth.
2,10,11
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Figure 1. Global distribution of schistosomiasis. The map highlights countries with different schistosomiasis 
prevalences. (Source: reference 
12
). 
 
The schistosomes’ life cycles include different species of aquatic and amphibious snails 
as intermediate hosts (Figure 2). Aquatic snails from the genus Bulinus are the intermediate 
hosts for S. guineensis, S. haematobium and S. intercalatum, whereas aquatic Biomphalaria 
and Tricula aperta snails act as intermediate hosts for S. mansoni and S. mekongi, 
respectively. Amphibious snails from the genus Oncomelania serve as intermediate hosts for 
S. japonicum.
3-5
 
Human infections begin with the exposure of the skin to freshwater bodies, which contain 
infected intermediate host snails. The infected snails release cercariae that penetrate the intact 
exposed skin.
2-5
 In the human host, cercariae develop into schistosomula and migrate with the 
blood stream via the lungs and the heart to the liver. In the liver, the parasites mature and pair 
off. Finally, the adult worm pairs further migrate to the mesenteric vessels of the bowel or 
bladder, where they remain.
2-5
 Four to six weeks after the initial human host infection, adult 
females start producing hundreds (S. haematobium, S. mansoni) to thousands (S. japonicum) 
of eggs each day for several years.
3,5
 One part of the eggs may become trapped in the tissue of 
organs, causing inflammation and severe morbidity in the chronic stages of the disease. 
Another part of the eggs are excreted in the host’s urine (S. haematobium) or feaces (other 
species), have to reach freshwater bodies, and hatch into miracidia, which are infective to 
intermediate host snails for about 8-12 hours. After about one month, infected snails release 
cercariae.
2-5
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Figure 2. Life cycle of schistosomiasis. (Source: reference 
2
). 
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1.1.2. Soil-transmitted helminthiasis 
Soil-transmitted helminthiasis is a parasitic disease caused by intestinal nematode worms, 
which undergo parts of their development in the soil.
13,14
 The most common soil-transmitted 
helminths are the whipworms (Trichuris trichiura), the roundworms (Ascaris lumbricoides), 
and the hookworms (Ancylostoma duodenale and Necator americanus).
13,14
 Soil-transmitted 
helminth infections are one of the most common human infection, occur worldwide, but are 
most prevalent in tropical and sub-tropical regions (Figure 3).
13-15
 High prevalences of all 
soil-transmitted helminth infections have been reported from South, East, and Southeast Asia, 
from sub-Saharan Africa and parts of Latin America and the Caribbean.
13-15
 Of note, socio-
economic development and sustained control efforts helped to reduce T. trichiura prevalence 
levels in East Asia and Latin America.
13
 
 
 
Figure 3. Global distribution of soil-transmitted helminthiasis. The map highlights countries with different 
soil-transmitted helminthiasis prevalences. (Source: reference 
16
). 
 
Globally, 4,211 million people are currently considered at risk of ascariasis, 3,212 million 
people at risk of trichuriasis, and 3,195 million people at risk of hookworm infections.
8,9,15
 
807-1,221 million, 604-795 million, and 576-740 million people are estimated to be infected 
with A. lumbricoides, T. trichiura, and hookworm, respectively.
8,9,14,15
 Hence, more than a 
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billion people harbor at least one soil-transmitted helminth species, but concurrent infections 
with multiple species are common.
17-20
 350 million, 220 million, and 150 million people of 
those infected with A. lumbricoides, T. trichiura, and hookworm, respectively, may suffer 
from clinical manifestations.
8,9
 Annual numbers of deaths due to A. lumbricoides, T. trichiura, 
and hookworm infections range between 3,000-60,000, 3,000-10,000, and 3,000-65,000, 
respectively.
8,9
 These figures result in global burden estimates of 1.8-10.5 million, 1.0-6.4 
million, and 0.1-22.1 million DALYs due to A. lumbricoides, T. trichiura, and hookworm 
infections, respectively.
8,9,14
 
Humans are the only major definitive host of soil-transmitted helminths.
14
 The life cycles 
of soil-transmitted helminths can be divided into three types: direct, modified direct and skin 
penetration.
13
 T. trichiura has a direct life-cycle, indicating that already embryonated eggs are 
excreted by infected individuals. Excreted eggs do not necessarily have to reach the soil as 
they do not require a development stage there. After the eggs are carried back to the mouth 
via contaminated fingers or raw food (e.g., fruits and vegetables) and eventually swallowed, 
they hatch in the intestine and infect individuals within 2-3 hours. The released larvae pass to 
the caecum and colorectum, mature into adults within about 12 weeks and the females start 
producing 3,000-5,000 new eggs per day.
13,14
 
A. lumbricoides have a modified direct life-cycle, which means that, before being 
swallowed again, the excreted eggs have to be 1-4 months in damp warm soil to develop an 
embryo (Figure 4).
13
 In the human host, hatched A. lumbricoides larvae penetrate the 
intestinal mucosa, enter the bloodstream and then the lungs, migrate up the trachea to the 
larynx, are swallowed a second time and reach again the intestine, where they remain. During 
this migration, the parasites undergo further development stages and finally become adult 
worms 9-11 weeks after the hosts’ initial egg ingestion.13,14 The egg output of a female 
A. lumbricoides worm may be as high as 200,000 eggs per day. 
Similar to A. lumbricoides, hookworm undergoes certain development stages outside the 
human body. In damp shaded soil, excreted eggs hatch into larvae and molt twice before 
becoming infective third-stage larvae (L3).
13,14
 These larvae cannot survive in water, move 
towards oxygen, and are therefore most numerous in the top layer of the soil, where they can 
survive for 1-2 years.
13
 Unlike the other soil-transmitted helminths, the larvae directly 
penetrate the human skin if in contact and only A. duodenale is also orally infective. Again 
similar to A. lumbricoides, hookworm larvae then enter the bloodstream and reach via the 
lungs, trachea, larynx and oesophagus the small intestine, where they mature and each female 
produces 9,000-10,000 (N. americanus) or even 25,000-30,000 (A. duodenale) eggs per day 
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for several years.
13,14
 About 5-9 weeks are needed from initial host skin penetration until the 
production of the first eggs.
14
 
 
 
 
 
Figure 4. Life cycle of ascariasis. (Source: http://dpd.cdc.gov/dpdx/HTML/Ascariasis.htm). 
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1.2. Determinants and patterns of schistosomiasis and soil-transmitted helminthiasis 
transmission 
1.2.1. Schistosomiasis 
Due to the importance of the intermediate host snails, schistosomiasis transmission is highly 
dependent on interrelated environmental factors.
2
 The climate (temperature, precipitation), 
hydrology and relief (freshwater quality, flow velocity), and vegetation are key determinants 
as most snails prefer moderately flowing, shallow, more or less shady freshwater bodies or 
marshlands, with plenty of submerged, emergent or intrusive vegetation that offer sufficient 
food and egg deposition places.
5,7,21-23
 However, all intermediate host snails are able to 
aestivate and thereby enable the schistosomes to survive temporary dry seasons.
5
 Man-made 
environmental changes such as water resources development projects for flood control, 
drinking water provision, hydropower generation, irrigation,
3,5,7,24-28
 or mining projects
5,29,30
 
may further the spread of schistosomiasis without appropriate mitigation activities. 
Furthermore, development projects may lead to more or less voluntary migration and the 
introduction of the parasites in previously non-endemic areas.
3,5,29,30
 
Beyond environmental parameters, land use patterns, and migration, there is a variety of 
socio-economic and behavioral factors, which influence disease transmission. Schistosomes 
thrive where inadequate sanitation and poor hygiene allow them to establish their life 
cycles.
5,31-33
 Of note, animal reservoir hosts play an important role in S. japonicum 
transmission, whereas their role in S. mansoni transmission might be of subordinate 
importance and negligible in S. haematobium transmission.
4,5
 Infection intensity in humans 
depends on the frequency, duration and surface of body in contact with contaminated water 
and it is therefore intimately connected with human behavior such as farming, fishing, water 
fetching, washing or swimming.
5,34,35
 Infection may increase exponentially with water contact 
duration, peaking at ~30 minutes,
2
 and surface of body exposed to infested water.
5
 
The complex social-ecological interactions act on the snail intermediate hosts, the human 
definitive host, and the parasites and result in focalized geographical distribution patterns of 
schistosomiasis.
4,5,33
 For instance, Yapi and colleagues found in 2005 that rice cultivation may 
increase the risk of schistosomiasis in the savannah zone of Côte d’Ivoire, but not in the forest 
zone.
36
 Exemplary for NTDs, schistosomiasis primarily affects socio-economically deprived 
populations with insufficient information, education and access to health care.
5,31,33,34
 
Clustering occurs even within the same village and between individuals.
4,5,33
 A minority of 
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people harbors the majority of parasites and sheds most of the eggs in a community.
37-39
 
Highest prevalence rates and infection intensities are commonly found in school-aged 
children, adolescents and young adults.
4,5,33
 The decrease in older ages have been explained 
with changing behavior, partially acquired immunity and increasingly incurred tissue fibrosis, 
which may prevent eggs from reaching the exterior.
4,5
 Sex-related patterns may also occur, 
depending on cultural, behavioral, professional and religious factors.
4
 
 
1.2.2. Soil-transmitted helminthiasis 
A. lumbricoides and hookworm undergo important stages of their life cycle in the soil and the 
survival of all free living stages of soil-transmitted helminths (i.e., including T. trichiura) 
depends on the availability of suitable soil habitats.
13,14
 Land surface temperature and 
atmospheric humidity are crucial parameters as the free living stages cannot withstand 
temperatures below 5-10°C and above 38-40°C or desiccation.
40
 However, unlike 
A. lumbricoides and T. trichiura ova, the free living larvae of hookworm have some limited 
motility and can move downward into the soil to escape from potentially fatal temperatures or 
desiccation.
13,40
 The normalized difference vegetation index (NDVI) and elevation models 
have been used for prediction of soil-transmitted helminth prevalences
40
 as the vegetation and 
relief are ecologically linked with temperature and humidity. 
At smaller spatial scale, socio-economic factors and human behavior become increasingly 
important.
40
 As with the schistosomes, soil-transmitted helminths thrive wherever suitable 
environmental conditions are coupled with impoverished areas characterized by inadequate 
sanitation and hygiene, poor education and overcrowding.
13-15,31,32,40,41
 Behavioral factors such 
as the use of faeces as fertilizers, hand washing patterns, food preparation habits and 
geophagia – the eating of soil – potentiate the risk of infection.13,42 
Clustering between communities and households and highly aggregated distributions 
among individuals have also been observed with soil-transmitted helminths. Individuals’ pre-
disposition may be influenced by genetic, nutritional, socio-economic and behavioral 
factors.
13,14,19,43-51
 Prevalence rates and intensities of T. trichiura and A. lumbricoides are 
highest among school-aged children and adolescents,
13,14,40
 whereas hookworm infections and 
infection intensities seem to increase more steadily with age or plateaus in adulthood.
14,52,53
 
No consistent sex-specific patterns have been reported, but may also occur depending on 
cultural, behavioral, professional and religious determinants. 
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1.3. Pathological consequences and clinical manifestations of schistosomiasis and soil-
transmitted helminthiasis 
1.3.1. Schistosomiasis 
Schistosomiasis progresses usually in an acute, a chronic and an advanced phase. However, 
the often described, gradual and clearly differentiated pathological consequences and clinical 
manifestations according to the parasites development stage may appear in people who are 
infected for the first time (e.g., travelers, immigrants), but are usually blurred in people living 
in endemic areas by the endless series of epidemiological, immunological, and physiological 
interactions (e.g., re-infection, super-infection, and co-infection). Furthermore, the aggregated 
distribution of parasites among human hosts and the diverse distribution within infected 
individuals result in a variety of pathological consequences and clinical manifestations and 
many schistosomiasis cases remain rather asymptomatic.
2,5
 
As an early manifestation, a limited dermatitis may arise at the site where the schistosome 
cercariae penetrated the skin and particularly people infected for the first time may develop an 
itchy rash, which is less severe and should not be confused with “swimmer’s itch”.2-5 After 
cercarial invasion, during the schistosomula migration, maturation, pairing and beginning of 
egg deposition into host tissue, an acute hypersensitivity reaction may lead to acute 
schistosomiasis, also known as Katayama syndrome.
2-5,54
 Symptoms in this phase may 
include fever, fatigue, headache, loss of appetite, nausea, myalgia, non-productive cough, 
right upper quadrant pain and diarrhoea (with or without presence of blood).
2-4,54
 
Adult worms by themselves cause little or no pathology and the lesions that occur during 
infection are mainly caused by the increasing number of eggs that were laid in the organ walls 
and become trapped in the host’s tissue.2,4,5 Via collateral vascular bypasses, Schistosoma 
eggs can also reach other organs in the host’s body.5 The eggs evoke granuloma formation, 
which destroys the eggs, but results in fibrosis in the host tissue.
2-5
 After years of chronic 
infection, sustained local inflammation and fibrosis leads to the advanced stage of the disease 
with severe complications at the sites of maximal egg accumulation.
2-5
 Complications include 
intestinal complaints, ascites, hepatosplenic inflammation and hepatosplenomegaly, and liver 
fibrosis.
2-5
 Progressive obstruction of the blood flow results in portal hypertension, varices 
and intestinal bleeding.
2-4
 Particularly in case of S. haematobium, obstructive and 
inflammatory disease in the urinary tract, bladder calcification and renal failure occurs.
2-5
 
Unlike early lesions, late obstructive fibrous lesions respond poorly to antischistosomal 
treatment.
5
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Additional symptoms in the chronic and advanced phase include colicky abdominal pain, 
diarrhoea that may alternate with constipation, and blood in stool as gastrointestinal 
complaints.
2-5
 Urinary disease caused by S. haematobium presents with haematuria, dysuria, 
lower abdominal pain and renal colic.
2-5
 Population studies indicate that schistosomiasis 
causes anaemia, malnutrition, growth retardations, reduced exercise tolerance, cognitive and 
memory impairment and adversely affects maternal health and the unborn fetus.
2,4,5,10,11
 Such 
subtle or indirect morbidity remains difficult to measure, but received more attention over the 
last years as severe morbidity becomes less common due to treatment efforts with modern 
antischistosomal drugs.
4,10,11
 Schistosomiasis may also influence the individual’s 
susceptibility to HIV, malaria, tuberculosis, viral hepatitis and other helminth infections and 
alter the natural history of these diseases.
2,10,11
 In about a third of infected women genital 
disease may occur and advanced genitourinary schistosomiasis has been associated with 
dyspareunia and infertility.
2-5,10,11
 One of the most severe clinical outcome of schistosome 
infection is neuroschistosomiasis, resulting from aberrant migration of adult worms and/or 
egg accumulation in the spinal cord and the brain.
2-5,55,56
 An association between 
S. haematobium infection and bladder cancer has been suggested.
2-5,57
 
 
1.3.2. Soil-transmitted helminthiasis 
Pathological consequences and clinical manifestations of soil-transmitted helminthiasis is – 
similar to other helminth infections – often not overt, blurred by frequent re-infection, super-
infection and co-infection, and strongly related to the number of worms in the human host, 
i.e., infection intensity.
13,14
 After ingestion, hatching, and maturation, adult T. trichiura attach 
themselves to the mucosa of the large intestine, thereby causing mucosal damage.
13,14,58
 This 
leads to haemorrhages, mucopurulent and bloody stools, colitis, and acute phase immune 
response may induce Trichuris dysentery syndrome, whose symptoms include anaemia, 
clubbing of fingers and rectal prolapse.
13,14,58
 Mucosal damage can also facilitate the invasion 
of other infections.
13
 Additional symptoms of trichuriasis are distension, flatulence, epigastric 
pain, vomiting, anorexia and weight loss.
13,14,58
 In children, severe anaemia, negative impact 
on nutritional status, and retardation of physical and intellectual growth can occur.
13,14
 
Pathology due to A. lumbricoides is the result not only of the adults residing in the small 
intestine, but also by adults in abnormal locations and the larvae migrating through the 
lungs.
13,14,59
 Larval migration causes pathology and symptoms from their physical presence 
and elicited inflammatory reactions.
13
 During larval lung passage, eosinophilic pneumonia 
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(Löffler’s syndrome) may occur with skin rash, fever, wheezing, cough, dyspnoea and 
asthma.
13,14,59
 In addition. large numbers of adults in the small intestine may lead to nausea, 
anorexia, vomiting, diarrhoea, abdominal distension, intestinal colic, volvulus and 
obstruction.
13,14,59
 Wandering A. lumbricoides can cause abnormal situations, i.e., blocking or 
perforation of the bowel, appendicitis, invasion of the genital tract, blocking of the ampulla of 
Vater or the common bile duct, and invasion of the liver.
13,14
 Hepatobiliary ascariasis is not 
uncommon in endemic settings, elicit cholangitis, cholecystitis, hepatolithiasis, and liver 
abscess with associated fever, right upper abdominal pain and jaundice.
13,14
 Ascariasis-related 
damage in the intestine can result in malabsorption, malnutrition, vitamin A deficiency and 
night blindness, as well as growth and cognitive impairment.
13,14
 
Hookworm infections may cause pathological consequences and clinical manifestations at 
three stages.
13
 People who are infected for the first time (e.g., travelers, immigrants) may 
experience an itchy vesiculation and postulation (ground itch) at the site of skin invasion 
(usually feet and hands).
13,14,53
 Also mainly in people being infected for the first time, larval 
migration through the lungs can cause non-specific asthma and bronchitis with a dry cough, 
wheezing, dyspnoea and fever.
13,14,53
 In established infections, mainly in inhabitants of 
endemic areas, the attachment of the hookworms to the intestinal mucosa and blood sucking 
results in chronic blood loss and leads to iron deficiency and hookworm anaemia.
13,14,53
 
Protein loss due to enteropathy may lead to oedema or even anasarca.
13,14,53
 Other symptoms 
of hookworm disease include fatigue, anorexia, vomiting, nausea, headache, digestive 
disturbances and dyspepsia, epigastric discomfort and pain, diarrhoea and blood in stool, 
anaemic pallor and koilonychia, breathlessness, heart palpitation and heart failure, reduced 
work capacity, growth stunting and impaired cognition in children.
13,53
 Women of child-
bearing age, pregnant women, and children are usually the most susceptible to hookworm 
disease and anaemia due to their underlying iron and nutritional status, with adverse effects on 
pregnancy and birth outcome, school achievements and wage earning potential in 
adulthood.
13,14,53
 
 
1.4. Diagnosis of schistosomiasis and soil-transmitted helminthiasis 
1.4.1. Schistosomiasis 
Microscopic parasite egg detection in urine (in case of S. haematobium) and stool (in case of 
S. mansoni, S. japonicum, S. intercalatum, S. guineensis and S. mekongi) remains the gold 
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standard for the diagnosis of schistosomiasis.
2-5,12,60
 Filtration, sedimentation, and/or 
centrifugation of collected urine samples is applied to diagnose urinary 
schistosomiasis.
2,4,5,12,60
 The rapid, simple, and inexpensive Kato-Katz thick smear stool 
examination is probably the most widely used technique to diagnose intestinal schistosomiasis 
and requires a minimum of 40-50 mg of feaces.
2-5,12,60,61
 Direct faecal smear is also commonly 
used and formalin-based concentration, sedimentation, and flotation techniques have been put 
forth to increase diagnostic accuracy.
2-4,12,62-64
 Such direct parasitological methods, if 
correctly performed, offer a specificity of 100%. However, due to the parasites pre-patent 
period, individual day-to-day variation and variation within the excreta, sensitivity varies with 
intensity of infection, the number of consecutive urine or stool samples collected and the 
number of microscope slides prepared and examined and may reach 70-100%.
2,4,5,65-71
 
Infection intensities are usually measured as the number of eggs detected in 10 ml of urine 
(urinary schistosomiasis) or the number of eggs detected in a small amount of stool (e.g., 
42 mg using the Kato-Katz thick smear), which is then translated to the number of eggs per 
gram of stool (EPG; intestinal schistosomiasis). Thus defined infection intensities are often 
considered as indicator for the worm-burden in the host and categorized according to WHO 
guidelines (Table 1).
33
 
 
Table 1. Classification of infection intensities for S. haematobium and S. mansoni. 
Parasite Infection intensity 
  Light Moderate Heavy 
Schistosoma haematobium <50 eggs/10 ml urine --- ≥50 eggs/10 ml urine, 
   or visible haematuria 
Schistosoma mansoni 1-99 EPG 100-399 EPG ≥400 EPG 
This table is based on reference 
33
. EPG = eggs per gram of stool. 
 
Indirect diagnostic methods aim at the detection of pathological consequences, clinical 
manifestations, human antibodies or parasitic antigens. Indirect methods include anamnestic 
questioning and reagent strips testing for blood in urine (urinary schistosomiasis) or stool 
(intestinal schistosomiasis) or radiological imaging techniques and ultrasonography, and 
immunodiagnostic tests such as enzyme-linked immunosorbent assays (ELISA) and indirect 
haemagglutination assays (IHA).
2,4,5,12,72,73
 These methods are comparatively unspecific, but 
considered particularly useful in patients who are not excreting eggs and in field studies for 
community screening.
2-4,72,73
 Recently, first promising results have been reported for urine 
circulating cathiodic antigen tests.
2,3,5,12,74-76
 A highly specific, sensitive, but also expensive 
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molecular diagnostic approach is based on polymerase chain reaction (PCR), which identifies 
schistosome DNA in faeces, sera and plasma.
2,12,73
  
 
1.4.2. Soil-transmitted helminthiasis 
Analogously to the diagnosis of schistosomiasis, soil-transmitted helminths can be diagnosed 
directly by identification of parasites and their eggs or indirectly by detection of pathological 
consequences, clinical manifestations, human antibodies and parasitic antigens. Kato-Katz 
thick smear stool examination is widely used for soil-transmitted helminthiasis and 
recommended as a standard method by WHO.
13,14,60,61
 Direct faecal smear, concentration and 
flotation methods are potential alternatives and particularly the latter may even have a higher 
test accuracy than the Kato-Katz technique.
13,14,63,64,77-80
 Infection intensities are also 
measured as the number of eggs detected in a small quantity of stool, which are then 
translated to numbers of EPG. EPG are considered as an indicator for the host’s worm burden, 
and categorized according to WHO guidelines (Table 2).
33
 
 
Table 2. Classification of infection intensities for soil-transmitted helminths. 
Parasite Infection intensity 
  Light Moderate Heavy 
Trichuris trichiura 1-999 EPG 1,000-9,999 EPG ≥10,000 EPG 
Ascaris lumbricoides 1-4,999 EPG 5,000-49,999 EPG ≥50,000 EPG 
Hookworms 1-1,999 EPG 2,000-3,999 EPG ≥4,000 EPG 
This table is based on reference 
33
. EPG = eggs per gram of stool. 
 
Indirect serological diagnosis with ELISA is an alternative diagnostic method, but has a 
limited specificity due to cross-reactivity.
13,81
 Again, PCR to detect helminth DNA in stool 
specimens offers high specificity and sensitivity.
13,81
 Radiological imaging and 
ultrasonography may be considered as complementary tools.
13,14
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1.5. Treatment of schistosomiasis and soil-transmitted helminthiasis 
1.5.1. Schistosomiasis 
Drugs against the two most prevalent schistosome species, S. haematobium and S. mansoni, 
which are also in the main focus of the present thesis, are listed in Table 3, along with 
recently reported cure rates, egg reduction rates, and deduced efficacy. Frequently 
recommended oral dosages are presented in Table 4. All listed drugs are currently on the 
World Health Organization (WHO) model list of essential drugs
82
 and generally considered 
safe with restrained use mainly among pregnant or breast feeding women and infants. 
Of note, oxamniquine is currently available in only very few countries, but the 
manufacturer has assured WHO to continue the production of this antischistosomal compound 
for the foreseeable future.
5
 However, oxamniquine is only active against S. mansoni.
4,5,12
 The 
artemisinin derivatives artemether and artesunate can be used as chemotherapy or 
chemoprophylaxis against schistosomiasis, but they are currently among the most potent 
antimalarials and biological and epidemiological issues such as the fear of resistance in 
Plasmodium. spp. have to be clarified before routine use of these substances may be 
recommended.
2-5
 Hence, the current mainstay of antischistosomal treatment is praziquantel, 
which is active against all schistosome species parasitizing humans.
2-5,12
 Adjuvant treatment 
may be indicated in cases with severe complications.
2-5,54,56
 Importantly, the prices of most 
anthelminthic drugs have plummeted as the patents run out. For instance, a 600 mg tablet of 
praziquantel now costs approximately US$. 0.08, and hence treatment of a school-aged child 
costs less than US$ 0.30-0.40.
33,83
 Furthermore, donations of anthelminthic drugs have been 
made by the pharmaceutical industry over the last years.
84
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Table 3. Oral chemotherapeutic treatment against schistosomiasis, reported cure and egg reduction rates, 
and deduced efficacy. 
Parasite Drug Cure rate Egg reduction rate Efficacy
a
 Source 
S. haematobium Praziquantel
b
 44-93% 84-97% +++(++) 
85,86
 
 Artesunate
c
 20-100% 55-100% ++(+++) 
85,86
 
 Artemether
c
 25% ND ++ 
85,86
 
S. mansoni Oxamniquine
d
 60-100% up to 100% ++++(+) 
5,85
 
 Praziquantel
b
 73-90% 89-94% ++++(+) 
85,86
 
 Artemether
c
 50-100% up to 100% +++(++) 
85,86
 
  Artesunate
c
 23-100% 59-100% ++(+++) 
85,86
 
All drugs are currently on the WHO model list of essential drugs, but artesunate and artemether as antimalarials 
and not as antischistosomals.
82
 ND = not determined. 
a
Treatment efficacy: +++++ = cure rate and egg reduction 
rate of 80-100%; ++++ = cure rate and egg reduction rate of 60-79%;  +++ = cure rate and egg reduction rate of 
40-59%; ++ = cure rate and egg reduction rate of 20-39%; + = cure rate and egg reduction rate of 0-19%. 
b
Limited resistance documented. 
c
Used as chemotherapy or chemoprophylaxis; currently among the most potent 
antimalarials. 
d
Limited resistance documented; no activity against S. haematobium. 
 
Table 4. Frequently recommended oral dosage of antischistosomal chemotherapeutic treatment. 
Drug Recommended oral dose Source 
Praziquantel
a
 40 (or 60) mg/kg single or divided doses 
2-5,85
 
Oxamniquine 15-60 mg/kg single or divided doses 
5,85
 
Artemether Chemoprophylaxis: 6 mg/kg once every 2-4 weeks 
2,3,85,86
 
 Chemotherapy: varying dosages 
85,86
 
Artesunate Chemoprophylaxis: 6 mg/kg once every 2-4 weeks 
2,85,86
 
 Chemotherapy: varying dosages 
85,86
 
a
Praziquantel is currently the treatment of choice. 
 
1.5.2. Soil-transmitted helminthiasis 
Drugs against T. trichiura, A. lumbricoides, and hookworm and respective cure rates, egg 
reduction rates, and deduced efficacy are listed in Table 5. Anthelminthics on the WHO 
model list of essential drugs
82
 are indicated in bold. Recommended oral drug dosage is shown 
in Table 6. Again, the listed drugs are considered safe, with restraints mainly for pregnant or 
breast feeding women and infants. 
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Table 5. Oral chemotherapeutic treatment against soil-transmitted helminthiasis, reported cure and egg 
reduction rates, and deduced efficacy. 
Parasite Drug Cure rate Egg reduction rate Efficacy
a
 Source 
T. trichiura Mebendazole 19-78% 52-93% +(++++) 
85,87,88
 
 Albendazole 0-99% 0-92% +(++++) 
85,87-91
 
 Tribendimidine 33% 76% ++(++) 
85
 
 Pyrantel pamoate
b
 11-38% 52% +(++) 
85,87,90,91
 
 Ivermectin 11-35% 43-59% +(++) 
85,89,90
 
 Levamisole 9-10% 42% +(++) 
85,87
 
 Diethylcarbamazine 3% 20% +(+) 
90
 
A. lumbricoides Levamisole 87-100% 92-100% +++++ 
85,87
 
 Pyrantel pamoate
b
 85-100% 88-100% +++++ 
85,87,90,91
 
 Tribendimidine 98% 96% +++++ 
85
 
 Mebendazole 78-100% 96-100% ++++(+) 
85,87,88
 
 Ivermectin 78-100% up to 100% ++++(+) 
85,89,90
 
 Albendazole 70-100% 87-100% ++++(+) 
85,87-91
 
 Piperazine 62-85% ND ++++(+) 
85
 
 Diethylcarbamazine 17-31% 18-77% +(+++) 
85,90
 
Hookworm
c
 Tribendimidine 78-86% 99% ++++(+) 
85
 
 Albendazole 40-100% 64-100% +++(++) 
85,87-91
 
 Mebendazole 8-91% 0-98% +(++++) 
85,87,88
 
 Pyrantel pamoate
b
 9-88% 56-75% +(++++) 
85,87,90,91
 
 Levamisole 0-93% 61% +(++++) 
85,87
 
 Ivermectin 0-64% 0-92% +(++++) 
85,89,90
 
  Diethylcarbamazine 22-26% 19-36% ++ 
85,90
 
Drugs currently on the WHO model list of essential drugs
82
 are indicated in bold. ND = not determined. 
a
Treatment efficacy: +++++ = cure rate and egg reduction rate of 80-100%; ++++ = cure rate and egg reduction 
rate of 60-79%; +++ = cure rate  and  egg  reduction  rate  of  40-59%;  ++  =  cure  rate  and  egg  reduction  rate  
of  20-39%; + = cure rate and egg reduction rate of 0-19%. 
b
Not recommended for pregnant women or children. 
c
A. duodenale and N. americanus. 
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Table 6. Frequently recommended oral dosage of drugs against soil-transmitted helminthiasis. 
Drug Recommended oral dose Source 
Albendazole 400 mg single dose for 1-3 days (children aged 1-2 years 200 mg) 
83,85,87
 
Diethylcarbamazine 100 mg for 2-5 year old, 200 mg for 6-15 year old, 300 mg for >15 year old 
83
 
Ivermectin 200 µg/kg single dose for 1-2 days 
85,89
 
Levamisole 2.5 mg/kg single dose 
83,85,87
 
Mebendazole 500 mg single dose 
83,85,87
 
Piperazine 75 mg/kg single dose 
85
 
Pyrantel pamoate 10-40 mg/kg single dose for 1-3 days  
83,85,87
 
Tribendimidine Various doses: 200 mg/kg to 400 mg/kg single dose for 1-3 days 
85
 
 
As illustrated by Table 5, the armoury against ascariasis contains several highly 
efficacious drugs, whereas the situation is less satisfactory with regard to hookworm 
infections and even worse with regard to trichuriasis. Currently, albendazole and mebendazole 
are the recommended treatment by WHO against ascariasis, hookworm infection, and 
trichuriasis, and hence also the most widely used drugs.
13,14,83,87
 As with schistosomiasis, 
adjuvant therapy may be needed in case of severe complications and/or sequelae.
13
 One tablet 
of 400 mg albendazole or 500 mg mebendazole costs as little as US$ 0.02 and donations 
made by the pharmaceutical industry included also drugs against soil-transmitted 
helminthiasis.
33,83,84
 
 
1.6. Control of schistosomiasis and soil-transmitted helminthiasis 
Due to many common features, this chapter combines the discussion pertaining to the control 
of schistosomiasis and soil-transmitted helminthiasis. This is in line with growing efforts for 
integrated control of multiple NTDs.
33,73,92,93
 
As described in the previous chapters, schistosomiasis and soil-transmitted helminthiasis 
mainly affect developing countries in the tropics and particularly poor rural communities. 
High intensity or long-standing infections lead to a variety of sequelae and negatively impact 
on pregnancy and birth outcome, cognitive and physical development, and work capacity, 
thus draining the social and economic development of affected communities.
1,94,95
 The 
awareness of this vicious cycle and the availability of efficacious, safe, affordable and easy to 
use drugs resulted in a control strategy phrased “preventive chemotherapy”.12 Preventive 
chemotherapy means the regular untargeted or targeted drug administration to populations 
considered at-risk of morbidity without prior diagnosis and with the primary objective to 
control morbidity and transmission.
12,83,96
 This strategy of helminth control through large-
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scale administration of chemotherapy was endorsed by WHO in the mid-1980s
25,33,97-99
 and 
gained further momentum at the beginning of the new millennium as the World Health 
Assembly (WHA) resolution 54.19 urged member states to treat at least 75% and up to 100% 
of all school-aged children and other high-risk groups with praziquantel against 
schistosomiasis and albendazole or mebendazole against soil-transmitted helminthiasis.
33,73,84
 
Following current WHO guidelines, all schoolchildren and high-risk groups should be treated 
once or twice every year in high prevalence communities (≥50%) and once or twice every two 
years in moderate prevalence communities (10-50%). In low prevalence communities 
(<10%), chemotherapy should be made available through health facilities for the treatment of 
suspected cases.
83
 Experience with preventive chemotherapy suggests that this strategy, 
implemented in highly endemic areas, indeed effectively reduces morbidity.
33,100,101
 
However, preventive chemotherapy raises several issues that must be considered. For 
instance, the potential development of resistance to widely and repeatedly administered 
anthelminthic drugs necessitates careful monitoring to duly recognize treatment failures. Of 
note, anthelminthic drug resistance is already a major issue in veterinary public health, where 
drugs are applied on a large scale with very high coverage rates.
41,102-111
 Despite ongoing 
efforts, there are currently no vaccines available against schistosomiasis and soil-transmitted 
helminthiasis and vaccines may only become part of a solution in the future.
1,112,113
 Hence, the 
need for the development of novel anthelminthic drugs and innovative approaches to prolong 
the useful lifespan of existing drugs, such as their alternating or combined use, have been 
emphasized.
41,85-87
 Thus far, no indications for severe negative pharmacokinetic interactions 
or limitations due to decreased safety and tolerability have been reported with regard to tested 
combinations of drugs listed in Table 3 and Table 5.
85,86,88,90,91
 Interestingly though, while 
some combinations of drugs with different modes of action showed efficacies that were 
comparable to single drug treatments, other combinations such as praziquantel plus artesunate 
against S. haematobium and S. mansoni,
85,86
 mebendazole plus levamisole against 
hookworm,
85
 and albendazole or mebendazole plus ivermectin against T. trichiura
85,88,90
 
revealed higher cure and/or egg reduction rates. 
In order to reinforce and consolidate achievements made by preventive chemotherapy, 
and to lower the dependency from chemotherapy, more integrated approaches, including 
improved sanitation, education and, particularly for schistosomiasis, intermediate host snail 
control are of pivotal importance.
5,13,41,114
 Improved sanitation mainly consists of toilets and 
latrines that ensure the hygienic disposal of human excreta and access to clean water that 
permits safe recreational and occupational usage (e.g., bathing, fishing, watering, washing, 
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drinking and cooking).
31,32,41,115,116
 A promising approach to reduce the faecal contamination 
of the environment is community-led total sanitation (CLTS), for instance.
117,118
 Health 
education – or better interactive health communication – is essential to inform, motivate, 
encourage and train people, to receive feedback from them, and to ensure continuing 
participation, self-reliance and, if need be, behavior change.
31,34,119,120
 Intermediate host snail 
control as part of an integrated control approach against schistosomiasis is mainly based on 
the use of molluscicides and to some extent on environmental management.
5,28
 
Improved sanitation, education and intermediate host snail control aim at interrupting the 
parasite’s life cycle and therefore the control of transmission. Interestingly, transmission 
control was the recommended strategy to fight schistosomiasis until the mid-1980s. However, 
with the advent of safe and efficacious drugs (e.g., praziquantel), the emphasis shifted from 
transmission to morbidity control.
5,13,41,73,114,121
 Nowadays, control plans envisage morbidity 
control in highly endemic settings and with decreasing endemicity prevalence control, 
transmission control and, ultimately, surveillance and detection of the few remaining cases in 
order to eliminate the diseases (Figure 5).
73,100
 There is broad consensus that avoiding severe 
morbidity should be the first priority in high-endemicity settings.
83,100
 At this early stage, the 
identification of such high-endemicity areas is more important than exact individual diagnosis 
and preventive chemotherapy with the current arsenal of available cheap and safe drugs 
indeed prevents from most severe sequelae.
73,83,100
 Once the initial efforts successfully 
reduced morbidity and partially also prevalence and transmission, cost-effectiveness and 
sustainability of the continuation becomes essential.
33,100
 Screening and treatment strategies 
have to be adjusted to the changing epidemiological situation.
122,123
 With decreasing number 
of infected individuals, more targeted treatment is likely to become more cost-effective than 
continued large-scale drug administration,
124
 but asks for increasing accuracy of diagnostics.
73
 
Furthermore, while vertical programs may be initially successful, they should be carefully 
absorbed into more horizontal sector-wide and intersectoral approaches.
12,114,125-130
 However, 
the appropriate mix and timing of interventions, diagnostics and governance depend on the 
characteristics of the targeted helminth species and location and have been at the root of many 
fervent debates, including the question whether continued drug-based interventions could 
push transmission even below a “transmission breakpoint” and thereby reaching elimination 
on its own without ever being supported by additional interventions.
96
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Figure 5. Schematic illustration of how falling endemicity levels influence helminth control programs. This 
figure has been further developed based on references 
73,96,100
. 
 
Over the past years, disease mapping and modeling by using geographical information 
systems (GIS) and remote sensing became important tools in control programs and 
demonstrated considerable geographical overlaps of different NTDs.
1,9,40,113
 Furthermore, as 
the NTDs share certain risk factors, concurrent infections with multiple parasite species are 
often the norm rather than the exception.
20
 Awareness of these facts, the availability of drugs, 
which act against several of the causative agents simultaneously or can be safely combined, 
and cost-effectiveness considerations led to the quest for the integration of NTD control 
programs.
1,9,113
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1.7. Assessing human health on a global scale 
1.7.1. Why is it important to assess human health on a global scale? 
Having valid, reliable and comparable data is a precondition for the most effective use of 
scarce resources. This is important for donors, decision makers and health program managers 
at the one end of the public health system, but even more important for those in need at the 
other end of the system.
131
 Hence, evidence on the magnitude and distribution of the global 
burden of disease and its trends over time are a critical input to well-informed decision 
making at all levels.
132
 In an increasingly globalized world with new, powerful players in the 
public health sector (e.g., Bill & Melinda Gates Foundation) and increasingly globalized 
target-setting (e.g., the United Nation’s (UN) millennium development goals (MDGs)), 
decisions on the global level are an important factor and need to be governed by global 
evidence. 
Unfortunately, descriptive epidemiology and health measurement at the population level 
may not be sufficiently novel for major funding bodies, other investigators, and journal 
audiences, and are therefore underrepresented in the epidemiological literature.
132,133
 
Traditional epidemiological journals tended to concentrate on causal and quasi-experimental 
studies over the past years and cross-disciplinary debate became increasingly fragmented. 
Hence, there is a need for increased efforts in population health measurement, which could 
also bridge a range of currently disjoint fields relating to health such as medicine, biology, 
epidemiology, demography, health economics and broader social science disciplines.
133
 
 
1.7.2. Definition and historical background of the DALY concept 
The assessment of human health on a global scale made a big step forward in the late 1980s 
and early 1990, when WHO and the World Bank developed the DALY concept, as a new, 
scalable, time-based measuring unit for quantifying the health burdens caused by different 
diseases and injuries.
132
 The DALY is a time-based measure that combines years of life lost 
(YLLs) and years lived with disability (YLDs).
134
 Hence, it does not directly measure health, 
but rather the loss of healthy life by combining the burden of fatal with that of non-fatal 
conditions. In economic terms, they are a “bad” which should be minimized. In this sense, the 
terminology of DALY can be misleading as more of a “life year”, even when “adjusted”, 
should be a good and therefore maximized and not minimized.
135
 
Chapter 1 – Introduction 
22 
Simplified, the burden for a particular health state as expressed in DALYs is computed as 
follows:  
 
DALYs = Σ YLLs + Σ YLDs, 
with YLLs from a single death equal to (standard life expectation - age at death)          
* (age weight) * (future discount) 
and YLDs from a certain disabling condition equal to (disability weight) * (incidence) 
* (duration of disabling event) * (age weight) * (future discount). 
 
The first global burden of diseases study commenced in 1992. The study was based on the 
DALY concept and had the following three major objectives: 
(i) to facilitate the inclusion of non-fatal health outcomes; 
(ii) to decouple epidemiological assessment from advocacy so that estimates are as 
objective as possible; and 
(iii) to quantify the burden of disease using a measure that could also be used for cost-
effectiveness analysis.
136
 
It provided the first comprehensive, consistent and comparable set of DALY estimates for 
107 diseases and injuries and 10 selected risk factors. Results were stratified by age, sex and 
the eight world regions (those used by the World Bank at the time) and reported for the year 
1990 with projections made for the year 2020.
134,137
 
After the original global burden of disease study, work continued to improve the 
methods
138-141
 and to analyze additional and newly acquired data.
142
 Between 1999 and 2004, 
WHO published annual global burden of disease estimates in the annex tables of the World 
Health Report.
143-148
 The global burden of disease results also provided a framework for the 
disease control priorities project (DCPP), which focused on cost-effectiveness and priority 
setting analysis.
149
 New estimates for 136 diseases and injuries and 19 risk factors for eight 
different world regions in the year 2001 were published in 2006.
150
 The global burden of 
diseases 2001 study included newly available data, but some burden of disease estimates and 
most disability weights used for calculation continued to rely on the original work done in 
1990.
132
 
In 2007, the first complete systematic revision of the original global burden of diseases 
1990 study was launched. Its goal is to (re-)evaluate the global burden of 175 diseases and 
injuries (based on ICD-10 codes) and 43 risk factors for 21 regions of the world in 1990 and 
2005.
132,134,151
 Postponed several times, final results of this major update and overhaul are 
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now scheduled for publication in summer 2012. Indeed, the final study results will 
incorporate a complete (re-)assessment of all available primary data sources and harness all 
methodological improvements achieved over the past years. Amongst other issues, new 
disability weights for an updated list of sequelae will be derived and attempts are made to 
further decouple the initial disability weights from pure expert elicitation.
132,134,151
 
 
1.7.3. Critical appraisal of previous global burden of disease studies 
An undeniable merit of the global burden of disease concept is the renewed interest in 
descriptive epidemiology and population health measurement. It has stimulated a controversy 
that circled around three main topics. First and foremost, criticism focused on the construction 
of the DALY metrics
132
 and the determination of age-specific weights, future discounting and 
disability weights.
135,136,152-157
 Of particular interest for the present PhD thesis, the original 
disability weights, which should capture the disability incurred by an average case suffering 
from a certain condition in percentages, were solely based on expert opinion.
136
 As a second 
main point of criticism, concerns have been raised about the desirability and implications of 
extrapolation of population health estimates where basic descriptive epidemiological data are 
limited, uncertain or even missing.
132,158,159
 As a third main point of criticism, some health 
economists have argued that the global burden of disease analyses do not help in setting 
health priorities. They were afraid that future priority setting could be based only on the 
magnitude of disease burdens, whereas the marginal cost-effectiveness of potential 
interventions, in their eyes the crucial parameter, could be ignored.
153,160
 Also, they 
highlighted some consequences which run against equity principles if DALY minimization 
becomes the most important criterion.
135,161
 
The ongoing debate about the most accurate way to evaluate the global burden of diseases 
as well as discussions about the best organizational structure for data compilation
162
 also 
reflect the political power of such statistics. The fervent pleas of a wide range of interest 
groups to (re-)evaluate certain disease burden calculations
11,152,163-165
 or the partial or 
complete refusal of the DALY concept mainly due to “ethical” reservations point in the same 
direction.
156,166,167
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1.7.4. Parasitic infections in the tropics: the “big three” and the NTDs 
In 2004 the global burden of disease was estimated to be over 1.5 billion DALYs lost. 
Approximately 60% of this burden was due to YLLs and 40% to YLDs.
168
 Among the 10 
leading diseases and conditions in terms of global burden were a number of diseases that are 
particularly widespread in the developing world, namely perinatal conditions, lower 
respiratory tract infections, HIV/AIDS, diarrhoeal diseases, malaria and tuberculosis.
158
 
Africa is the continent with the highest disease burden per person of all world regions. Indeed, 
while only 11.5% of the world’s population live in Africa, almost one quarter (24.7%) of the 
global burden is concentrated there. This high burden is predominantly due to group I 
conditions (communicable diseases, maternal, perinatal and nutritional conditions), which 
comprise all the aforementioned diseases. According to these figures, 44.3% of the global 
burden of group I conditions and even 52.9% of the global burden of infectious and parasitic 
diseases occur in Africa.
168
 
Thus far, most control efforts addressed the three most devastating diseases in developing 
countries, i.e., HIV/AIDS, tuberculosis and malaria, which, together, account for a staggering 
166 million DALYs.
1
 Considerable progress has been made in the control of these “big three” 
diseases, but success has been uneven.
169,170
 Indeed, analysis for Africa indicate that the UN’s 
MDGs will not be achieved in 2015 at the current rates of improvement for most indicators.
171
 
In general, differences in morbidity and mortality among different world regions are still large 
and have even widened over the past years.
172,173
 
Less attention has been paid to the NTDs, which include a number of helminth infections 
(e.g., schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and food-borne 
trematodiasis), vector-borne protozoan infections (e.g., human African trypanosomiasis), and 
certain bacterial infections (e.g., Buruli ulcer and trachoma). Estimates for the global burden 
of all NTDs together are as high as 56.6 million DALYs, which is in the range of each of the 
“big three”.1,174 Effective treatment and prevention strategies are available for several of the 
NTDs for less than US$ 1 per capita per year. New evidence indicates substantial 
geographical overlap between some NTDs and the “big three”, co-morbidity seems common 
and treatment and control of NTDs might also positively affect the progression of the “big 
three”.1,113,125,174,175 Nevertheless, NTDs are often disregarded because their primary impact is 
on the poorest of the poor and their public health, economic and societal impact is still 
underestimated.
1,125,152,174
 
It is important to note, however, that large uncertainties are attached to current burden 
estimates. This prevailing ambiguity is partially explained by the lack of general vital 
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registration and cause-of-death statistics across large parts of the developing world
131,176,177
 
and partially by systematic problems in the DALY construction.
132,152,178
 
 
1.8. Assessing human health on a local scale: why is it important? 
The importance of assessing human health on a local scale can be justified on at least three 
grounds. First, it is important to eliminate the “scandal of invisibility” and make “everyone 
count by counting everyone”.131 The roots of this scandal of invisibility are the absence of 
reliable data for births, deaths and causes of deaths, i.e., vital statistics. Civil registration, as 
the most efficient tool for generating vital statistics, is the only means of establishing and 
protecting identities, citizenship and property rights. Visibility demands accountability, which 
in turn generates the ability to count. Unregistered people remain unseen.
131
 This does not 
only apply to vital events, but also to morbidity due to diseases and injuries. The awareness 
for certain health problems can be raised only if cases are noticed and properly registered. 
Second, precise information of human health on a local scale are the foundation of the 
global summary measures. The more accurate and comprehensive they are, the more precise 
the resulting global estimates. Otherwise, we would have “uncertain inputs multiplied by 
uncertain weights (which) yield estimates that are even more uncertain”.159 Unfortunately, the 
limitations of available data often resulted in the use of expert opinion.
132
 Current research 
demonstrates the feasibility of filling the gap by generating high-precision community-based 
data instead of expert opinion.
163
 Further efforts specifically designed to detect incidence 
rates, disability weights and transition rates, among others, could follow a standardized 
protocol and generate crucial data. Furthermore, existing large-scale demographic and 
epidemiological data, which are collected in the frame of population surveillance projects 
(e.g., the International Network for the Continuous Demographic Evaluation of Populations 
and their Health in Developing Countries (INDEPTH network)) may also help to fill existing 
gaps.
165
 
Third, assessing human health on a local scale is crucial to any intervention such as 
disease control programs. The most appropriate approach for the identification of those in 
need and for monitoring progress made may change over the lifespan of a control program. 
Hence, the development of rapid, inexpensive, simple and culturally adapted diagnostic 
approaches at each stage of a control programs received increasing attention since the late 
1980s.
72
 Particularly for morbidity and prevalence control, simple anamnestic questionnaire 
tools were developed and widely used in programs against urinary schistosomiasis by asking 
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people whether they had “blood in urine” (haematuria) over the past 2-4 weeks.72,179-183 The 
questionnaires have also been adapted for the screening of S. mansoni
72,179,184-188
 and 
S. japonicum.
189,190
 They included questions about signs, symptoms, and/or risk factors and 
were intended for the identification of high-risk communities (for public health) or individuals 
(for clinical practice). Thus far, their application revealed satisfactory diagnostic performance 
in the screening for S. haematobium and S. japonicum, but only moderate accuracy for 
S. mansoni
189,191
 and their adaptation for additional helminthic infections was considered 
challenging.
73,192
 Consequentially, additional efforts are needed to verify the true potential and 
limitations of anamnestic questionnaires. 
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2. Identified research needs 
2.1. Identified research needs 
There is a lack of health-related data, particularly in developing countries,
1-5
 where most of 
the NTDs prevail and mainly affect the poorest of the poor.
6-9
 NTDs predominantly cause 
disability and not death
6,7,10
 and morbidity is more difficult to measure than mortality as there 
are different levels or “intensities” of morbidity (i.e., disability, as tentatively measured in the 
disability weights in the global burden of disease studies) but not of mortality (i.e., death). 
Hence, uncertainties in morbidity assessments tend to be even higher than in mortality 
assessments.
11
 All these facts contribute to the reality that the public health and socio-
economic significance of NTDs are often underestimated. Consequently, there is a lack of 
coordinated research and control efforts directed towards these diseases.
6-9
 
Among the many issues raised, we decided to focus on the assessment of morbidity and 
burden caused by NTDs. In order to raise the profile of the NTDs, and hence to come closer 
to realistic estimates and an appropriate handling of the problem, there is an urgent need for a 
more comprehensive, credible and critical morbidity assessment of this group of diseases at 
all geographical levels. On a global scale, it is important “to explicitly address additional 
diseases not currently included in the global burden of diseases study”.3 Of particular interest 
here, food-borne trematode infections constitute such a widely neglected cluster of diseases. 
In addition, the list of sequelae and disability weights associated to NTDs in burden 
calculations warrant further scientific inquiry by including also population-based evidence 
and addressing the issues of subtle morbidity, age- and sex-specificity, chronic infection and 
co-infection, which are the norm rather than the exception for the NTDs.
3,7,8,10,12-14
 This 
second point would also help to bridge the gap between more theoretical, global 
contemplations and real survey data from the field. 
Finally, as detailed in the introduction, reliable and efficient methods for the identification 
of individuals and communities in need of treatment are key to sustainable and cost-efficient 
disease control programs. Simple anamnestic questionnaires are considered as rapid and 
inexpensive screening techniques in the field in order to guide local morbidity and infection 
control. Hence, new research should verify whether the existing questionnaire tools can be 
further refined and their usefulness extended over the course of control programs, i.e., when 
prevalence rates and infection intensities begin to decline or are already low (Figure 5).
15
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Moreover, the usefulness of combined questionnaire approaches, which aim not only at single 
species but also broader (anthelminthic) treatment groups should be explored. 
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3. Goal and specific objectives 
3.1. Goal 
The goal of this PhD thesis was to develop, validate, and apply tools for assessing the 
morbidity and burden caused by different NTDs at different geographical scales. 
 
3.2. Specific objectives 
The following three specific and interrelated objectives were pursued in order to achieve this 
goal: 
Objective 1: To participate in the global burden of diseases, injuries and risk factors study 
2010 and assess – for the first time ever – the global burden of human food-
borne trematodiasis following study guidelines. 
Objective 2:  To generate new evidence on the disability incurred by individuals infected 
with schistosomes and/or soil-transmitted helminths in field-based 
epidemiological investigations and compare the results with the most recent 
disability weights of the global burden of disease study. 
Objective 3: To explore the potential of simple and low-cost anamnestic questionnaire tools 
for the assessment of morbidity due to schistosomiasis and soil-transmitted 
helminthiasis in the recently established Taabo health demographic 
surveillance site (HDSS) in Côte d’Ivoire in order to identify high-risk groups 
and guide control measures. 
The present PhD thesis included different NTDs and combined theoretical desktop work 
on the global scale (objective 1) with practical field work on the spot (objectives 2 and 3). The 
different geographical scales as well as desktop and field work were seen as complements, 
which fruitfully stimulate each other. The overarching goal, the three specific objectives, the 
different geographical scales, the methods, and the different NTDs considered in this thesis 
are summarized in the theoretical framework depicted in Figure 6. 
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Figure 6. Theoretical framework of the present PhD thesis. The framework highlights the goal, objectives, 
different geographical scales, methods, and neglected tropical diseases considered in the present PhD thesis. 
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4. Study sites 
4.1. Study sites 
The field work of the present study took place in two sites in south and south-central Côte 
d’Ivoire (Figure 7). A first cross-sectional survey was carried out in early 2010 in Grand 
Moutcho, a village just 3 km outside Agboville, which is the capital city of the equally named 
district. Grand Moutcho is located in the valley of the Agnéby River approximately 80 km 
north of Abidjan. The region is at the interface of the tropical rainforest zone in the south and 
the savannah zone in the north. The tropical climate follows a seasonal pattern with a dry 
season between November and April and one to two rainy season between May and October. 
Schistosomiasis and soil-transmitted helminthiasis are endemic in the area.
1-3
 People are 
mainly engaged in subsistence farming. 
Additional cross-sectional surveys were carried out in mid-2010 and mid-2011 in the 
Taabo health demographic surveillance system (HDSS). The Taabo HDSS is the first of its 
kind in Côte d’Ivoire and was established in 2008 by the following partners: the Unité de 
Formation et de Recherche (UFR) Biosciences, Université de Cocody (Abidjan, Côte 
d’Ivoire), the Centre Suisse de Recherches Scientifiques en Côte d’Ivoire (CSRS; Abidjan, 
Côte d’Ivoire), the Health District of Tiassalé, Sous-Préfecture de Taabo (Tiassalé and Taabo 
Cité, Côte d’Ivoire), the Swiss Tropical and Public Health Institute (Swiss TPH; Basel, 
Switzerland) and Fairmed (Bern, Switzerland). The 2-year start-up funding was provided by 
the Swiss non-profit organization Fairmed.
4
 Standard methodologies for demographic 
surveillance were implemented according to the INDEPTH network.
5
 
The Taabo HDSS covers most of the rural Sous-Préfecture de Taabo. Its main station is 
located in Taabo Cité, the only small urban center belonging to the Taabo HDSS, some 160 
km north-west of Abidjan. The area’s vegetation and climate are similar to those of the 
Agboville region. The Bandama River is running through the area and has been dammed up in 
the late 1970s for hydroelectric power generation.
6
 Neglected tropical diseases
6-9
 and 
malaria
10
 are highly endemic in the area and the understanding of transmission dynamics and 
associated morbidity and integrated control measures to reduce the burden of these diseases 
are specific aims of the Taabo HDSS. 
About 38,500 individuals in 6,400 households are under longitudinal demographic and 
health surveillance in the Taabo HDSS. Approximately one fifth of the households reside in 
Taabo Cité, another three fifths in 13 main villages, and the remaining fifth in more or less 
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remote hamlets. People are mainly engaged in subsistence farming of yams, banana and 
manioc, with limited cash crop production of coffee and cacao. Furthermore, there are some 
artisans, some fishermen around Lake Taabo and some shopkeepers and businessmen mainly 
in Taabo Cité (Taabo HDSS, unpublished data). 
 
 
Figure 7. Study sites. The field work of the present thesis took place in Grand Moutcho (early 2010) and the 
Taabo HDSS (mid-2010 and mid-2011), south and south-central Côte d’Ivoire. (Adapted from: 
http://www.lib.utexas.edu/maps/africa/cote_divoire_rel04.jpg). 
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Summary points. 
Food-borne trematodiasis is a cluster of zoonotic infections caused by parasitic trematodes ingested in 
undercooked, mainly aquatic, food 
Prevalence is increasing because of the growth of inland fish production; most cases are in Asia and Latin 
America, but infections in migrants and returning travellers are reported elsewhere, including Europe and North 
America 
Food-borne trematodes are grouped as liver, lung, and intestinal flukes and—depending on the species, the 
duration and intensity of infection, and host susceptibility—inflammatory lesions and damage to tissues and 
organs occur with various clinical manifestations 
The most serious clinical consequences are cancer of the bile duct (in clonorchiasis and opisthorchiasis) and 
ectopic infections (mainly in paragonimiasis, but also in fascioliasis and intestinal fluke infections) 
Direct parasitological diagnosis via the detection of eggs in faeces (all flukes) and sputum (lung flukes only) is 
the most common approach 
Praziquantel and triclabendazole are safe and efficacious treatments but other drugs are being investigated 
 
 
Sources and selection criteria for included information. 
Information for this clinical review was obtained from a database that we established for a project to estimate the 
global burden of food-borne trematodiasis.
2
 The database originated from a systematic review of 11 electronic 
datasources: PubMed, WHOLIS, FAOBIB, Embase, CAB Abstracts, LILACS, ISI Web of Science, BIOSIS 
Preview, Science Direct, African Journals Online, and SIGLE. It included all available literature from 1 January 
1980 to 31 December 2008 and had no language restrictions. Details on the initial search strategy and database 
have been presented elsewhere.
2
 For this review, the database was updated to include all available information 
until 30 September 2011. The data were complemented by personal reference archives and the authors’ 
experience. 
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Food-borne trematodiasis is a cluster of zoonotic infections caused by parasitic worms (class: 
trematoda; also known as flukes), which are transmitted via the ingestion of contaminated, 
mainly aquatic, food. More than one billion people are at risk of infection according to a 
systematic review from 2005.
1
 Another systematic review and meta-analysis suggests that 56 
million people were infected in 2005, mainly in Asia and Latin America, with a global burden 
of 665,000 disability adjusted life years.
2
 
Depending on the fluke species, food-borne trematodiasis is associated with a variety of 
signs, symptoms, and pathological consequences. The non-specificity of the clinical 
manifestations, the wide range of fluke species, and shortcomings in current diagnostic 
techniques are some of the reasons why food-borne trematodiasis is underestimated.
3,4
 
This review introduces the most important food-borne trematode species and describes 
their geographical distribution. It also discusses pathological consequences, clinical 
manifestations, diagnosis, treatment, and control of food-borne trematodiasis. Our review is 
based on the limited evidence obtained from the peer reviewed literature, textbooks, reports, 
and international guidelines. 
 
5.1. What causes food-borne trematodiasis? 
A recent systematic review listed more than 80 different trematode species that have been 
identified from human infections.
2
 According to the target organ in the definitive host, they 
are grouped as liver, lung, or intestinal flukes. However, on the basis of recent biomedical 
reviews and still incomplete national prevalence data, only a dozen species are of public 
health importance (Box 1).
2,5-8
 
 
Box 1. Food-borne trematode species of public health importance. 
Liver flukes: Clonorchis sinensis, Opisthorchis felineus, O. viverrini, Fasciola gigantica, F. hepatica 
Lung flukes: Paragonimus spp. 
Intestinal flukes: Echinostoma spp., Fasciolopsis buski, Gymnophalloides seoi, Haplorchis spp., 
Heterophyes spp., Metagonimus spp. 
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The life cycles of the food-borne trematodes are species specific, with distinct snail species 
being first intermediate hosts, and fish, mollusc, crustacean, amphibian, and insect species 
being second intermediate hosts (Figure 8). Notable exceptions are Fasciola spp. and 
F. buski, which do not need a second intermediate host, as their infectious stages (so called 
metacercariae) adhere directly to aquatic plants.
3
 A detailed list of known first and second 
intermediate hosts can be found in the annex of a comprehensive technical report published 
by the World Health Organization.
9
 
 
 
Figure 8. Representative life cycles of five food-borne trematodes – a liver fluke (Clonorchis sinensis), a 
lung fluke (Paragonimus westermani), and three intestinal flukes (Echinostoma hortense, Fasciolopsis 
buski, and Heterophyes heterophyes). Adapted from Keiser and Utzinger,
3
 with permission from the American 
Society for Microbiology. 
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Humans usually acquire an infection through the ingestion of second intermediate hosts or, 
in the case of Fasciola spp. and F. buski, aquatic plants that contain viable metacercariae. 
With the exception of Fasciola spp. and F. buski, metacercariae are not released from their 
intermediate hosts into water, so the risk of infection from drinking untreated water is 
small.
9,10
 It is unclear which aspects of food processing (such as heating, freezing, smoking, 
acidification, salting, drying, washing, disinfection, irradiation, and pressure treatment) inhibit 
the infectivity of metacercariae, but properly cooked or deeply frozen food is considered 
safe.
9,11
 In the duodenum of an infected human, hermaphroditic juvenile flukes develop from 
the metacercariae, migrate to their target organ, mature, mate, and start producing eggs. 
Parasite eggs are then released via the human host’s faeces (all food-borne trematodes, 
including coughed up and swallowed eggs of Paragonimus spp.) or sputum (only coughed up 
eggs of Paragonimus spp.) and have to reach appropriate water bodies with suitable 
intermediate hosts to complete their life cycles.
3,12
 
 
5.2. Where does food-borne trematodiasis occur? 
Food-borne trematodiasis is commonly classified as a tropical disease, even though the 
endemic area is not limited to the tropics.
9,11
 C. sinensis is endemic in East and South East 
Asia; O. viverrini in South East Asia; and O. felineus in central, northern, and western 
Eurasia. Fasciola spp. exist worldwide, but most endemic areas are in the Andean region, 
North Africa, and the Caspian Sea region. Paragonimus spp. occur in parts of the Andean 
region, West and Central Africa, East and South East Asia, and North America. Intestinal 
flukes are found worldwide, with most endemic areas in East and South East Asia. A 
comprehensive literature review identified allochthonous cases (diagnosed in countries where 
disease transmission does not naturally occur) all over the world, probably as a result of 
increasing international travel, human migration, and the food trade.
13
 A series of recent 
reviews suggests that human food-borne trematodiasis is increasing, mainly because of the 
exponential growth of inland fish production (aquaculture).
1,2,9,11,w1,w2
 
At a regional level, food-borne trematodiasis usually shows a focal distribution, which is 
governed by social-ecological contexts (such as specific eating habits and environmental 
conditions that favour maintaining the parasites’ life cycles).3,11 At the individual level, a 
meta-analysis of the proportion of infected humans shedding high numbers of eggs indicates 
that distribution is highly aggregated: a few people harbour most of the parasites.
2
 Hospital 
based and community based cross sectional surveys in endemic areas show that infection with 
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multiple species of food-borne trematodes is common because they are all acquired through 
consumption of raw food.
14,w3,w4
 
 
5.3. What are the pathological consequences and clinical manifestations? 
Morbidity depends on the species involved and also the host’s susceptibility, duration of 
infection, and the number of worms harboured (infection intensity). These parameters govern 
the occurrence and severity of inflammatory lesions and damage to tissues and target organs. 
The severity of infection is usually determined by the number of parasite eggs per gram of 
faeces or per 5 mL of sputum in paragonimiasis.
3-9,11,15-17,w5-w19
 Because the egg laying 
capacity of food-borne trematodes varies greatly – from fewer than 100 eggs per day per 
worm (Haplorchis taichui)
18
 to 13,000-26,000 (F. buski)
19
 – species specific thresholds are 
used to differentiate between light, moderate, and heavy infections. However, these thresholds 
have never been standardised. Furthermore, some studies challenge a direct association 
between egg counts and worm burden because crowding effects may lower egg production, 
obstructions in the hosts’ organs may affect the excretion of eggs, and the distribution of eggs 
in faeces can be uneven.
15,16,20,w20-w24
 
 
5.3.1. Clonorchiasis and opisthorchiasis 
The pathological consequences and clinical manifestations of infection with C. sinensis and 
Opisthorchis spp. are similar. After ingestion by the host, the metacercariae excyst in gastric 
juice and migrate via the duodenum, the ampulla of Vater, and the extrahepatic biliary system 
to the intrahepatic bile ducts.
11
 Pathological changes are mainly confined to the bile duct, 
liver, and gallbladder.
7
 Tissue damage is caused directly by the parasite via mechanical and 
chemical irritation and indirectly via the immune response, and it can lead to cancer of the 
bile duct (cholangiocarcinoma; Box 2).
11,21
 Hepatomegaly, gallbladder enlargement, 
gallstones, sludge, and periductal fibrosis along the intrahepatic biliary tree and periportal 
vein are often seen with ultrasonography (Figure 9 and Figure 10).
4
 
Acute and light infections are mostly asymptomatic,
3,9,11,21
 but an acute onset with 
hepatitis-like symptoms, including high fever and chills, has been reported, particularly for 
infection with O. felineus.
3,7,11,w25
 Some moderately infected people may have mild 
symptoms,
3,21,w8
 but even chronic infections may remain asymptomatic, and often only 
heavily infected people have symptoms, signs, and complications (Table 7).
3,7,9,11,21
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Box 2. Liver fluke induced cholangiocarcinoma. 
Pathological consequences and clinical manifestations: Cholangiocarcinoma is a malignant tumour of the bile 
duct epithelium. Although the exact mechanism of liver fluke induced carcinogenesis is unclear, chronic biliary 
infection increases the susceptibility of the bile ducts to the action of carcinogens. Patients usually present with 
non-specific symptoms, which are similar to those of liver fluke infections. Liver fluke induced 
cholangiocarcinoma cannot be differentiated from other forms of cholangiocarcinoma. Timely diagnosis is rare 
and prognosis is poor, even when patients receive appropriate treatment. 
Diagnosis: The diagnosis, localisation, and staging of cholangiocarcinoma are challenging and require a 
combination of imaging, biochemical investigations, and cytological techniques (ultrasonography, 
cholangiography, choledochoscopy, computed tomography, positron emission tomography, magnetic resonance 
imaging, biopsy and cytological analysis, and laboratory analysis of serum tumour markers). 
Management: Consultation with an infectious disease specialist, hepatologist, and oncologist is recommended. 
Response to chemotherapy is poor. Complete resection with negative histological margins or transplantation are 
the only curative interventions. Currently, no effective adjuvant treatment exists, but radiotherapy may be 
indicated postoperatively. Often, only palliative treatment remains. 
 
 
 
Figure 9. Ultrasonographic image showing highly echogenic pipestem fibrosis around the periportal veins, 
with echoes seen in two or three segments of the liver, in a man with opisthorchiasis. 
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Figure 10. Ultrasonographic image showing echogenic posterior acoustic shadowing or biliary duct stone 
formation without bile duct dilation in a woman with opisthorchiasis. 
 
 
Table 7. Clinical features of main food-borne trematodiasis. 
Parasitosis   Tropism   Start   Symptoms and 
signs 
  Complications 
Clonorchiasis 
and 
opisthorchiasis 
  Hepatobiliary 
tract 
  Insidious for 
several years: non-
specific abdominal 
pain 
  Biliary colic, 
jaundice, 
cholestasis, 
cholelithiasis, 
recurrent 
pyogenic 
cholangitis, 
cholecystitis, 
hepatic abscess, 
rarely hepatitis 
  Pancreatitis, 
cirrhosis, portal 
hypertension, 
cholangiocarcinoma 
Fascioliasis     Abrupt start: 1-4 
weeks after 
infection high 
fever, weakness, 
weight loss, 
urticaria, right 
hypochondrial pain 
    Pancreatitis, 
cirrhosis, portal 
hypertension, rarely 
ectopic infection 
Paragonimiasis   Pulmonary 
tract 
  Insidious: anorexia, 
moderate weight 
loss, rarely fever 
  Chronic cough, 
chest pain, 
dyspnoea, 
haemoptysis, 
rusty sputum 
  Bronchiectasis, 
pulmonary 
consolidation, cyst 
formation, pleural 
effusion, ectopic 
infection 
Intestinal fluke 
infections 
  Intestinal 
tract 
  Insidious: 
unspecific 
gastrointestinal 
problems 
  Ulceration of 
intestinal 
mucosa, 
malabsorption 
  Malnutrition, 
anaemia, oedema or 
anasarca, rarely 
ectopic infection 
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5.3.2. Fascioliasis 
Unlike other liver flukes, after ingestion and excystment in the duodenum Fasciola spp. 
migrate through the intestinal wall into the body cavity and then through the liver into the bile 
ducts.
11,15
 Major pathological changes are associated with migration and the related 
destruction, focal bleeding, and inflammation in the host’s body (acute phase). Some 
migrating flukes may die on their way, leaving cavities filled with necrotic debris, or deviate 
from their usual route to cause ectopic infections (Box 3). In the bile ducts (latent phase), the 
parasites may cause inflammation, resulting in thickening and expansion of the ducts and 
fibrosis. Imaging may depict these lesions as “tunnels and caves” in peripheral parts of the 
liver.
4
 
Early acute manifestations are typical (Table 7).
8,11,15
 Although some infected people are 
asymptomatic in the latent phase, others may experience repeated relapses of the acute 
manifestations.
8,11,15
 When the irritation in the biliary system is severe enough, a permanent 
obstructive phase, which has additional symptoms, signs, and complications (Table 7), may 
develop.
3,4,8,9,11,15
 Rarely, fascioliasis can be fatal.
15,w26
 
 
Box 3: Ectopic food-borne trematode infections. 
Pathological consequences and clinical manifestations: Paragonimus spp., and less often Fasciola spp. and 
intestinal flukes of the families heterophyidae and microphallidae, can cause ectopic infections. The reasons for 
incomplete migration are unclear. Migratory tracks and cavities filled with trapped dead parasites or eggs often 
cause tissue damage with inflammatory reactions and fibrosis. Clinical manifestations depend on the exact 
location, and such infections can even cause death. Paragonimus spp. have been reported in the central nervous 
system, eyes, skin, heart, abdominal organs, and reproductive organs; Fasciola spp. in the central nervous 
system, orbit, subcutaneous tissue, abdominal wall, heart, genitals, spleen, muscles, gastrointestinal tract, blood 
vessels, lungs, and pleural cavity; and heterophyidae and microphallidae in the central nervous system and heart. 
Diagnosis: Suspect ectopic food-borne trematodiasis in a patient with a diagnosis of food-borne trematode 
infection and unexplained, often severe, manifestations (such as neurological disorders, abscesses) that could 
result from damage in ectopic locations mentioned above. To confirm the diagnosis, a combination of 
ultrasonography, radiography, endoscopy, computed tomography, positron emission tomography, magnetic 
resonance imaging, and biopsy is needed. 
Management: Consultation with infectious disease specialists and other relevant specialists is recommended. 
Treatment with praziquantel or triclabendazole may help in the early phases of infection but should be used with 
care. Parasite death may lead to antigen release and increased risk of inflammation. Anti-inflammatory drugs 
(such as corticosteroids) may help to reduce oedema and inflammation during treatment. Parasites, eggs, and 
lesions may need to be surgically removed. Adjuvant therapy should be used as appropriate. 
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 5.3.3. Paragonimiasis 
In the classic natural course of pleuropulmonary paragonimiasis, swallowed metacercariae 
of Paragonimus spp. excyst in the duodenum, penetrate the intestinal wall, and migrate over 
several days to the pleural cavity and into the lungs where they mature. After several weeks, 
adults become encapsulated in fibrotic tissue, where they mate or reproduce 
parthenogenetically. Eggs pass via the bronchioles into the sputum or, if swallowed, the 
faeces, and then into the environment. Some of the eggs may be trapped in tissue and, 
together with aberrantly migrating flukes, provoke further irritation and ectopic infections 
(Box 3).
6,9,11,22
 A recent cross sectional study from India found cavity and cyst formations, 
nodular lesions, fibrotic infiltrates, calcifications, bronchiectasis, pulmonary consolidations, 
pleural thickening and effusion, mediastinal lymphadenopathy, and patchy ground glass 
opacity as pleuropulmonary radiological features in paragonimiasis (Figure 11).
23
 
Unless the patient is heavily infected, early stages of pleuropulmonary infection tend to be 
asymptomatic. Heavy pleuropulmonary infections may present with many different 
bronchitis-like, asthma-like, and tuberculosis-like symptoms and signs (Table 7). The 
similarity of the clinical manifestations often result in pleuropulmonary paragonimiasis being 
misdiagnosed as bronchitis, asthma, or (non-responsive) tuberculosis,
3,6,9,11,22
 even though 
patients with paragonimiasis usually present in comparatively better general health. 
 
5.3.4. Intestinal fluke infection 
More than 70 species of intestinal flukes are implicated in human infection.
2,5
 The 
morphology of these flukes is diverse, and their life cycles and geographical distributions not 
well studied. After ingestion of viable metacercariae, flukes excyst and adhere to the intestinal 
wall, where mechanical irritation and inflammation may lead to the manifestations described 
in Table 7.
3,5,9,11
 Similar to other food-borne trematode infections, mild intestinal fluke 
infections are mainly asymptomatic, but heavy infections can be severe.
3,5,9,11,w27 
 
Chapter 5 – Clinical review of human food-borne trematodiasis 
65 
 
Figure 11. Chest radiograph of a 14 year old boy with paragonimiasis and a bilateral pleural effusion. He 
had chronic cough, chest pain (>12 months), and haemoptysis. Aspiration showed a thick chylous-like fluid 
containing 16% eosinophils and 20 typical trematode operculated eggs per mL. Paragonimus eggs were found in 
sputum and stool samples. He admitted that he often ate raw river crabs.
w52
 Courtesy of the Institut de la 
Francophonie pour la Médecine Tropicale (IFMT), Lao People’s Democratic Republic. 
 
5.4. What are other complications of food-borne trematodiasis? 
Recent reviews have summarised the association between infection with C. sinensis and 
O. viverrini and cholangiocarcinoma, as well as the mechanisms of carcinogenesis, diagnosis, 
and management (Box 2).
21,24,25,w8,w27-w33
 On the basis of the epidemiological, experimental, 
and pathological evidence, these two trematodes have been classified as definite carcinogens 
(group 1) by the International Agency for Research on Cancer (IARC).
26,27
 There is still 
insufficient evidence of the oncogenic potential of O. felineus and Fasciola spp. for them to 
be classified.
26,27,w28,w34
 
Ectopic infections are severe and potentially fatal complications of food-borne 
trematodiasis (Box 3). As highlighted in other reviews, Paragonimus spp.,
6,9,11,22,w5,w11,w35-w39
 
and more rarely Fasciola spp. and intestinal flukes of the heterophyidae and microphallidae 
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families,
9,11,15,w26,w27
 do not always enter their usual target organs in the host’s body, but 
continue to migrate to ectopic locations. 
 
5.5. How can food-borne trematodiasis be diagnosed? 
Accurate diagnosis of food-borne trematodiasis remains a challenge. The three main 
diagnostic approaches are direct parasitological diagnosis, immunodiagnosis, and molecular 
diagnosis. Direct parasitological diagnosis is facilitated by the detection of eggs in faeces (all 
flukes), sputum (only lung flukes), and, more rarely, other biofluids such as bile or duodenal 
content. Egg detection in faecal samples is the most common approach, and methods include 
Kato-Katz thick smear, formalin-ethyl-acetate technique, Stoll’s dilution egg count method, 
and sedimentation techniques. However, differential diagnosis is difficult because parasite 
eggs from different species resemble each other.
3-8,11
 Furthermore, the small number of eggs 
discharged by some fluke species, crowding effects, obstructions in the patients’ organs, 
heterogeneous distribution of eggs in the patients’ faeces (or sputum in Paragonimus spp.), 
and light infections are additional challenges for an accurate diagnosis and require multiple 
sampling and testing. Occasionally, it is possible to demonstrate adult parasites—for example, 
when the flukes are excreted in the faeces, coughed up (lung flukes), or removed during 
surgery.
5,7-9,11
 The website of the US Centers for Disease Control and Prevention features 
photographs of parasite eggs, which might help in the diagnosis of food-borne trematode 
infections. 
Immunodiagnostic methods such as intradermal tests, indirect haemagglutination assays, 
indirect fluorescent antibody tests, and indirect enzyme linked immunosorbent assays 
(ELISAs) aim to detect specific antibodies.
3,6-8,11
 Immunodiagnosis is especially useful during 
the prepatent phase and ectopic infections, or if direct parasitological diagnosis is ambiguous. 
However, false positive results after the infection has resolved, cross reactivity, high costs, 
and lack of availability at the point of care in remote rural areas are important problems that 
need to be tackled.
3,6,7
 
Molecular diagnosis—the detection of trematode DNA in samples using the polymerase 
chain reaction—has a high sensitivity and specificity.3,6-8,11 However, for the foreseeable 
future, molecular diagnosis is unlikely to be used at the point of care in endemic areas.
3,6
 
Radiological methods such as ultrasound, computer tomography, and magnetic resonance 
imaging are complementary tools for an accurate diagnosis. Although these techniques might 
be available in well equipped laboratories in the developed world and undoubtedly help 
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characterise pathological changes caused by food-borne trematodiasis, they are currently out 
of reach in resource constrained areas.
3,6-9,11
 
 
5.6. How can food-borne trematodiasis be treated? 
Praziquantel and triclabendazole are the two drugs of choice; however, triclabendazole is 
currently registered for human use in only four countries. Various treatment regimens are 
suggested for the treatment of food-borne trematodiasis.
3,5-8,11,28,w40
 For clonorchiasis and 
opisthorchiasis, the recommended treatment schedule is praziquantel 25 mg/kg three times a 
day for two consecutive days.
3,7,11,28
 The same treatment regimen has been successfully used 
in paragonimiasis.
3,6,11,28
 The first choice treatment against intestinal fluke infections is also 
praziquantel, and a single dose of 10-20 mg/kg is efficacious against all intestinal fluke 
species,
29
 but higher dosages of three times 25 mg/kg in one day have also been 
proposed.
3,5,8,11,28
 The drug of choice against fascioliasis is a single (10 mg/kg) or double dose 
(two times 10 mg/kg) of triclabendazole.
 3,8,11,28
 Triclabendazole (single dose of 10 mg/kg, or 
two doses of 10 mg/kg each within 12-24 hours) is also efficacious against paragonimiasis.
3
 
In general, all treatments are safe with no serious adverse events. Table 8 summarises the 
dosages of praziquantel, triclabendazole, and alternative drugs, including reported adverse 
events and contraindications. Figure 12 shows a diagnostic and treatment algorithm. 
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5.7. Towards control and elimination: challenges and opportunities 
New diagnostic techniques that have a high sensitivity and specificity and are simple and 
inexpensive are key to understanding the extent of the problem.
2
 Improved point of care 
diagnostics could conceivably improve the management of cases and avoid severe sequelae. 
The development of new drugs is a low priority for drug companies.
28
 The treatment of 
food-borne trematodiasis currently relies on two drugs, and two small drug intervention 
studies reported unexpectedly low cure rates against clonorchiasis and fascioliasis.
30,31
 A 
recent review recommended pursuing promising drug candidates (such as tribendimidine, the 
artemisinins, and synthetic trioxolanes) and combination treatments.
32
 The development of 
vaccines for animals against infections with Fasciola spp. is at an advanced stage. 
Vaccination of animals and humans may become an important means of interrupting 
transmission.
33,w43
 
Drugs are currently the main method of controlling the morbidity associated with food-
borne trematodiasis, but integrated programmes are vital for sustainable disease control and 
eventual elimination.
11,15,19,w22,w27,w44,w45
 Several follow-up studies highlighted the complexity 
of the epidemiological settings and showed high reinfection rates after drug based 
interventions.
w21,w46-w51
 Hence, integrated control strategies should also include improved 
sanitation, food inspections, information, education, and communication campaigns (also for 
travellers) and, as far as feasible, control of intermediate, reservoir, and non-human definitive 
hosts. These additional interventions aim to change human behaviour and interrupt disease 
transmission.
3,6-9,11,21,w2,w30
 However, considering deeply rooted eating habits in humans and 
the myriad non-human hosts these aims pose formidable challenges. Only a few endemic 
countries have embarked on national control programmes against food-borne trematodiasis. 
Integration with control programmes targeting other infectious diseases as well as 
collaborations beyond the health sector (such as with the agricultural, environmental, and 
educational sectors) may offer largely untapped opportunities for prevention and control.
9,34,w2
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A patient’s perspective: opisthorchiasis in Lao People’s Democratic Republic. 
I am a 46 year old teacher and often go fishing in the Mekong River with friends. We eat the caught fish 
uncooked. 
For more than a year I felt unwell—tired and without energy. I had many gastritis-like symptoms, such as 
abdominal pain, bowel rumbling, nausea, and bloating. I also had itchy rashes on my arms, stomach, and legs. I 
lost about 5 kg in weight but always felt hungry. After meals, particularly dinner, I often had stomach cramps 
and sometimes vomiting. 
After repeated visits to different health services, I went to the hospital and had an abdominal ultrasound scan, in 
addition to blood and stool tests. The ultrasound results were normal and my blood was negative for hepatitis. 
However, liver fluke eggs were detected in my stool. I learnt that this parasite is acquired by consumption of raw 
fish and that after treatment I could be reinfected if I continue to eat undercooked fish. I received medicine called 
praziquantel. The rash on my arms, legs, and abdomen disappeared two weeks after treatment and I generally felt 
better. One month later my stool was free of parasite eggs. However, the abdominal discomfort disappeared only 
slowly. Three months after treatment, I occasionally have bowel rumbling, nausea, and abdominal bloating. My 
doctor assures me that the cure takes time and that it is most important not to eat raw fish. 
 
 
Additional educational resources for patients and healthcare professionals. 
US Centers for Disease Control and Prevention website – one of the few fully functional, up to date, open access 
sources of information. It contains a wealth of data on the most important food-borne trematode infections and is 
suitable for healthcare professionals and patients. 
www.cdc.gov/parasites/clonorchis 
www.dpd.cdc.gov/dpdx/html/clonorchiasis.htm 
www.cdc.gov/parasites/opisthorchis 
www.dpd.cdc.gov/dpdx/html/opisthorchiasis.htm 
www.cdc.gov/parasites/fasciola 
www.dpd.cdc.gov/dpdx/html/fascioliasis.htm 
www.cdc.gov/parasites/paragonimus 
www.dpd.cdc.gov/dpdx/html/paragonimiasis.htm 
www.cdc.gov/parasites/fasciolopsis 
www.dpd.cdc.gov/dpdx/html/fasciolopsiasis.htm 
www.dpd.cdc.gov/dpdx/html/echinostomiasis.htm 
www.dpd.cdc.gov/dpdx/html/heterophyiasis.htm 
www.dpd.cdc.gov/dpdx/html/metagonimiasis.htm 
 
Chapter 5 – Clinical review of human food-borne trematodiasis 
73 
Areas for future research. 
More precise data on the extent of the human and veterinary disease burden of food-borne trematode infections 
(geographical distribution, prevalence, infection intensity, coinfection, subtle morbidity, and societal impact) are 
needed to increase awareness (in patients and clinicians) and raise political commitment to foster control and 
elimination efforts 
Additional studies should verify the taxonomy of food-borne trematodes and associated intermediate, reservoir, 
and definitive hosts 
New diagnostic methods with a high sensitivity and specificity that are inexpensive and can be used at point of 
contact are needed 
New trematocidal drugs and alternative treatment regimens (for example, multiple dosing, combination 
treatment) that are safe and efficacious need to be developed 
Molecular research on the antigenic structure and immunology of food-borne trematodes and research into the 
immune mechanisms of infected humans and animals may be useful for vaccine development 
A better knowledge of liver fluke induced carcinogenesis may improve the diagnosis, treatment, and prevention 
of cholangiocarcinoma and provide fundamental insights into carcinogenesis in general 
Mechanisms of ectopic food-borne trematode infections should be further explored to improve diagnosis, 
treatment, and prevention of severe complications 
Improved knowledge on physical and chemical parameters to inhibit infectivity of metacercariae could help to 
advance safe food processing methods and guidelines 
The cost effectiveness of integrated control programmes for food-borne trematodes—which include different 
stakeholders, a variety of interventions (such as chemotherapy, improved sanitation, food inspections, 
information, education and communication campaigns, and control of non-human parasite life cycles), and that 
take advantage of synergy between different sectors (public health, livestock production, food industry, water 
and sanitation, socio-economic development, education)—should be determined 
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6.1. Summary 
Background: Food-borne trematodiases are a group of neglected tropical diseases caused by 
liver, lung, and intestinal parasitic fluke infections. As part of the Global Burden of Diseases, 
Injuries, and Risk Factors Study (GBD 2010 study) and a WHO initiative, we assessed the 
global burden of human food-borne trematodiasis, as expressed in disability-adjusted life 
years (DALYs) for the year 2005. 
Methods: We systematically searched electronic databases for reports about human food-
borne trematodiasis without language restriction, between Jan 1, 1980, and Dec 31, 2008. We 
used a broad search strategy with a combination of search terms and parasite and disease 
names. The initial search results were then screened on the basis of title, abstract, and, finally, 
full text. Relevant quantitative and qualitative data on human prevalence, morbidity, and 
mortality of food-borne trematodiasis were extracted. On the basis of available information on 
pathological and clinical appearance, we developed simplified disease models and did meta-
analyses on the proportions and odds ratios of specified sequelae and estimated the global 
burden of human food-borne trematodiasis. 
Findings: We screened 33,921 articles and identified 181 eligible studies containing 
quantitative information for inclusion in the meta-analyses. About 56.2 million people were 
infected with food-borne trematodes in 2005, 7.9 million had severe sequelae, and 7,158 died, 
most from cholangiocarcinoma and cerebral infection. Taken together, we estimate that the 
global burden of food-borne trematodiasis was 665,352 DALYs (lower estimate 479,496 
DALYs; upper estimate 859,051 DALYs). Furthermore, knowledge gaps in crucial 
epidemiological disease parameters and methodological features for estimating the global 
burden of parasitic diseases that are characterised by highly focal spatial occurrence and 
scarce and patchy information were highlighted. 
Interpretation: Despite making conservative estimates, we found that food-borne 
trematodiases are an important cluster of neglected diseases. 
Keywords: Global burden of diseases, food-borne trematodiasis, disability-adjusted life years 
(DALYs), review, meta-analysis. 
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6.2. Introduction 
Our analysis of the global burden of human food-borne trematodiasis is part of the Global 
Burden of Diseases, Injuries, and Risk Factors Study (the GBD 2010 study)
1 
and an initiative 
by WHO to estimate the global burden of food-borne diseases, facilitated by WHO’s Food-
borne Disease Burden Epidemiology Reference Group (FERG).
2
 Food-borne trematodiases 
are a cluster of infections with trematodes transmitted by consumption of undercooked, 
mainly aquatic, products. Species-specific life cycles have been presented elsewhere.
3
 
Although the first documented cases of human food-borne trematodiasis date back several 
thousand years,
3,4
 uncertainty remains about taxonomy, with new species being identified and 
described.
5,6
 Over 80 different species of food-borne trematode have been reported from 
human infections (Appendix 13.2.1.).
5-8
 
Food-borne trematodes are classified as liver, intestinal, or lung flukes, on the basis of 
their typical location in the host. From a public health point of view, the most important 
species are Clonorchis sinensis, Opisthorchis felineus, Opisthorchis viverrini, Fasciola 
gigantica, and Fasciola hepatica among the liver flukes, Echinostoma spp., Fasciolopsis 
buski, Heterophyes spp., and Metagonimus spp. among the intestinal flukes, and Paragonimus 
spp. among the lung flukes.
5-8
 Other species rarely infect human beings, and are less relevant 
to public health. 
Direct parasitological techniques via detection of eggs in the hosts’ faeces, sputum, and 
more rarely other biofluids (e.g., bile or duodenal content) are widely used for diagnosis. 
However, accurate detection and species-specific distinction of eggs is a challenge.
3,5-10
 
Immunodiagnostic techniques and molecular methods are comparatively resource and skill 
intensive alternatives and therefore unlikely to become methods for routine diagnosis in 
endemic settings in the foreseeable future.
3,6-8,10
 
Chemotherapy is the mainstay for treatment and morbidity control of food-borne 
trematodiasis; drugs of choice are praziquantel (against clonorchiasis, opisthorchiasis, 
intestinal fluke infections, and paragonimiasis)
3,5-8,10,11
 and triclabendazole (against 
fascioliasis).
3,7,10,11
 Integrated control strategies, including preventive and curative measures 
such as improved access to adequate sanitation, information, communication, and education 
campaigns, food inspections, and, as much as possible, control of intermediate and final-
reservoir hosts are essential.
3,6,7,9,10,12,13
 Unfortunately, awareness of food-borne trematodiasis 
as a public health problem is limited, and hence only a few endemic countries (e.g., Japan and 
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South Korea) have successfully initiated or maintain fully fledged national control 
programmes.
9,13,14
 
Because of the diversity of causative pathogens, diagnostic challenges, and idiosyncrasies 
in the natural histories of diseases, food-borne trematode infections are among the most 
neglected of the so-called neglected tropical diseases.
3,15,16
 As with most other neglected 
tropical diseases, these trematode infections are intimately connected with and exacerbate 
conditions of poverty.
3,15,17
 However, because consequences are not overt and morbidity often 
subtle, the social, economic, and public health effects of food-borne trematodiasis are 
underestimated, which might also explain previous lack of estimates of global burden.
3,15-18
 
Our study had two aims: first, to estimate the global burden of human food-borne 
trematodiasis in terms of disability-adjusted life years (DALYs) by following the guidelines 
and concepts of the GBD 2010 study;
1
 and second, to identify knowledge gaps in the 
respective epidemiological disease parameters. Furthermore, our method is presented and 
discussed in detail, because it could be useful for estimating the global burden of other 
parasitic diseases that are characterised by highly focal spatial occurrence and scarce, 
scattered, and patchy information. 
 
6.3. Methods 
6.3.1. Search strategy and selection criteria 
We did a broad-based computer-aided systematic review to identify all relevant information 
about the global burden of food-borne trematodiasis. We searched PubMed, WHOLIS, 
FAOBIB, Embase, CAB Abstracts, Literatura Latino Americana e do Caribe em Ciências de 
Saùde (LILACS), ISI Web of Science, BIOSIS preview, Science Direct, African Journals 
OnLine (AJOL), and the System for Information on Grey Literature in Europe (SIGLE). A 
broad-based search strategy was used, applying, whenever available, the respective 
thesauruses of the databases, and a corresponding combination of search terms including 
specific parasite and disease names. No language restrictions were set. On the basis of GBD 
2010 study guidelines,
1
 all references published between Jan 1, 1980 and Dec 31, 2008 were 
reviewed. Further details on the databases and search terms that were checked, initial 
inclusion and exclusion terms, and, wherever applicable, the respective thesauruses, Boolean 
operators, and wildcards used are summarised in Appendix 13.2.1. and Appendix 13.2.2. The 
bibliographies of all finally included documents were hand-searched for additional references. 
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Further more, we did a targeted search for data that were classed as still missing on the basis 
of information obtained. Articles reporting on time-independent biomedical facts before 1980 
and after 2008 were also included in a final step. The search of published works and data 
abstraction was done by TF. In case of ambiguity the other authors were consulted. 
 
6.3.2. Simplified disease models 
For the quantitative analyses, we divided food-borne trematodiasis into five disease categories: 
(1) clonorchiasis, (2) opisthorchiasis, (3) fascioliasis, (4) intestinal fluke infections, and (5) 
paragonimiasis. On the basis of identified qualitative information about pathological and 
clinical symptoms, and the availability of quantitative data, three different simplified disease 
models were constructed. These models permitted the quantification of global burden of all 
five food-borne trematodiasis categories, as expressed in DALYs (Figure 13, Box 4). In 
subsequent burden calculations, we gave highest priority to population-based quantitative data 
to avoid strong selection bias. 
 
 
Figure 13. Simplified disease models used to estimate the global burden of food-borne trematodiasis. 
1 = prevalence rate. 2 = proportion of light infections among all infections. 3 = proportion of heavy infections 
among all infections. 4 = remission rate. 5 = mortality rate due to liver-fluke-induced cholangiocarcinoma. 
6 = proportion of cerebral infections among all Paragonimus spp. infections. 7 = mortality due to cerebral 
paragonimiasis. 
 
Because of the focal occurrence of food-borne trematodiasis and resulting high variation 
in prevalences on a small spatial scale,
9,13
 we only further assessed the most recent national 
prevalence estimates identified in the systematic review with priority given to estimates based 
on molecular diagnosis, then those based on direct parasitological diagnosis, 
immunodiagnosis, and, finally, expert opinion. Identified national prevalence rates were 
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multiplied by the official GBD 2010 study population estimates to project the total national 
numbers of infected people in 2005 (Figure 13). 
 
Box 4. Pathological and clinical appearances of food-borne trematodiasis in humans. 
Background: Human food-borne trematodiasis is species-specific and governed by the number of worms in the 
body (i.e., infection intensity), the duration of infection, and host susceptibility.
3,6-10
 Pathological changes 
include inflammatory lesions, tissue damage, and damage of the target organs caused either directly through 
mechanical and chemical irritation by the parasites or indirectly through the hosts’ immune response.10 
Clonorchis sinensis and Opisthorchis viverrini: C. sinensis and O. viverrini can induce cholelithiasis, 
cholestasis, cholangitis, cholecystitis, biliary and liver abscess and cirrhosis, pancreatitis, hepatitis, and, as a 
most severe consequence, the bile-duct cancer cholangiocarcinoma (Figure 13).
3,8-10,19
 Clinical manifestations 
range from asymptomatic, mostly light infections, to mild symptoms such as fever, fatigue, anorexia, and 
gastrointestinal complaints in moderate infections, to severe diarrhoea, sometimes in alternation with 
constipation, nausea, colicky pain, dyspepsia, malnutrition, and anaemia in heavy infections.
3,8-10,19
 Even though 
the exact mechanism of cholangiocarcinogenesis is not yet fully understood, irritation caused by the parasites 
plays a crucial part.
12,19-21
 The International Agency for Research on Cancer has classified O. viverrini as a 
definite carcinogen since 1994 and C. sinensis since 2009.
22,23
 Cholangiocarcinoma is the most common cause of 
death attributable to food-borne trematodiasis. Timely diagnosis of this cancer is rare, because symptoms are 
mostly non-specific.
12,24
 Hence, patients who finally seek care usually present with advanced, inoperable disease 
with very poor prognoses on diagnosis. Resection or transplantation are the only curative intervention, but often 
only palliative treatment remains and most patients die within a year after diagnosis.
12,24
 
Opisthorchis felineus, Fasciola spp., and intestinal flukes: Patients with the liver flukes O. felineus and 
Fasciola spp. can present with the same pathological changes and clinical manifestations as C. sinensis and 
O. viverrini (Figure 13).3,7-10 However, evidence for the carcinogenic potential of O. felineus and Fasciola spp. is 
not available.
22,23,25
 Intestinal flukes can also cause intestinal obstruction and ulceration.
5,10
 Rarely, the liver 
flukes Fasciola spp. and some of the intestinal flukes can substantially deviate from their usual migratory route 
in human hosts. These flukes have occurred in ectopic locations such as the skin, eyes, abdominal organs, heart, 
or CNS.
5,7,9,10,26,27
 In very rare cases, infections with Fasciola spp., Fasciolopsis buski, heterophyidae, or 
microphallidae can be fatal,
5,9,10,26,28,29
 but information on ectopic or fatal infections is very scarce. 
Paragonimus spp.: Patients with lung-fluke infection can present with haemorrhagic pneumonia, pneumothorax, 
pleuropulmonary cysts, abscesses, and calcifications (Figure 13).
6,9,10,30
 Heavy pleuropulmonary paragonimiasis 
is often characterised by tuberculosis-like, bronchitis-like, and asthma-like symptoms, such as chronic cough 
with bloody sputum, chest pain, and dyspnoea.
3,6,9,10
 Among the food-borne trematodes, Paragonimus spp. is 
most commonly associated with ectopic infections. The most common extrapulmonary location of 
Paragonimus spp. is the brain,6,30 and in rare cases the skin, eyes, abdominal organs, genitalia, or other parts of 
the CNS.
3,6,9,10
 Patients with cerebral infection can present with headache, mental confusion, behavioural change, 
meningismus, convulsions, hemiplegia, visual impairment, and cerebral haemorrhage. Cerebral infection is the 
most common cause of death due to paragonimiasis
3,6,9,10,30
 with most deaths occurring at the beginning of 
cerebral involvement.
6,31
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To distinguish male and female cases, all sex-specific population-based data from cross-
sectional surveys were aggregated and prevalence sex ratios for the five food-borne 
trematodiasis categories were established. Similarly, these data from cross-sectional surveys 
were used to create sex-specific age prevalence profiles for each food-borne trematodiasis 
category, except fascioliasis. Because of insufficient sex-specific and age-specific data on 
fascioliasis, the respective age prevalence profile was not further differentiated between males 
and females. To harmonise the reported age categories from the identified studies with those 
of the GBD 2010 study,
1
 we assumed an equal distribution of the number of people examined 
and infected over the different ages included in each reported age category. To differentiate 
between asymptomatic and symptomatic cases, we had to rely on infection intensities (Figure 
13). The number of parasite eggs per g of faeces or, for paragonimiasis, the number of 
parasite eggs per 5 mL of sputum are the most commonly used proxies for infection 
intensity.
3,6-10,19,26,32-41
 On the basis of available information, disease-specific thresholds for 
heavy infections were set at 10,000 eggs per g of faeces for clonorchiasis and opisthorchiasis, 
1,000 eggs per g of faeces for fascioliasis and intestinal fluke infections, and 100 eggs per 
5 mL of sputum for paragonimiasis. All age-independent and sex-independent population-
based cross-sectional survey data on the proportion of heavily infected individuals among all 
infected individuals were used to model the proportion of light, asymptomatic infections and 
heavy, symptomatic infections. Furthermore, all age-independent and sex-independent 
population-based data on the proportion of cerebral involvement in all patients with 
Paragonimus spp. infection were assessed for the extrapolation of the number of cerebral 
paragonimiasis cases. Data on remission from the different stages of food-borne trematodiasis 
are scant and as initial model input, we assumed zero remission. 
Because of few quantitative data, mortality rate estimates relied partly on hospital-based 
case-control studies and case series and were modelled irrespective of infection intensity. 
Mortality from C. sinensis and O. viverrini infections were modelled as attributable cases of 
cholangiocarcinoma (Figure 13). All information on odds ratios between C. sinensis and 
O. viverrini infection and cholangiocarcinoma from age-independent and sex-independent 
case-control studies and large (>100) autopsy series were incorporated. The resulting odds 
ratios were then combined with the cholangiocarcinoma incidence rate of a population, which 
is highly affected by liver flukes (north-east Thailand),
42
 to calculate the incidence rate of this 
carcinoma, which is attributable to liver-fluke infections. Because of poor prognosis of 
patients with cholangiocarcinoma, incidence rates of this disease attributable to liver-fluke 
infections were set equal to mortality rates. 
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Mortality from Paragonimus spp. infection was modeled on the basis of information 
about the proportion of deaths among all patients with paragonimiasis and cerebral 
involvement in all identified case series (Figure 13). Since most fatal cases occur at the 
beginning of cerebral infection,
6,31
 the proportion of deaths was multiplied by the incidence 
rate of cerebral paragonimiasis to obtain the attributable number of deaths. 
 
6.3.3. Statistical analysis 
Quantitative information about infection intensity, odds ratios for cholangiocarcinoma, 
cerebral involvement, and mortality attributable to food-borne trematodiasis was entered into 
StatsDirect (version 2.7.2) for meta-analysis. Random-effect models were used to account, at 
least partly, for data heterogeneity (Cochran’s Q statistic with p < 0·001 for all datasets). 
To transform all the reviewed information into DALY estimates, we used DisMod 3. This 
software replaced earlier DisMod versions and was especially developed for the GBD 2010 
study. On the basis of Bayesian models and a minimum of three of five epidemiological key 
indicators (i.e., prevalence, incidence, remission, mortality, and duration), the software 
computed an internally consistent and complete set of all five epidemiological key indicators.
1
 
In an iterative process, key indicators for each sequela attributable to food-borne trematodiasis 
were calculated and assessed with regard to initial inputs and expert opinion. Bayesian model 
priors were adjusted in DisMod 3 on the basis of expert opinion to force model outputs to be 
internally and logically consistent and plausible. Once a set of five epidemiological key 
indicators was accepted, it was combined with the most recent version of already established 
disability weights of similar sequelae (Table 9)
43
 to calculate DALYs. 
If applicable, 95% CIs and credible intervals were added for analysis of uncertainty in 
DisMod 3 input and output. However, no 95% CIs were calculated for initial country-wide 
prevalence estimates because they were mainly based on expert opinion. Furthermore, no 
credible intervals could be established for the resulting total numbers of infected people 
because of DisMod 3 model specifications. Moreover, no 95% CIs were given for sex and age 
profiles because they were only used for assigning the cases to the different sex-specific and 
age-specific groups. 
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Table 9. Disability weights used for the calculation of the disability-adjusted life years due to food-borne 
trematodiasis. 
 Sequela Most similar sequela from GBD 2004 Weight 
Heavy clonorchiasis Schistosomiasis: advanced hepatic disease 0.104 
Heavy opisthorchiasis Schistosomiasis: advanced hepatic disease 0.104 
Heavy fascioliasis Schistosomiasis: advanced hepatic disease 0.104 
Heavy intestinal fluke infection Intestinal nematode infection: massive dysentery syndrome 0.116 
Heavy paragonimiasis Lower respiratory infection: chronic sequelae 0.099 
Cerebral paragonimiasis Meningitis: seizure disorder 0.100 
Most recent version of already established disability weights of most similar sequelae were selected from the 
WHO Global Burden of Disease (GBD) 2004 update.
43
 By definition, disability weights range on a scale from 0 
(perfect health) to 1 (death). 
 
6.3.4. Role of the funding source 
The sponsors of the study had no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. The corresponding author had full access to all the data 
in the study and had final responsibility for the decision to submit for publication. 
 
6.4. Results 
Our systematic review identified 33,921 studies; 181 were included in the quantitative 
analyses (Figure 14, Appendix 13.2.3. and Appendix 13.2.4.). The highest national prevalence 
rates of food-borne trematodiasis occurred with regard to O. viverrini in Laos and Thailand 
(Table 10). More men than women were infected with C sinesis, Opisthorchis spp., all 
intestinal flukes, and Paragonimus spp., whereas slightly more women than men were 
infected with Fasciola spp. (Table 11). Most pronounced sex-specific and age-specific 
prevalence profiles were for C. sinensis with prevalences in 45-54 year-old men more than 
nine-times higher than prevalences in 1-4 year-old boys (Figure 15). 
Meta-analysis of proportions of heavy and therefore symptomatic infections among all 
infections resulted in estimates of 26.0% for paragonimiasis, 15.4% for intestinal fluke 
infections, 14.0% for fascioliasis, 8.2% for clonorchiasis, and 4.9% for opisthorchiasis 
(Appendix 13.2.5.). We identified only one high-quality, population-based study with 
information on the proportion of cerebral involvement among all cases of paragonimiasis.
50
 
Unfortunately, this study from South Korea gave no information on infection intensities, but 
showed that 0.8% of all patients with paragonimiasis could have cerebral infection. 
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With C. sinensis infection the odds ratio for cholangiocarcinoma was 6.1; with 
O. viverrini infection the odds ratio was 4.4. These ratios were established in meta-analyses 
and needed as proxies for estimating mortality (Appendix 13.2.6.). Meta-analysis of 
proportions of deaths among all patients with paragonimiasis and cerebral involvement 
resulted in a proportion of 10.0% (Appendix 13.2.7.). 
Outputs from the DisMod 3 models for relevant sequelae are shown in Appendix 13.2.8. 
Remission rates deviated from the initial model input of zero remission. Overall, our 
estimates showed that 56.2 million people might be infected with food-borne trematodes 
(Table 12). About 7.9 million people (7.2-8.8) were modelled as having heavy or cerebral 
infections. The estimated number of deaths for 2005 was 7,158 (5,795-8,952). These figures 
resulted in 351,026 years lived with disability (224,847-466,042) and 314,326 years of life 
lost (254,649-393,009). Taken together, we estimate that, in 2005, the global burden due to 
food-borne trematodiasis was 665,352 DALYs (479,496-859,051). All lower and upper 
estimates based on 95% CIs and credible intervals are shown in Appendix 13.2.9. 
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Table 11. Parasite-specific and sex-specific prevalence rates of food-borne trematodiasis and derived 
standardised prevalence sex ratios. 
 Parasite Male     Female     Sex ratio 
             (male:female) 
 Total Total Prevalence Total Total Prevalence  
  examined infected (%) examined infected (%)   
Clonorchis sinensis 977,113 42,274 4.326 965,957 22,726 2.353 1.839 
Opisthorchis spp. 19,864 7,398 37.243 26,624 8,249 30.983 1.202 
Fasciola spp. 758,660 1,535 0.202 768,630 1,589 0.207 0.979 
All intestinal flukes 2,273,007 5,866 0.258 2,306,863 4,887 0.212 1.218 
Paragonimus spp. 109,879 10,344 9.414 157,096 11,670 7.429 1.267 
All sex-specific population based cross-sectional survey data identified in the systematic review were aggregated 
to calculate male-to-female prevalence ratios. Bibliographic details on the references of the quantitative datasets 
included are in Appendix 13.2.3. und Appendix 13.2.4. 
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6.5. Discussion 
We estimate that in 2005 about 56.2 million people were infected with food-borne 
trematodes, 7.9 million had severe sequelae, and 7,158 died. Taken together, the global 
burden of food-borne trematodiasis was 665,352 DALYs. Importantly, food-borne trematode 
infections are also a disease of veterinary importance causing substantial losses in animal 
production and trade
9
 and thereby affecting human well-being in indirect ways. 
Several peculiarities of the initial model inputs and intermediate results in our study 
warrant further discussion. First, reliable prevalence data for calculating the global burden of 
food-borne trematodiasis were scarce. Because of the highly focal occurrences of these 
diseases,
9,13
 localised small-scale surveys cannot directly serve as proxies for entire countries 
or larger regions (i.e., the 14 world regions defined by WHO). Hence, we decided to rely only 
on national prevalence data, despite the fact that many countries report some cases of food-
borne trematodiasis but not on national totals.
51
 In most countries, the few isolated surveys 
that have been done are not sufficient to be combined with other epidemiological information 
and remote sensing data in a geographical information system and successfully applied spatial 
statistical modelling techniques. Nevertheless, spatial modelling of fascioliasis has been 
attempted for Latin America
7,52
 and similar approaches might be adopted for other settings 
and parasites in the future. 
Second, most national prevalence rates included in our models were based on expert 
opinion and only a few on nationwide parasitological surveys. All prevalence rates based on 
nationwide surveys were established by coprology, except for that of paragonimiasis in China, 
where IgG ELISAs were used. These tests have a high sensitivity and a reasonable 
specificity.
53,54
 Diagnostically relevant seroreversion occurs between 3 and 18 months,
55-57
 
with the delay presumably related to comparatively slow resolution of lesions containing 
antigenic material.
55
 However, we cannot rule out a certain overestimation of paragonimiasis 
prevalence in China in our model. Other estimates for paragonimiasis in China are based on 
expert opinion and ranged between 0.078% and 1.73%, but explicitly refer to the national 
survey,
9,13,37
 which also mentions that the number of paragonimiasis cases could increase in 
the future.
44
 Measurement errors resulting from diagnostic limitations (e.g., confusion of 
paragonimiasis as non-responsive tuberculosis, non-detection or misdiagnosis of worm eggs 
in biospecimens)
3,5-8,10,13,26,54
 might be common, but except for IgG ELISA they would lead to 
underestimates rather than overestimates. 
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Third, a few prevalence rates used in our study were from before 1995, and hence dating 
back more than 10 years to our estimation time point of 2005. Recent social and economic 
developments in endemic countries could have influenced the epidemiological situation of 
food-borne trematodiasis, but whether these changes resulted in enhanced or reduced risk of 
infection is unknown.
14
 The high prevalence rates for O. viverrini in Thailand and Laos were 
expected, because the parasite is highly endemic in these two countries.
3,8-10,13,58
 
Fourth, regarding sex-specific prevalence rates, many qualitative sources report that men 
are more often affected by clonorchiasis and opisthorchiasis and women by 
fascioliasis,
3,4,8,10,26,53
 as confirmed in our models. No such qualitative evidence on differences 
in sex-related prevalence could be identified for intestinal fluke infections and paragonimiasis. 
For age-specific prevalence profiles of clonorchiasis and opisthorchiasis, the initial increase in 
prevalence in young individuals, a maximum in middle age, and a slight decrease in old age is 
frequently described,
3,8,10,59,60
 and these prevalence profiles also occurred in our models. The 
slight decrease in prevalence in elderly people has sometimes been attributed to early death of 
infected individuals due to cholangiocarcinoma and other associated complications.
61
 For 
fascioliasis, an increase in prevalence rates during childhood and a slight decrease in 
prevalence in adults has also been reported.
4,62
 A potential explanation for the modelled 
equalised profile of intestinal fluke infections could be that various species were subsumed 
under this category, which in turn might have had a levelling-off effect. The profile of 
paragonimiasis might reveal a changing epidemiological situation. In poor regions, usually no 
paragonimiasis control efforts are in place and children catching and eating raw crustaceans 
while playing or helping their parents in agricultural activities are at highest risk of infection. 
In wealthier regions where control measures have been implemented for many years (e.g., 
Japan and South Korea), most cases are not in childhood, but rather in older age groups. 
However, many age-specific and sex-specific exceptions might exist due to local cultural 
habits.
6
 
Fifth, comparatively high egg-count thresholds were applied to define heavy infections 
and therefore cases with severe sequelae attributable to food-borne trematodiasis. For instance, 
a threshold of 1,000 eggs per g of faeces was used for defining heavy cases of fascioliasis 
even though lower infection intensity cutoffs of 400 eggs per g of faeces were also used in 
other studies.
63
 Because of missing information, thresholds were not adjusted for young age 
groups despite the fact that substantially lower worm burdens might be sufficient to cause 
severe disease in children and age-specific thresholds have already been used in the 
assessment of the global burden of intestinal nematode infections.
64
 All light infections were 
Chapter 6 – Global burden of human food-borne trematodiasis 
98 
assumed to be asymptomatic because reliable quantitative data on the morbidity effect of 
infection duration or host susceptibility were not available. Hence, temporal effects such as 
the sometimes acute onset of O. felineus infection
3,8,10
 and fascioliasis,
7,26,29,31,65
 which might 
be prolonged and overlap with subsequent phases because of repetitive infections, were not 
assessed. Also subtle morbidity caused even by light infections, opportunistic infections (e.g., 
helminth infections and HIV/AIDS
66
), or sequelae with many sources such as anaemia, 
reduced physical fitness, and cognitive impairments could not be included in our estimates. 
Furthermore, the dependence of the simplified disease models on egg counts was an imperfect 
approximation because some studies questioned a direct relation between egg counts and 
worm burden. These studies showed irregular distribution of eggs in the faeces, obstructions 
in the hosts’ organs, which could prohibit excretion of eggs, and crowding effects, which 
could reduce the egg production of each fluke.
26,39,40,59,67-69
 
Sixth, other studies mention that about 5-10% of all clonorchiasis and opisthorchiasis 
cases might be heavy and symptomatic, which is comparable with our estimates.
8,23,41,70
 For 
fascioliasis, 17.5% of patients could have massive infections and up to half of all patients 
could have clinical signs and symptoms.
71,72
 No studies allowing for comparison could be 
identified for the diverse group of intestinal fluke infections. Reviews on paragonimiasis 
mention that 40-70% of all cases had pleural effusion and that about 80% of them might be 
symptomatic.
73-75
 Another study done in Vietnam found that 80-100% of all lung-fluke 
infections were symptomatic.
76
 Three reviews reported that cerebral involvement in all cases 
of paragonimiasis was about 1%,
30,77,78
 which is similar to our findings, whereas older studies 
suggested much higher proportions, but due to selection of patients at hospital these studies 
most likely overestimated percentages.
79-81
 
Seventh, our initial model assumption of zero remission was based on several factors. 
Food-borne trematodiases are neglected diseases, which primarily affect poor populations 
worldwide.
15
 A recent review states that food-borne trematodiasis control efforts were 
inadequate in 2006, and only a few countries had large-scale efforts to control morbidity.
82
 
Indeed, this review estimates that coverage of food-borne trematodiasis control interventions 
is about 0.03%, and even when taking into account beneficial effects of other helminth control 
programmes the coverage would increase to just 0.3%. However, a single liver or lung fluke 
can live 10 years or more in a human host
4,6,10,31,59,83
 if left untreated and only intestinal flukes 
have shorter life-spans (about 1-2 years).
28,84,85
 Furthermore, re-infection is common after 
spontaneous or chemotherapeutic cure if they are not accompanied by integrated control 
efforts.
4,10,28,59-62,86-89
 Heavily infected and therefore symptomatic cases are probably most 
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susceptible,
59,60
 and heavy infections lasting for years lead to irreversible organ and tissue 
damage, which impairs patients’ well-being even after parasite clearance.90 Also, non-fatal 
cases of cerebral paragonimiasis usually present with long-term recurrent symptoms.
31,91,92
 
Chemotherapy might help only in the early phase of cerebral infection, and surgical removal 
of worms, eggs, and cerebral lesions are supportive measures in chronic infections.
6,91,92
 
Eighth, odds ratios for cholangiocarcinoma with clonorchiasis and opisthorchiasis 
infections were comparable to the previously published odds ratios of 5.0 for both diseases.
93
 
The only population-based cross-sectional survey on O. viverrini and cholangiocarcinoma, 
which also assessed infection intensity, established an exposure-response relation with odds 
ratios ranging from 1.7 for infections with less than 1,500 eggs per g of faeces to 14.0 for 
infections with over 6,000 eggs per g of faeces.
35
 No point of reference was identified for 
mortality caused by cerebral paragonimiasis, but since most patients might not have access to 
any treatment, death of about every tenth incident case seems possible for a brain infection. 
Finally, as disability weights for sequelae of food-borne trematodiasis are not yet 
established, we had to rely on established disability weights of most similar sequelae from the 
GBD 2004 update
43
 for the final burden estimation. 
The modelled prevalence and mortality for the different food-borne trematode infections 
mostly follow the input data in our DisMod 3 models. Because we found no data on disease 
remission and duration, we assumed remission to be zero and duration was therefore 
implicitly defined as life-long. However, the ultimate DisMod 3 outputs represent 
conservative estimates with prevalences not always reaching the highest peaks of input data 
and remission rates higher than zero, especially in adults. The estimates for both parameters 
were nevertheless accepted to improve plausibility of all modelled parameters, and limited 
remission can be interpreted as spontaneous cure of some cases after a long period of 
infection, which seems plausible. Hence, the modelled incidence and all other output 
parameters are judged to be reliable and consistent even though good points of reference are 
not always available. 
Our estimates for total number of infections (56.2 million) in 2005 are 35% higher than 
WHO figures for 1995.
9
 For the same period (1995-2005), population figures from the GBD 
2010 study showed an average population increase of only 8% in the countries and special 
administrative regions with cases included in the estimates. Compared with the 
aforementioned WHO figures for 1995, we reported an increase of 423% for intestinal-fluke 
infections, 119% for clonorchiasis, 12% for paragonimiasis, and 11% for fascioliasis, and a 
decrease of 19% for opisthorchiasis. We could not identify any comparable figures for the 
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number of people presenting with severe signs and symptoms, but WHO reported about 
10,000 deaths attributable to food-borne trematodiasis in 1997.
94
 Particularly, estimates for 
liver fluke-induced cholangiocarcinoma have been corrected upwards in recent years. In 1997, 
researchers at the International Agency for Research on Cancer estimated that only 800 cases 
of cholangiocarcinoma were attributable to liver-fluke infection in 1990,
95
 which would 
translate into 800 liver fluke-associated deaths in our model. In 2002, the estimate was as high 
as 2,500 deaths,
96
 whereas a recent review mentioned that well over 6,000 cases of 
cholangiocarcinoma might be induced by liver-fluke infections.
97
 However, on the basis of 
the observation that almost all of the histologically confirmed cases of cholangiocarcinoma 
are related to O. viverrini infection in Khon Kaen, Thailand, realistic annual global estimates 
of cases of cholangiocarcinoma attributable to O. viverrini might be 8,000-10,000.
12,21
 
Furthermore, investigators of all previously mentioned studies labeled their estimates as 
conservative.
12,21,95-97
 Because of the close relation between liver flukes and 
cholangiocarcinoma, Vatanasapt and colleagues
12
 concluded that “the best way to control 
cholangiocarcinoma is to control liver flukes”. 
Our point estimate of DALYs in 2005 attributable to food-borne trematodiasis are 
preliminary results of the GBD 2010 study and will be juxtaposed with estimates for other 
diseases, injuries, and risk factors to improve consistency among all estimates before being 
released as final results. However, comparison of our estimates with currently available 
burden estimates for malaria and other neglected tropical diseases
15,98-102
 confirms human 
food-borne trematodiases as an important group of globally neglected diseases (Table 13). 
Because of the highly focal occurrence of food-borne trematodes, they might even be a major 
public health threat in the most highly affected areas. Furthermore, as a result of inadequate 
sanitary conditions, culturally deeply rooted food habits in some areas and changing food 
preferences in other areas, and associated growth of aquacultural production, food-borne 
trematodiasis seems to be a cluster of emerging infectious diseases with over a billion people, 
mainly in the southeast Asian and western Pacific region, at risk of infection.
14
 
Our estimates are likely to be only the tip of the iceberg. For instance, studies have 
reported 50 million intestinal fluke infections,
103
 over 30 million C. sinensis and 
Opisthorchis spp. infections together,
104
 and 17 million Fasciola spp. infections.
104
 
Uncertainty due to missing or incomplete data is also mirrored by the wide range between our 
lower (479,496 DALYs) and upper estimates (859,051 DALYs). Hence, the ultimate goal for 
future assessments of the burden of food-borne trematodiasis is to minimise the gap between 
actual and reported prevalences and between the complex natural histories of the diseases and 
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the simplified models as applied in our calculations. We therefore believe our study is a 
benchmark for future investigations and would like to invite readers to either send additional 
relevant information to us for inclusion in our models or prepare further analysis themselves. 
Our vision is to include all relevant information on human food-borne trematodiasis in the 
open-access Global Neglected Tropical Diseases Database (http://www.gntd.org) and to 
initiate similar documentation and control efforts as those under way for schistosomiasis (see 
for example http://www.eu-contrast.eu and http://score.uga.edu) or soil-transmitted 
helminthiasis (see for example http://www.thiswormyworld.org). 
 
Table 13. Global disease burden of malaria and selected neglected tropical diseases, including food-borne 
trematodiasis. 
Disease Reference Population People People Deaths DALYs 
   
at risk infected with (thousands) (thousands) 
   
(millions) (millions) morbidity 
            (millions)     
Malaria 
98,99
 2,211  NK  515 1,272 46,486 
Neglected tropical diseases 
      
 
Hookworm infection 
100,101
 3,195  576-740  150  3-65   59-22,100  
 
Ascariasis 
100,101
 4,211 807-1,221  350  3-60  1,817-10,500  
 
Trichuriasis 
100,101
 3,212  604-795  220  3-10  1,006-6,400  
 
Schisosomiasis 
101
 779 207 120  15-280   1,702-4,500  
 
Lymphatic filariasis 
101
  >1,000  120 43 0 5,777 
 
Trachoma 
98
  NK  150  NK  0 2,329 
 
Leishmaniasis 
98,102
 350 12  NK  51 2,090 
 
Trypanosomiasis 
98,102
  >60  0.5  NK  48 1,525 
 
Chagas disease 
98,102
 120  11-18   NK  14 667 
 
Food-borne trematodiasis 
14, a
 1,066 56.2 7.9 7.2 665 
 
Onchocerciasis 
98,102
 120 18  NK  0 484 
 
Leprosy 
98
  NK   NK   NK  6 199 
 
Dracunculiasis 
15
  NK   NK   NK   NK   <100  
 
Strongyloidiasis 
100
  NK   30-100   NK   NK   NK  
 
Buruli ulcer 
15
  NK   NK   NK   NK   NK  
  Taeniasis and cysticercosis 
15
  NK   NK   NK   NK   NK  
Estimates represent the population at risk, the number of people infected, the morbidity, the number of deaths, 
and the global burden as measured in disability-adjusted life years. DALYs = disability-adjusted life years. 
NK = not known. 
a
Data mainly gathered from our study. 
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7.1. Abstract 
Background: Schistosomiasis and soil-transmitted helminthiasis are important public health 
problems in sub-Saharan Africa causing malnutrition, anemia, and retardation of physical and 
cognitive development. However, the effect of these diseases on physical fitness remains to be 
determined. 
Methodology: We investigated the relationship between schistosomiasis, soil-transmitted 
helminthiasis and physical performance of children, controlling for potential confounding of 
Plasmodium spp. infections and environmental parameters (i.e., ambient air temperature and 
humidity). A cross-sectional survey was carried out among 156 schoolchildren aged 7-15 
years from Côte d’Ivoire. Each child had two stool and two urine samples examined for 
helminth eggs by microscopy. Additionally, children underwent a clinical examination, were 
tested for Plasmodium spp. infection with a rapid diagnostic test, and performed a maximal 
multistage 20 m shuttle run test to assess their maximal oxygen uptake (VO2 max) as a proxy 
for physical fitness. 
Principal findings: The prevalence of Schistosoma haematobium, Plasmodium spp., 
Schistosoma mansoni, hookworm and Ascaris lumbricoides infections was 85.3%, 71.2%, 
53.8%, 13.5% and 1.3%, respectively. Children with single, dual, triple, quadruple and 
quintuple species infections showed VO2 max of 52.7, 53.1, 52.2, 52.6 and 55.6 ml kg
-1
 min
-1
, 
respectively. The VO2 max of children with no parasite infections was 53.5 ml kg
-1
 min
-1
. No 
statistically significant difference was detected between any groups. Multivariable analysis 
revealed that VO2 max was influenced by sex (reference: female, coef. = 4.02, p < 0.001) and 
age (years, coef. = 21.23, p < 0.001), but not by helminth infection and intensity, 
Plasmodium spp. infection, and environmental parameters.
 
Conclusion/Significance: School-aged children in Côte d’Ivoire showed good physical 
fitness, irrespective of their helminth infection status. Future studies on children’s physical 
fitness in settings where helminthiasis and malaria co-exist should include pre- and post-
intervention evaluations and the measurement of hemoglobin and hematocrit levels and 
nutritional parameters as potential co-factors to determine whether interventions further 
improve upon fitness. 
Keywords: Schistosomiasis, soil-transmitted helminthiasis, Plasmodium spp., physical fitness, 
shuttle run test, Côte d’Ivoire. 
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7.2. Author summary 
The burden of parasitic worm infections is considerable, particularly in developing countries. 
It is acknowledged that parasitic worm infections negatively impact on children’s school 
performance and physical development. A deeper understanding of these linkages is 
important for updating burden of disease measures. We investigated the relationship between 
worm infection status and physical fitness of 156 schoolchildren from Côte d’Ivoire and 
controlled for potential confounding of Plasmodium infection (the causative agent of malaria) 
and environmental parameters (temperature and humidity). Children were diagnosed for 
parasitic worm and Plasmodium infections, examined by a physician, and participated in a 20 
m shuttle run test to assess their maximal oxygen uptake (VO2 max) as a proxy for physical 
fitness. Most of the children had parasitic worms and a Plasmodium infection. Nevertheless, 
their physical fitness was excellent (average VO2 max: 52.7 ml kg
-1
 min
-1
). The level of VO2 
max was only influenced by sex and age, but not by parasitic worms and Plasmodium 
infections. In future studies, the dynamics of children’s physical performance should be 
assessed before and after control interventions, including the assessment of blood hemoglobin, 
hematocrit, and nutritional indicators to determine whether physical fitness in worm- and 
Plasmodium-infected individuals can be further improved. 
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7.3. Introduction 
Neglected tropical diseases and malaria are widespread on the African continent and 
elsewhere in the developing world. These diseases predominantly plague the poorest of the 
poor and delay their social and economic development.
1-3
 Infections with soil-transmitted 
helminths (Ascaris lumbricoides, hookworm, and Trichuris trichiura) and schistosomes 
(Schistosoma mansoni and S. haematobium), for example, affect hundreds of millions of 
people with untold morbid sequelae.
4-6
 Helminths parasitizing humans can destroy the organs 
and tissues in which they live and compete for nutrients with the human host. Consequently, 
infections can result in abdominal pain, diarrhea, intestinal obstruction, anemia, malnutrition, 
ulcers and, particularly in severe chronic and untreated infections, even death.
5,7-9
 These 
sequelae, in a chronic stage, may retard children’s physical development.8,10,11 It is also 
hypothesized that helminth infections negatively impact on cognitive abilities, and hence on 
children’s school performance.12 However, some more recent studies could not find any clear 
association between helminth infections and school performance, and hence additional 
research is needed.
13-15
 
To date, only few attempts have been made to quantify the effect of schistosomiasis and 
soil-transmitted helminth infections on children’s physical fitness.16,17 In the early stage of a 
schistosome infection, general fatigue is a common symptom described in various age 
groups.
18
 As helminth infections progress, the intensity and duration is thought to play an 
important role in influencing physical fitness.
19
 Hence, the assessment of infection intensities 
should be regarded as an important component of evaluating the effect of helmintic diseases 
on people’s general health and well-being. In the light of the currently ongoing 
comprehensive revision of the global burden of diseases estimates
20,21
 and the crucial role of 
disability weights, which are exceedingly difficult to estimate among the neglected tropical 
diseases,
22-24
 the quantitative impact of helminth infections on humans’ physical fitness 
deserves closer attention. 
The aim of this study was to investigate whether or not there is a relationship between 
helminth infection status among school-aged children and their physical fitness. The study 
was carried out in Côte d’Ivoire, in an area highly endemic for schistosomiasis and, to a lesser 
extent, soil-transmitted helminthiasis, using a cross-sectional study type. Malaria is co-
endemic, and hence we also determined Plasmodium spp. infections and controlled for 
environmental factors such as ambient air temperature and humidity. 
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7.4. Methods 
7.4.1. Ethics statement 
The study protocol was approved by the institutional research commission of the Swiss 
Tropical and Public Health Institute (Basel, Switzerland) and received clearance from the 
‘‘Ethikkommission beider Basel’’ (EKBB, reference no. 377/09) and the Comité National 
d’Ethique et de la Recherche (CNER) in Côte d’Ivoire (no. 1993 MSHP/CNER). The study 
was covered by an insurance company (GNA Assurance; Abidjan, Côte d’Ivoire, policy no. 
30105811010001). District health and education authorities, the village chief, 
parents/guardians, and schoolchildren were informed about the purpose, procedures, and 
potential risks and benefits of the study. Written informed consent was obtained from 
parents/guardians and children assented orally. Participation was voluntary and children could 
withdraw from the study anytime without further obligation. All results were coded and 
treated confidential. In some cases, where a need for medical intervention was required, the 
name of the individual was communicated to the local health service in order to provide 
appropriate medical follow-up. At the end of the study, all children attending the primary 
school of Grand Moutcho I, II and III were administered praziquantel (single 40 mg/kg oral 
dose) and albendazole (single 400 mg oral dose) free of charge, irrespective of the children’s 
helminth infection status. 
 
7.4.2. Study design and sample size calculation 
We conducted a cross-sectional survey on physical activity in schoolchildren. We assumed 
that the arithmetic mean of the maximal oxygen uptake (VO2 max), which was measured as a 
proxy for the school-aged children’s physical fitness, would be 50 ml kg-1 min-1 with a 
standard deviation of 5 ml kg
-1
 min
-1
 (see σ in formula 1).25 Moreover, we assumed that a 
difference of VO2 max of 5% (i.e., 2.5 ml kg
-1
 min
-1
; see D in formula 1) is of clinical 
relevance and that the ratio of children with the predominant helminth species versus non-
infected children would be roughly 1:1. According to formula (1) given by Eng (2003)
26
 
 
2
22 )(**4
D
zz
N
pwrcrit 


        (1) 
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and allowing for 10% non-compliance, we calculated that 186 children in total would need to 
be enrolled to achieve a power of 90% at an alpha error of 5% to find a statistical significance 
in VO2 max between helminth-infected and non-infected individuals. Finally, we aimed to 
enroll 200 children to account for imbalances in the study group sizes. 
 
7.4.3. Study area and population 
The study was carried out between January and April 2010 in the primary school Grand 
Moutcho, located in the health district of Agboville, south Côte d’Ivoire (geographical 
coordinates: 05°56’0’’ N latitude, 04°13’0’’ W longitude). The study area is located 76 km 
north of Abidjan, the economic capital of Côte d’Ivoire, at an altitude of below 100 m above 
sea level. In south Côte d’Ivoire, the vegetation primarily consists of rainforest, the relief is 
flat and the long and short rainy seasons occur between April and July and from mid-
September to November, respectively. During the school year 2009/2010, there were a total of 
204 children attending grades 4, 5, and 6 in Grand Moutcho II and III, and hence all of them 
were invited to participate in the study. 
 
7.4.4. Field and laboratory procedure 
Village authorities and teachers were informed about the purpose and procedures of the study. 
Subsequently, teachers were asked to prepare class lists with the name, age, and sex of the 
children attending grades 4-6 of Grand Moutcho II and III. After written informed consent 
was obtained from parents or guardians and children gave oral assent to participate, children 
were provided with plastic containers labeled with unique identification numbers and invited 
to submit a small portion of their own fresh morning stool the following day. Stool samples 
were collected between 08:00 and 10:00 hours and children were handed out a new empty 
container for urine collection starting at 10:00 hours. This procedure was repeated the 
following day in order to obtain two stool and two urine samples from each child. 
Stool and urine samples were transferred to a nearby laboratory in the district town 
Agboville. For the diagnosis of S. mansoni and soil-transmitted helminth infections, duplicate 
Kato-Katz thick smears, using 41.7 mg templates,
27
 were prepared from each stool sample 
and examined under a microscope by experienced laboratory technicians. The number of eggs 
was counted and recorded for each helminth species separately. For the diagnosis of 
S. haematobium, urine samples were subjected to the filtration method.
28,29
 In brief, 10 ml of 
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vigorously shaken urine were pressed through a small-meshed filter (30 mm), a drop of lugol 
solution was added to the filter paper on the microscope slide, and the slides were examined 
quantitatively under a microscope for S. haematobium eggs by experienced technicians. 
Consistent with our previous work, 10% of the slides were re-examined by a senior 
technician
30,31
 and, in case of disagreement, the results were discussed with the concerned 
technician and the corresponding samples read a third time and used as a reference. 
 
7.4.5. Physical examination and shuttle run test 
Children who had provided two stool and two urine samples were clinically examined by a 
physician three days after the laboratory examination and, based on observed signs and 
symptoms, checked for their general state of health. Additionally, a rapid diagnostic test 
(RDT) for malaria was performed (ICT ML01 malaria Pf kit; ICT Diagnostics, Cape Town, 
South Africa). Children with clinical malaria (defined as positive RDT plus recent history of 
fever), asthma (assessed by study physician using a stethoscope), anemia (assessed by study 
physician after pulling down of eyelid and noting pale color
32
), or dyspnea (assessed by study 
physician using a stethoscope), according to the physician’s appraisal, were excluded from the 
subsequent fitness test as motivating them to reach their maximal physical capacity was 
considered as potentially harmful. 
The aim of the physical fitness test was to measure children’s aerobe capacity and 
maximal oxygen up-take, the so-called VO2 max.
33
 The maximal multistage 20 m shuttle run 
test
25,34,35
 is considered to be reliable and valid and was therefore utilized to determine the 
maximal aerobic capacity of the schoolchildren. Seventeen groups with a maximum of 10 
children per group were running one group after the other on three consecutive days between 
08:30 and 11:30 hours and between 16:00 and 18:00 hours. While doing the 20 m shuttle run 
test, the maximal heart rate of participating children was assessed using a Polar RS400 watch 
(Polar Electro Europe BV; Zug, Switzerland) to ensure that children really tried to reach their 
maximal physical capacity. Achieving less than 180 heart beats per min was taken as criterion 
that a child did not perform the test until the physical capacity limit. 
To guarantee the comparability of the physical tests and to minimize external influences, 
which might affect the different test series of the 20 m shuttle run, ambient air temperature 
and humidity were monitored with a thermometer and a hygrometer, respectively. 
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7.4.6. Statistical analysis 
Parasitological data were double-entered and cross-checked in Access version 2007 
(Microsoft Corp.; Redmond, WA, USA) and analyzed in STATA version 10.1 (STATA Corp.; 
College Station, TX, USA). The completed race distance (levels and shuttles) according to the 
20 m shuttle run test were obtained from version 3.2 of the Team Beep Test 20 m software 
(RobJWood Designs; Mount Hawthorn, Australia). 
For each child, the arithmetic mean of the helminth species-specific egg counts from the 
four Kato-Katz thick smears was calculated and multiplied by a factor 24 to obtain a 
standardized measure of infection intensity, expressed as eggs per gram of stool (EPG). 
Helminth infection intensities were classified into light, moderate, and heavy, according to 
World Health Organization (WHO) guidelines.
29,36
 The upper limits of light and moderate 
infections were 100 and 400 EPG for S. mansoni; 2,000 and 4,000 EPG for hookworm; and 
5,000 and 50,000 EPG for A. lumbricoides, respectively. S. haematobium egg counts were 
classified into light (<50 eggs/10 ml of urine) and heavy (≥50 eggs/10 ml of urine or visible 
hematuria).
36
 
Physical fitness data were gathered and analyzed according to standard methodologies put 
forth in ‘‘The Guidelines for Exercise Testing and Prescription’’ from the American College 
of Sports Medicine (ACSM).
33
 VO2 max results were obtained by using the age-adjusted 
(X1 = age in years) positive linear relation between the shuttle running speed (X2 = speed in 
km/h) and VO2 max as expressed by Léger & Mercier
25
 in equation 2: 
 
VO2 max = 31.025 – 3.248 * X1 + 3.238 * X2 + 0.1536 * X1 * X2   (2) 
 
Only those children who had complete data records (i.e., written informed consent, four 
Kato-Katz thick smears, two urine filtrations, a RDT for malaria, completed clinical 
examination and 20 m shuttle run test) were included in the final analysis. Arithmetic mean, 
χ2 and t-test statistics, as well as univariate and multivariable regression analyses were 
employed to assess statistical significance (p < 0.05). Children with complete parasitological 
and clinical data, but no valid results from the physical fitness test due to exclusion in the 
clinical examination or an invalid maximum heart rate while completing the physical fitness 
test were included in an attrition analysis. 
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7.5. Results 
7.5.1. Compliance and demographic results 
All 204 schoolchildren attending grades 4-6 of Grand Moutcho II and III were invited to 
participate in the study. As shown in Figure 16, 200 children (98.0%) returned written 
informed consent sheets signed by their parents/guardians. Complete parasitological results 
(i.e., four Kato-Katz thick smears, two urine filtrations, and one RDT for malaria) were 
available from 188 children and they all took part in the clinical examination and were willing 
to perform the 20 m shuttle run test. Hence, the compliance rate was 92.2%. However, 
another 26 children were excluded from the 20 m shuttle run test according to the physician’s 
judgment. Exclusion criteria were dyspnea (n = 14), clinical malaria (n = 9), anemia (n = 2), 
and asthma (n = 1). The remaining 162 children participated in the 20 m shuttle run test, but 
the results of six children were considered as invalid because of maximum heart rate below 
180 heart beats per min. Hence, the final study cohort consisted of 156 children (76.5% of the 
initial 204). 
The median age of the final study population was 12 years with a range of 7-15 years. 
However, most of the children were aged between 9 and 15 years (98.7%). The predominant 
age-group were 13-year-old (n = 39). There were more boys (n = 91) than girls (n = 65). 
 
7.5.2. Physical fitness 
The overall arithmetic mean of the VO2 max values of the 156 children was 52.7 ml kg
-1
 min
-1
 
(95% confidence interval (CI): 52.0-53.4 ml kg
-1
 min
-1
) (Table 14). Extreme values (minimum 
and maximum) were at 40.5 and 60.6 ml kg
-1
 min
-1
. While girls had a mean VO2 max of 50.4 
ml kg
-1
 min
-1
 (95% CI: 49.4-51.3 ml kg
-1
 min
-1
), the respective value for boys was 
significantly higher at 54.4 ml kg
-1
 min
-1
 (95% CI: 53.5-55.2 ml kg
-1
 min
-1
). The observed 
differences in mean VO2 max values between girls and boys varied with age. In general, mean 
VO2 max values gradually decreased with age; for boys it decreased from 56.8 ml kg
-1
 min
-1
 
among 7-year-old to 48.8 ml kg
-1
 min
-1
 among those aged 15 years. The respective decrease in 
girls was from 54.2 to 44.7 ml kg
-1
 min
-1
. 
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Figure 16. Study participation and compliance. Diagram showing the study participation and compliance of 
schoolchildren attending grades 4-6 of the primary school Grand Moutcho II and III, near Agboville, a rural 
community of south Côte d’Ivoire in early 2010. 
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Table 14. Comparison of age- and sex-specific mean VO2 max values among Ivoirian and Canadian 
children. 
Age Sex Agboville, Côte d'Ivoire, 2010   Québec, Canada, 1981 
Years   n Mean VO2 max 95% CI   n Mean VO2 max 95% CI
a
 
7 M 2 56.8 15.7-97.9  297 51.2 50.9-51.6 
 F 0 NA NA        299 50.3 50.0-50.6 
8 M 0 NA NA     303 51.7 51.2-52.1 
 F 0 NA NA     308 49.8 49.4-50.2 
9 M 5 55.9 53.3-58.4*  322 51.1 51.1-52.0* 
 F 6 54.2 52.2-56.1*  322 49.2 48.9-49.6* 
10 M 12 56.0 53.3-58.8*  404 51.6 51.2-52.1* 
 F 14 53.8 52.0-55.6*  335 46.8 46.5-47.1* 
11 M 9 56.3 53.9-58.8*  386 51.1 50.7-51.6* 
 F 7 50.2 47.1-53.3  382 47.5 47.1-47.9 
12 M 24 54.5 53.0-56.0*  341 51.9 51.4-52.5* 
 F 9 50.2 47.9-52.5*  292 46.7 46.2-47.1* 
13 M 22 54.4 52.8-55.9*  325 50.1 49.5-50.7* 
 F 17 48.4 47.0-49.8*  298 44.4 43.9-45.0* 
14 M 10 52.9 50.5-55.3  289 50.1 49.5-50.7 
 F 8 48.9 45.7-52.1*  260 41.7 41.1-42.2* 
15 M 7 48.8 42.9-54.7  333 50.2 49.6-50.9 
 F 4 44.7 39.0-50.3  260 41.2 40.5-41.8 
7-15 M 91 54.4 53.5-55.2  3,000 51.1 NA    
7-15 F 65 50.4 49.4-51.3  2,756 46.6 NA    
7-15 Both 156 52.7 52.0-53.4   5,756 48.9 NA    
VO2 max values (expressed in ml kg
-1
 min
-1
) were obtained from 20 m shuttle run tests performed by 156 
children attending grades 4-6 in the primary school of Grand Moutcho II and III near Agboville, south Côte 
d’Ivoire in early 2010 (present study) and from children in Québec, Canada, in 1981. CI = confidence interval. 
F = female. M = male. NA = not applicable. 
a
Values calculated by authors of the present article, based on data in 
Léger et al. (1988).
25
 
*
Statistically significant difference between the two studies according to non-overlapping 
95% CI. 
 
7.5.3. Parasitological characteristics in relation to VO2 max 
Prevalence and infection intensity of helminth and Plasmodium spp. infections, stratified by 
age and sex, are summarized in Table S1 (Appendix 13.3.1.). Overall prevalences for 
S. haematobium, Plasmodium spp., S. mansoni, hookworm and A. lumbricoides were 85.3%, 
71.2%, 53.8%, 13.5% and 1.3%, respectively. No eggs of T. trichiura were identified, 
whereas eggs of Hymenolepis diminuta were found in the stool of one child. 
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Among the 133 children infected with S. haematobium, 57.9% carried light and 42.1% 
heavy infections. The arithmetic mean egg count was 52 eggs/10 ml of urine (range: 1-346 
eggs/10 ml of urine). Among the 84 S. mansoni-infected children, 64.3% presented with light, 
32.1% with moderate, and 3.6% with heavy infection intensity. The arithmetic mean fecal egg 
count (FEC) of all S. mansoni-infected children was 116 EPG (range: 6-852 EPG). All 21 
hookworm infections were diagnosed as light, with an arithmetic mean FEC of 42 EPG (range: 
6-120 EPG). Only one light (4,668 EPG) and one moderate (11,226 EPG) A. lumbricoides 
infection was detected. 
VO2 max values of children with a S. haematobium, S. mansoni, hookworm or 
A. lumbricoides infection were 52.5, 52.2, 54.8 or 52.3 ml kg
-1
 min
-1
, respectively, whereas 
children without helminth infection showed a mean VO2 max of 52.9 ml kg
-1
 min
-1
 (Table 15). 
Multi-parasitism was very common. While only 3.8% of all children were neither infected 
with helminths nor with Plasmodium spp., 16.7% harbored one, 35.9% two, 38.5% three, 
4.5% four and 0.6% even five parasite species concurrently. Children with single, dual, triple, 
quadruple and quintuple species infections showed VO2 max values of 52.7, 53.1, 52.2, 52.6 
and 55.6 ml kg
-1
 min
-1
, respectively. The exact parasite combinations and respective VO2 max 
values are presented in Table 16. 
However, as demonstrated by overlapping 95% CIs in Tables 15 and 16, no significant 
differences were found in the VO2 max values of helminth-infected and non-infected children, 
regardless of the helminth species investigated, regardless of whether children were infected 
with one or multiple species concurrently, and regardless of the helminth infection intensity. 
The results of the two parasites with the most diverse infection intensities, as measured by the 
number of eggs in a given amount of urine or stool, namely S. haematobium and S. mansoni, 
were used to illustrate their effect on the children’s VO2 max. As documented in Figure 17, no 
clear trend was observable. 
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Table 15. Helminth infection intensities in accordance with WHO guidelines
36
 and mean VO2 max values. 
Infection Intensity n VO2 max 
      Mean 95% CI 
No helminth infection NA 17 52.9 51.1-54.7 
S. haematobium All 133 52.2 51.8-53.4 
 Light (<50 eggs/10 ml of urine) 77 52.8 51.8-53.8 
 Heavy (≥50 eggs/10 ml of urine or visible hematuria) 56 52.2 50.9-53.5 
S. mansoni All 84 52.2 51.1-53.3 
 Light (1-99 EPG) 54 52.8 51.4-54.2 
 Moderate (100-399 EPG) 27 51.2 49.3-53.1 
 Heavy (≥400 EPG) 3 51.4 37.0-65.8 
Hookworm All 21 54.8 52.8-56.8 
 Light (1-1,999 EPG) 21 54.8 52.8-56.8 
 Moderate (2,000-3,999 EPG) 0 NA NA 
 Heavy (≥4,000 EPG) 0 NA NA 
A. lumbricoides All 2 52.3 10.4-94.2 
 Light (1-4,999 EPG) 1 55.6 NA 
 Moderate (5,000-49,999 EPG) 1 49.0 NA 
  Heavy (≥50,000 EPG) 0 NA NA 
VO2 max values (expressed in ml kg
-1
 min
-1
) were achieved from 20 m shuttle run tests performed by 156 
children attending grades 4-6 in the primary school of Grand Moutcho II and III near Agboville, a rural 
community of south Côte d’Ivoire in early 2010. CI = confidence interval. EPG = eggs per gram of stool. 
NA = not applicable. 
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Figure 17. Sex-specific scatter plots of VO2 max values among Ivoirian schoolchildren. VO2 max values 
were obtained from 156 children attending grades 4-6 in the primary school of Grand Moutcho II and III near 
Agboville, south Côte d’Ivoire, in early 2010 after performing a 20 m shuttle run test. Data are shown in 
accordance with children’s infection status of S. haematobium, measured in number of eggs per 10 ml of 
urine  (A), and S. mansoni, measured in number of eggs per gram of stool (EPG) (B). Scatter plots on the top 
represent males and scatter plots on the bottom females. Second order polynomial regression lines (solid lines) 
and their 95% confidence intervals (dotted lines) are presented. 
 
7.5.4. Mutlivariable regression analyses with physical fitness as outcome 
A multivariable regression analysis supported our findings from the descriptive statistics. 
After adjusting for temperature (range: 31-43°C) and relative humidity (range: 42-69%) of the 
ambient air (measures taken when the children performed the physical activity test), sex and 
age, differences in VO2 max values between children with differing parasitic infection status 
were not statistically significant (Table 17). The only statistically significant explanatories 
remained sex (reference: female, coeff. = 4.02, p < 0.001) and age (coeff. = -1.23, p < 0.001). 
These findings were robust and whether we used helminth infection intensity categories as 
defined by WHO or exact FECs had no influence on the outcome of the multivariable 
regression model. 
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Table 17. Multivariable regression analysis between VO2 max values and air temperature, humidity, sex, 
age, and infection status as explanatory variables. 
Explanatory variables Multivariable regression analysis
a
 
  Coef. 95% CI p-value 
Air temperature (in °C) 0.33 -0.16–0.83 0.185 
Relative humidity of the air (in %) 0.09 -0.13–0.31 0.404 
Sex (reference: female) 4.02 2.83–5.21 <0.001* 
Age (in years) -1.23 -1.56– -0.89 <0.001* 
Malaria (reference: not infected) -0.02 -1.31–1.26 0.973 
Helminth infection (reference: not infected)    
   S. haematobium: light infection -2.18 -10.37–6.00 0.599 
   S. haematobium: heavy infection -2.11 -10.45–6.23 0.618 
   S. mansoni: light infection -1.57 -9.52–6.38 0.697 
   S. mansoni: moderate infection -2.49 -10.34–5.36 0.532 
   S. mansoni: heavy infection -2.59 -11.35–6.16 0.559 
   Hookworm:light infection 1.14 -6.36–8.64 0.764 
No. of concurrent helminth infections (reference: 0)    
   One 3.95 -4.41–12.30 0.352 
   Two 5.33 -10.46–21.12 0.506 
   Three 4.90 -17.63–27.42 0.668 
VO2 max (ml kg
-1
 min
-1
) values resulting from 20 m shuttle run tests performed by 156 children attending grades 
4-6 in the primary school of Grand Moutcho II and III near Agboville, a rural community of south Côte d’Ivoire 
in early 2010. Only explanatories with n > 1 observations were included. CI = confidence interval. 
a
Key 
indicators of the multivariable regression model: F (14, 140) = 8.20; p < 0.001; R-squared = 0.450. *Statistically 
significant (p < 0.05). 
 
7.5.5. Attrition analysis 
Characteristics of the 32 children with complete parasitological and clinical data, but no 
results from the physical fitness test were compared with the 156 children comprising the 
final study sample. This attrition analysis revealed that the two groups were similar with 
regard to the proportions of girls (43.8% vs. 41.7%) and mean age (11.7 vs. 12.0 years). No 
statistically significant differences in helminth infection intensity categories were detected for 
S. haematobium, S. mansoni, hookworm and A. lumbricoides (all p > 0.05), and occurrence of 
multiple helminth infections was comparable (p = 0.928) in both groups. 
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7.6. Discussion 
Only few attempts have been made to determine the effect of schistosomiasis and soil-
transmitted helminth infections on children’s physical performance, which is closely related 
to their general health and well-being, and hence a proxy measure of disability and disease 
burden. We investigated the relationship between helminth infection status and physical 
fitness in schoolchildren from Côte d’Ivoire and controlled for potential confounding of 
malaria and environmental influences. Schistosoma spp. and Plasmodium spp. infection were 
present in more than two thirds of the surveyed children with 37.2% of the children 
concurrently infected with both S. haematobium and S. mansoni. Hookworm infections were 
also common. However, neither single infections with any investigated parasite species at any 
infection intensity, nor multiple species infections were associated with the maximal oxygen 
uptake VO2 max, which is a widely used parameter to determine and quantify physical fitness. 
VO2 max was only significantly related to children’s age and sex and our cohort of children 
from Côte d’Ivoire presented with better physical fitness than children of the same age and 
sex in Canada. 
Our data confirm previous studies showing that schistosomiasis and soil-transmitted 
helminthiasis are highly endemic in the Agboville area in south Côte d’Ivoire.37-40 
Interestingly, we found that children’s physical activity in the current epidemiological setting 
of Côte d’Ivoire was, on average, considerably better than that of a large group of children 
from Canada. Indeed, the mean VO2 max, among our cohort of children was 52.7 ml kg
-1
 min
-
1
, whereas a lower mean VO2 max (48.9 ml kg
-1
 min
-1
) had been observed in the 
aforementioned  Canadian  study.
25
  Generally,  schoolchildren  in  Grand  Moutcho  had  a  
3-7 ml kg
-1
 min
-1
 higher VO2 max than their age-matched Canadian counterparts (Table 14), 
which corresponds to a positive overall offset of about 8%, despite the fact that the Ivorian 
children were running during high ambient air temperatures (up to 43°C) on an unpaved 
schoolyard and some of them had only sandals or no shoes at all. Moreover, we could not find 
evidence that a helminth of Plasmodium infection, multiple species helminth infections, and 
heavy helminth infection intensities negatively impact on children’s performance in a 20 m 
shuttle run test. Our findings are in contrast to two Kenyan studies published in the early 
1990s,
16,17
 but in line with other investigations carried out in the 1970s,
11,41,42
 and therefore 
raise the question as to why there is discrepancy between the widely held view that 
schistosomiasis and soil-transmitted helminthiasis prejudices physical fitness and the lack of 
consistent empirical data to support this claim. 
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The following points are offered for consideration. First, children in Grand Moutcho walk 
to school, day after day, often for several kilometers. Moreover, children are engaged in daily 
family chores, such as fetching water, help with subsistence agriculture and other physically 
demanding tasks. Compared to industrialized countries, where physical inactivity and other 
life-style modifiers have become important risk factors for ill-health,
43-45
 children living in 
rural parts of Africa still show high levels of physical activity. Second, what might also 
contribute to an increased fitness level of children in Africa is their potentially lower protein 
and fat intake compared to children in developed countries.
46
 Hence, a limitation of our study 
is that neither nutritional parameters nor hemoglobin nor hematocrit levels of participating 
children were assessed. Third, according to Åstrand & Ryhming (1954),
47
 neither sex nor 
anthropometric measures are significant predictors for physical fitness test results. In the 
present study, however, sex was associated with VO2 max with boys showing a statistically 
significantly higher mean value than girls. Moreover, there was a negative correlation 
between age and VO2 max capacity in the examined children. Fourth, children are at highest 
risk of helminth infections and, at the same time, easier to motivate for participation in a 
physical performance test than adults. This latter fact may also explain the relatively high 
voluntary compliance rate of 92.2% (i.e., 188 out of 204). Fifth, children attending school 
might not be fully representative for a specific epidemiological setting, as school-aged 
children from the poorest and furthest away households are less likely to be registered at 
school. These children might be at a higher risk of helminth and Plasmodium infections. Sixth, 
it is conceivable that those children suffering from a heavy helminth infection or clinical 
malaria rest at home because of abdominal pain, nausea or headache, and hence were absent 
at the time of the study. Seventh, an attrition analysis of the 32 children who had complete 
parasitological and clinical data but were excluded from the physical fitness test due to 
medical complaints (n = 26) or unreasonably low pulse rate (n = 6) revealed that they were 
not significantly different from the 156 included children in terms of sex, age, or parasite 
infection status. Nevertheless, 29 of the 32 children harbored at least one of the helminth 
species investigated, and hence it is possible that we excluded at least some individuals who 
suffered from severe disabilities attributable to their helmintic infections and thereby 
introduced a certain bias. Finally, our assumptions in the sample size calculation proofed to be 
too optimistic and mainly due to the unexpected high number of children, who had to be 
excluded from the physical fitness test because of medical complaints, the intended sample 
size could not be reached. 
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Currently, the results of the present study may support expert opinion that had assigned a 
minuscule disability weight for schistosomiasis, i.e., 0.005 for children aged 5-14 years and 
0.006 for individuals aged 15 years and above on a scale from 0 (no disability) to 1 (death). 
These tiny disability weights, regardless of the schistosome species and infection intensity, 
are at the root of the low global burden estimate due to schistosomiasis, which, nonetheless, 
remains a heavily contested issue.
6,48-50
 Based on our findings one might indeed challenge the 
effect of a helminth infection on physical performance of school-aged children. Due to the 
lack of advanced chronic disease in this age group, low disability weights might be justified. 
However, schistosome infections that remain untreated ultimately lead to chronic morbid 
sequelae in later life, and hence the current emphasis on regular administration of 
anthelmintic drugs to entire at-risk populations is reasonable.
51,52
 
Future efforts to further investigate the often subtle disabling effects of helminth 
infections are still needed, as the previous elaborations manifest. Hence, it would be 
interesting to investigate the dynamics of children’s physical fitness in a pretest-posttest 
design with an intermittent treatment, or, even better, within the frame of continuous 
preventive chemotherapy campaigns, which was not feasible in the present study due to 
administrative and organizational constraints in the field. Such surveys should also apply 
quantitative tests instead of RDTs to diagnose Plasmodium species-specific infection 
intensities (i.e., thick and thin blood films for parasitemia appraisal) and consider nutritional 
status as well as hemoglobin values as potential co-factors influencing individual physical 
fitness. They could again use a similar maximal physical capacity test like the one used in this 
study and which had the advantage that a group of children could be processed at once 
without the requirement of any sophisticated equipment. However, to avoid the 
aforementioned problem that a large number of individuals suffering from the most severe 
attributable disabilities have to be excluded due to potentially harmful exertion, one could 
also think of low intensity physical fitness tests using, for example, pedo-, speedo- and/or 
accelerometers. In recent years, such high-quality measuring instruments have become 
available and handy, and they have been used extensively and reported as valid objective 
measures of physical activity.
53
 The results of studies adhering to such further elaborated 
protocols could help to shed light on the true health consequences incurred by single and – 
hitherto even more neglected – multiple helminth species infections.54 By assisting in the 
definition of appropriate disability weights for global burden of diseases calculations, such 
data would directly improve key stakeholders knowledge-base, and hence enable them to take 
well-informed decisions about future priority setting in the public health agenda. 
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8. Questionnaire-based approach to assess schoolchildren’s physical fitness and its 
potential role in exploring the putative impact of helminth and Plasmodium spp. 
infections in Côte d’Ivoire 
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8.1. Abstract 
Background: Disability weights (DWs) are important for estimating burden of disease in 
terms of disability-adjusted life years. The previous practice of eliciting DWs by expert 
opinion has been challenged. More recent approaches employed quality of life (QoL) 
questionnaires to establish patient-based DWs, but results are ambiguous. 
Methods: In early 2010, we administered a questionnaire pertaining to physical fitness to 200 
schoolchildren in Côte d’Ivoire. Helminth and Plasmodium spp. infections were determined 
and schoolchildren’s physical fitness objectively measured in a maximal multistage 20 m 
shuttle run test. Associations between objectively measured and self-reported physical fitness 
and between self-reported physical fitness and infection status were determined. Spearman 
rank correlation coefficient, uni- and multivariable linear regression models adjusting for 
children’s age and sex, ambient air temperature and humidity, Fisher’s test, χ² and t-test 
statistics were used for statistical analysis. 
Results: The prevalence of Schistosoma haematobium, Plasmodium spp., Schistosoma 
mansoni, hookworm and Ascaris lumbricoides in 167 children with complete parasitological 
results was 84.4%, 74.9%, 54.5%, 14.4% and 1.2%, respectively. High infection intensities 
and multiple species parasite infections were common. In the 137 children with complete data 
also from the shuttle run test, we found statistically significant correlations between 
objectively measured and self-reported physical fitness. However, no statistically significant 
correlation between the children’s parasitic infection status and self-reported physical fitness 
was identified. An attrition analysis revealed considerably lower self-reported physical fitness 
scores of parasitized children who were excluded from shuttle run testing due to medical 
concerns in comparison to parasitized children who were able to successfully complete the 
shuttle run test. 
Conclusions: Our QoL questionnaire proofed valid to assess children’s physical fitness in the 
current study area. Reasons why no differences in self-reported physical fitness in children 
with different parasitic infections were found are manifold, but do not preclude the use of 
QoL questionnaires in the elicitation of DWs. Indeed, the questionnaire was particularly 
useful in assessing physical fitness of those children, who were – supposedly due to parasitic 
infections – unable to complete the shuttle run test. Hence, we encourage others to use QoL 
questionnaires to determine not only physical fitness, but also more subtle morbidities. 
Keywords: Schistosomiasis, soil-transmitted helminthiasis, Plasmodium spp., physical fitness, 
shuttle run test, questionnaire, quality of life, Côte d’Ivoire. 
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8.2. Background 
The current revision of the Global Burden of Diseases, Injuries and Risk Factors (GBD) 2010 
study has sparked new interest in quantifying disability attributable to all kinds of diseases, 
injuries and risk factors.
1
 A crucial variable to estimate the GBD in terms of disability-
adjusted life years (DALYs) is the disability weight (DW); a measure which ranges between 0 
(perfect health) and 1 (death). Indeed, DWs should capture the disability incurred by an 
average case suffering from a specific sequela.
2
 Of note, DWs are complementary to the 
utility weights used in the earlier but related quality-adjusted life years (QALYs) metrics.
3,4
 In 
the initial GBD 1990 study, DWs were assessed by person trade-off exercises assigned to 
panels of public health experts.
2
 This dependence on theoretical contemplation was one 
important source of criticism on the DALY metrics.
4-7
 Hence, different research groups 
started to use one of the growing number of quality of life (QoL) questionnaire tools to 
estimate patient-based proxies for DWs for a wide range of health impairments
8
 – amongst 
them the often subtle and therefore particularly difficult to elicit morbidity caused by 
neglected tropical diseases (NTDs). While some results indicate that QoL is significantly 
lower among individuals affected by NTDs compared to their non-affected counterparts,
9,10
 
others do not.
11
 These conflicting findings might reflect the early state of research 
investigating the relationship between QoL and NTDs, and hence the need for further 
scientific inquiry has been emphasised.
12,13
 However, the ambiguity of this early research also 
raises questions about the reliability and validity of a questionnaire-based approach in the 
assessment of impairments in QoL due to NTDs. 
We used data from a cross-sectional survey pertaining to schoolchildren’s helminth and 
Plasmodium spp. infections, as determined by standardised, quality-controlled parasitological 
methods. The data were juxtaposed to children’s physical fitness, as objectively measured in a 
maximal multistage 20 m shuttle run test. Additionally, children’s self-reported physical 
fitness was obtained by means of a QoL questionnaire. We determined associations between 
objectively measured and self-reported physical fitness on one hand, and self-reported 
physical fitness and infection status on the other hand. Particular emphasis was placed on 
physical fitness as it is a crucial dimension of QoL. Indeed, physical fitness is included in all 
generic QoL questionnaires
14-16
 and, in our view, the dimension of QoL that can be most 
easily assessed objectively. We present an evaluation of a QoL questionnaire focusing on the 
dimension of physical activity. This tool was embedded in a cross-sectional epidemiological 
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survey, which aimed at assessing the effect of helminth and Plasmodium spp. infections on 
schoolchildren’s physical fitness in a rural setting of southern Côte d’Ivoire.17 
 
8.3. Methods 
8.3.1. Study area and data collection 
In early 2010, we invited all 204 schoolchildren attending grades 4-6 of Grand Moutcho 
primary school in Agboville, south Côte d’Ivoire, to participate in a cross-sectional 
epidemiological survey. In a first step, district health and education authorities, village leaders 
and teachers were informed about the purpose, procedures and potential risks of the study. 
After obtaining their oral agreement, written informed consent was sought from the parents or 
legal guardians of the children, whereas children assented orally. 
In a next step, children were asked to fill out a brief questionnaire, assisted by their class 
teachers if needed. The questionnaire was based on two sections about physical functioning 
(PF) and physical role (PR) from the most widely used generic SF-36v2 questionnaire 
(Medical Outcome Trust, Boston, MA, USA; Health Assessment Lab, Boston, MA, USA; 
QualityMetric, Lincoln, RI, USA).
8,14,18
 Fourteen questions were included and readily adapted 
to the specific study setting. The questionnaire was pre-tested with support of the head of the 
school and further revised (Appendix 13.4.1. Additional material. Questionnaire used to 
assess self-reported physical fitness in the present study; in French). 
Next, participating children were given plastic containers and invited to submit, on the 
next day, a small portion of their fresh morning stool. After stool collection, from 10:00 hours 
onwards, children were given a second plastic container and asked to bring a urine sample by 
14:00 hours the latest. This procedure was repeated over two consecutive days. Stool and 
urine samples were transferred to the nearby hospital laboratory of the district town Agboville. 
Duplicate Kato-Katz thick smears were prepared from each of the two stool samples and 
quantitatively examined by experienced laboratory technicians for eggs of Schistosoma 
mansoni and soil-transmitted helminths (i.e., Ascaris lumbricoides, hookworm and Trichuris 
trichiura) on the same day.
19
 Urine samples were subjected to the filtration method and the 
number of Schistosoma haematobium eggs in a filtrate of 10 ml of urine counted under a 
microscope.
20,21
 Ten percent of all parasitological results were re-examined by a senior 
technician for quality control. In case of disagreement with initial findings, the results were 
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discussed with the respective technician and the corresponding sample reanalyzed until 
agreement was reached. 
After the helminthological screening, children were clinically examined by a physician to 
check their general state of health. Additionally, a rapid diagnostic test (RDT) for malaria was 
performed (ICT ML01 malaria Pf kit, ICT Diagnostics; Cape Town, South Africa). Children 
with clinical malaria (defined as positive RDT plus recent history of fever), asthma (assessed 
by stethoscopy), anaemia (assessed by observing conjunctival vasculature
22
) or dyspnoea 
(assessed by stethoscopy), according to the physician’s appraisal, were excluded from the 
subsequent fitness test, as participation was considered potentially harmful to them. 
Finally, all remaining children were invited to participate in a maximal multistage 20 m 
shuttle run test to assess the cumulatively covered distance and the aerobe capacity, as 
measured by their maximal oxygen uptake, the so-called VO2max (expressed in ml kg
-1
 min
-
1
).
23,24
 The shuttle run test was conducted in groups of not more than 10 children. The 
obtained results were used as objectively determined proxies for the children’s physical 
fitness. To ensure that children really tried to reach their maximal physical capacity, their 
heart rate was observed with a Polar RS400 watch (Polar Electro Europe BV; Zug, 
Switzerland) and only results of children with more than 180 heart beats per min were 
considered valid. Throughout the shuttle run test, we monitored ambient air temperature and 
humidity, as these external factors might influence children’s test performance. 
 
8.3.2. Ethical approval 
The study was approved by the institutional research commission of the Swiss Tropical and 
Public Health Institute (Basel, Switzerland) and received clearance from the ethics 
committees of Basel (EKBB, reference no. 377/09) and Côte d’Ivoire (reference no. 1993 
MSHP/CNER). Insurance coverage was obtained from GNA Assurance (Abidjan, Côte 
d’Ivoire; policy no. 30105811010001). 
At the end of the study, all children attending Grand Moutcho primary school were 
administered praziquantel (single 40 mg/kg oral dose) and albendazole (single 400 mg oral 
dose) free of charge, irrespective of their helminth infection status and whether or not they 
participated in the study. Children who required further medical treatment were referred to the 
local health service. 
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8.3.3. Data analysis 
Data were double-entered and cross-checked in Access version 2007 (Microsoft Corporation; 
Redmond, WA, USA) and analysed in STATA version 10.1 (STATA Corporation; College 
Station, TX, USA). Questionnaire answers were coded as 1, 2 or 3 (for some questions also 4) 
with lower scores given to reports of more problems in a certain activity. The individual 
scores from questions 1 to 10 and 11 to 14, respectively (Appendix 13.4.1. Additional 
material. Questionnaire used to assess self-reported physical fitness in the present study; in 
French) were summed up in order to obtain a summary measure on PF (questions 1 to 10) and 
PR (questions 11 to 14). While PF is a summary measure for the ability to fulfill distinct 
physical tasks (e.g., walking, running and climbing), PR pertains to the physical potential to 
handle certain (social) roles (e.g., learning, helping and playing). According to this procedure, 
higher values for PF and PR indicate fewer problems in the respective domain. In a last step, 
scores for PF and PR were transformed to values between 0 and 100, according to equation 
(1):
25
 
 
 
100*




 

rangescorerawpossible
scorerawpossiblelowestscorerawactual
scoredtransforme   (1) 
 
Helminth infection intensities were classified as light, moderate and heavy, using readily 
available guidelines from the World Health Organization (WHO).
26
 Children’s VO2max was 
derived from equation (2), considering age (X1 = age in years), the achieved maximal shuttle 
running speed (X2 = speed in km/h) and a linear relation according to Léger and Mercier:
23
 
 
21212 **154.0*238.3*248.3025.31max XXXXVO      (2) 
 
Two different samples were considered in the final analysis in order to assess also the 
value added by a QoL questionnaire. Sample 1 consisted of all children with complete 
questionnaire, parasitological and clinical data records. Sample 2 included all children from 
sample 1 who had not only complete questionnaire, parasitological and clinical data, but also 
valid physical fitness test results. An attrition analysis was carried out with those children 
who were included in sample 1, but not in sample 2, i.e., who had complete data records 
except for the physical fitness test. Besides descriptive statistics, Spearman rank correlation 
coefficient, uni- and multivariable linear regression models adjusted for participants’ age and 
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sex, ambient air temperature and humidity, Fisher’s test, χ² and t-test statistics were employed 
as appropriate to assess statistical significance (p < 0.05). 
 
8.4. Results 
8.4.1. Operational results 
Operational results of the study are summarised in Figure 18. The two final study samples 
consisted of 167 children (97 boys and 70 girls) and 137 children (79 boys and 58 girls), both 
with a mean age of 12.0 years (range: 7-15 years). No statistically significant differences in 
terms of children’s sex and age were identified between the two samples (p > 0.05). The 30 
children (18 boys and 12 girls) who were part of sample 1 but excluded from sample 2 due to 
incomplete physical fitness test data had a mean age of 11.8 years (range: 8-14 years). 
Reasons for having no valid physical fitness test data were the exclusion from the shuttle run 
test due to medical concerns (i.e., dyspnea (n = 12), clinical malaria (n = 9), anemia (n = 2) 
and asthma (n = 1)) or reaching too low maximum heart rate (<180 beats per min) in the 
shuttle run test (n = 6). 
 
8.4.2. Parasitological results 
Tables 18 and 19 summarise the parasitological results. The prevalence of S. haematobium, 
Plasmodium spp., S. mansoni, hookworm and A. lumbricoides in the 167 children with 
complete parasitological results was 84.4%, 74.9%, 54.5%, 14.4% and 1.2%, respectively. No 
T. trichiura infection was diagnosed. High intensity helminth infections were common and 
only 10.8% of all children were completely helminth-free, while 32.9% harboured a single 
and 56.3% two or more helminth species concurrently. No significant differences in helminth 
prevalences, infection intensities or helminth co-infections were found between sample 1 and 
sample 2 (p > 0.05). 
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Figure 18. Flow chart detailing operational study results and the two different samples further considered 
in the analysis. The study was carried out in Grand Moutcho school, Agboville, Côte d’Ivoire, in early 2010. 
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Table 18. Parasitic infections and infection intensities in the two samples analysed. 
Parasite Infection Sample 1   Sample 2 
    Male Female Total   Male Female Total 
S. haematobium no 18 8 26  14 7 21 
 light (1-49 eggs/10 ml urine) 46 35 81  38 27 65 
 heavy (≥50 eggs/10 ml urine) 33 27 60  27 24 51 
S. mansoni no 52 24 76  42 19 61 
 light (1-99 EPG) 31 26 57  26 23 49 
 moderate (100-399 EPG) 12 19 31  10 15 25 
 heavy (≥400 EPG) 2 1 3  1 1 2 
A. lumbricoides no 96 69 165  78 57 135 
 light (1-4,999 EPG) 1 0 1  1 0 1 
 moderate (5,000-49,999 EPG) 0 1 1  0 1 1 
Hookworm no 78 65 143  64 53 117 
 light (1-1,999 EPG) 18 5 23  15 5 20 
 moderate (2,000-3,999 EPG) 1 0 1  0 0 0 
Plasmodium spp. no 24 18 42  23 15 38 
  yes 73 52 125   56 43 99 
Parasitological data stem from a study carried out in Grand Moutcho school, Agboville, Côte d’Ivoire, in early 
2010.
17
 Sample 1 with n = 167 observations (97 boys, 70 girls) includes all children with complete questionnaire, 
parasitological and clinical data. Sample 2 with n = 137 observations (79 boys, 58 girls) includes all children 
from sample 1 who had not only complete questionnaire, parasitological and clinical data, but also valid shuttle 
run test results (see also Figure 18). Infection intensities were defined according to WHO guidelines.
26
 
EPG = eggs per gram of stool. 
 
 
Table 19. Helminth co-infections in the two samples analysed. 
No. of concurrent helminth infections Sample 1   Sample 2 
  Male Female Total   Male Female Total 
Zero 13 5 18  11 4 15 
One 35 20 55  27 16 43 
Two 39 41 80  33 34 67 
Three 9 4 13  7 4 11 
Four 1 0 1   1 0 1 
Parasitological data stem from a study carried out in Grand Moutcho school, Agboville, Côte d’Ivoire, in early 
2010.
17
 Sample 1 with n = 167 observations (97 boys, 70 girls) includes all children with complete questionnaire, 
parasitological and clinical data. Sample 2 with n = 137 observations (79 boys, 58 girls) includes all children 
from sample 1 who had not only complete questionnaire, parasitological and clinical data, but also valid shuttle 
run test results (see also Figure 18). 
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8.4.3. Results of the questionnaire survey and shuttle run test 
Mean scores for PF were 51.3 (95% confidence interval (CI): 48.9-53.6) and 52.2 (95% CI: 
49.8-54.7) in samples 1 and 2, respectively (Table 20). Mean scores for PR equalled 50.4 
(95% CI: 46.7-54.0) and 51.3 (95% CI: 47.3-55.4). Means of the two objectively measured 
outcome variables, namely cumulative distance covered by the children in the shuttle run test 
and VO2max, as measured only in sample 2, were 1,301 m (95% CI: 1,242-1,360 m) and 
52.7 ml kg
-1
 min
-1
 (95% CI: 51.9-53.5 ml kg
-1
 min
-1
), respectively. 
Spearman rank correlation coefficients indicated statistically significant and positive 
correlation between PF and cumulative distance and VO2max (Table 21). No such correlation 
was found between PR and the cumulative distance or VO2max. 
Uni- and multivariable regression models demonstrated statistically significant 
correlations of PF and sex with cumulative distance and of PF, sex and age with VO2max 
(Table 22). PR showed no statistically significant association with the cumulative distance or 
VO2max. 
Despite diverse infection patterns of the children, uni- and multivariable regression 
models revealed no statistically significant correlations between participating schoolchildren’s 
score on PF, which proofed to be valid as predictor for their physical fitness, and their 
parasitic infection status (Table 23). 
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Table 20. Summary of the questionnaire scores and shuttle run test results in the two samples analysed. 
Test Variable Sample 1   Sample 2 
    Male Female Total   Male Female Total 
Questionnaire score Physical functioning 53.0 48.9 51.3  53.2 50.9 52.2 
 Physical role 50.9 49.6 50.4  51.2 51.6 51.3 
Shuttle run test Distance NA NA NA  1,452 1,094 1,301 
  VO2max NA NA NA   54.5 50.3 52.7 
Cumulative distance (in m) and VO2max (in ml kg
-1
 min
-1
) as objectively measured and questionnaire scores on 
physical functioning and physical role as self-reported variables in samples 1 and 2 from a study carried out in 
Grand Moutcho school, Agboville, Côte d’Ivoire, in early 2010.17 Sample 1 with n = 167 observations (97 boys, 
70 girls) includes all children with complete questionnaire, parasitological and clinical data. Sample 2 with 
n = 137 observations (79 boys, 58 girls) includes all children from sample 1 who had not only complete 
questionnaire, parasitological and clinical data, but also valid shuttle run test results (see also Figure 18). 
NA = not applicable. 
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Table 21. Spearman rank correlation coefficients. 
  Distance   VO2max 
  Coefficient p-value   Coefficient p-value 
Physical functioning 0.215   0.012*  0.186   0.029* 
Physical role 0.009   0.922   0.096   0.263 
Cumulative distance (in m) and VO2max (in ml kg
-1
 min
-1
) as objectively measured and questionnaire scores on 
physical functioning (PF) and physical role (PR) as self-reported variables in sample 2 from a study carried out 
in Grand Moutcho school, Agboville, Côte d’Ivoire, in early 2010.17 Sample 2 with n = 137 observations (79 
boys, 58 girls) includes all children with complete questionnaire, parasitological, clinical and shuttle run test 
results (see also Figure 18). *Statistically significant (p < 0.05). 
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8.4.4. Results of the attrition analysis 
An attrition analysis of the group of 30 children excluded in sample 2 showed that this group 
was neither significantly different in terms of their sex- or age-composition, nor their 
respective parasite prevalences, infection intensities or levels of multiple helminth species 
infections (p > 0.05). However, as expected because of their medical complaints, they 
reported lower PF scores as a group (mean = 46.8; 95% CI: 39.9-53.8). Furthermore, while 
the three completely parasite-free children achieved considerably higher mean PF scores 
(mean = 66.7; 95% CI: 16.5-116.9), the 27 parasitized children reported lower mean PF 
scores (mean = 44.6; 95% CI: 37.8-51.5) than their peers from sample 2 (Table 24). 
 
Table 24. Attrition analysis of mean questionnaire scores on self-reported physical functioning. 
Parasitic infection status Sample 2   Excluded 
  n Mean score PF 95% CI   n Mean score PF 95% CI 
Parasite-free 15 51.7 41.3, 62.1  3 66.7 16.5, 116.9 
Parasitized 122 52.3 49.8, 54.8  27 44.6 37.8, 51.5 
All 137 52.2 49.7, 54.7   30 46.8 39.9, 53.8 
Questionnaire scores and parasitological results stem from a study carried out in Grand Moutcho school, 
Agboville, Côte d’Ivoire, in early 2010.17 Sample 2 with n = 137 observations (79 boys, 58 girls) includes all 
children who had complete questionnaire, parasitological, clinical and also shuttle run test results (see also 
Figure 18). The group of excluded with n = 30 observations (18 boys, 12 girls) consists of all children with 
complete questionnaire, parasitological and clinical data, but no valid shuttle run test results. Together, the two 
groups add up to sample 1 with n = 167 observations (97 boys, 70 girls), which includes all children with 
complete questionnaire, parasitological and clinical data, but not necessarily valid shuttle run test results. 
PF = physical fitness. CI = confidence interval. 
 
8.5. Discussion 
To our knowledge, this is one of the first attempts to compare objectively measured and self-
reported physical fitness in an area where malaria, schistosomiasis and soil-transmitted 
helminthiasis co-exist.
17
 We found a significant association between the cumulative distance 
covered in a maximal multistage 20 m shuttle run test by 7-15 year old schoolchildren and the 
index PF, as calculated from children’s answers to 10 questions in a simplified QoL 
questionnaire. The association between PF and the children’s estimated VO2max was also 
statistically significant, regardless of whether uni- or multivariable linear regression analyses 
were performed. VO2max is a widely used proxy for the aerobe capacity, and hence a key 
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indicator for the physical performance of a person.
24
 In contrast, the index PR, as calculated 
from the children’s answers on four additional questions in the same simplified QoL 
questionnaire, was neither associated with cumulative distance nor VO2max. 
The findings that (i) PF was a better predictor than PR for objectively measured physical 
fitness in the present study and that (ii) the association between PF and cumulative distance 
was even better than the association between PF and VO2max are reasonable. These claims 
are justified as follows. First, PF literally includes questions about fulfilling distinct physical 
functions such as running (questions 1 and 2), climbing a hill (questions 4 and 5) or walking 
(questions 7 to 9), while PR is more concerned with the physical ability to fulfil certain 
(social) roles (questions 11 to 14). Second, three questions (questions 7 to 9) are directly 
asking about the ability to cover certain distances (Appendix 13.4.1. Additional material. 
Questionnaire used to assess self-reported physical fitness in the present study; in French). 
Interestingly, no association between parasitic infection status and the indices based on 
self-reported physical fitness was identified. However, by logical deduction, this finding had 
to be expected after no association was detected between parasitic infections and the 
objectively measured physical fitness in the umbrella study into which the current 
investigation was embedded
17
 and a strong association was found between the objectively 
measured physical fitness and self-reported physical fitness in the present study. The finding 
that the parasitic infection status does not prejudice physical fitness is also in line with some 
older investigations,
27,28
 but contradicts newer research
29-31
 and the widely held belief that 
schistosmiasis, soil-transmitted helminthiasis and malaria impair the infected individuals’ 
physical fitness. Some potential explanations and approaches for further research to better 
understand and solve this discrepancy have been discussed elsewhere.
17
 In brief, the 
participating Ivorian schoolchildren presented with clearly better physical fitness as for 
example age-matched Canadian counterparts.
23
 Differences in life-styles and nutrition might, 
at least to some degree, explain this observation.
32-35
 It has also been implied that the Ivorian 
children with a parasitic infection could maybe mask the incurred disability by their generally 
excellent level of physical fitness. The children may adapt quite well to parasitic infections 
that are acquired early in their life and the children do not yet experience disability caused by 
advanced chronic disease. Furthermore, it has been suggested that children attending school 
might not be fully representative in a given epidemiological setting, as children from poorest 
and furthest away households are less likely to be registered at school and at the same time 
more likely to be infected with parasites. It is also conceivable that children really suffering 
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from the adverse effects of the infections rest at home because of their signs and symptoms, 
and hence did not take part in our study. 
Of particular interest was the fact that the use of a QoL questionnaire, which proofed to 
be a valid tool to assess the schoolchildren’s physical fitness in the respective study area, 
permitted the inclusion of an additional 30 children who had to be excluded from the shuttle 
run test due to medical concerns. An attrition analysis indicated that this excluded group of 
children was not different from the group that could successfully complete the shuttle run test 
with regard to sex, age or parasitic infection status. However, the mean PF scores of the 
parasitized and excluded children was considerably lower than the mean PF scores of the 
children who were parasitized as well but able to participate in the shuttle run test. It could be 
hypothesized that mainly children who suffer the most from their parasitic infections were 
excluded from the physical fitness test – precisely because of experiencing severe sequelae. 
Supposedly due to the relatively small sample size, which was at least partially owed to our 
rigorous study design, the difference in PF between the two groups showed no statistical 
significance. As revealed by the analysis of the two different samples in Table 8.6., the 
inclusion of the 30 children who were probably most seriously affected by parasitic infections 
could not overpower the results of the other 137 children. Nevertheless, their inclusion was 
only possibly thanks to the QoL questionnaire results and their exclusion would have led most 
likely to biased results. 
 
8.6. Conclusion 
We consider the questionnaire employed in the present study as a valid tool to assess 
schoolchildren’s physical fitness in the respective study area. Nevertheless, further validation 
in other settings of Côte d’Ivoire (e.g., urban areas) and elsewhere in sub-Saharan Africa is 
warranted. The questionnaire was particularly useful in assessing physical fitness of those 
children who were unable to complete an exhausting physical fitness test. Future and 
preferably larger studies to assess disability caused by helminthic infections, other NTDs and 
malaria should use a test-retest design with intermittent treatment or even piggyback on 
continuous preventive chemotherapy campaigns. Furthermore, they should also consider 
dimensions of QoL other than physical fitness, for instance bodily pain and potentially 
following affection of vitality, mental health and social functioning. However, these 
dimensions are exceedingly difficult to measure with tools that do not include one or the other 
form of a questionnaire. This is even more true when affection is subtle as it is often the case 
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with NTDs. We believe that QoL questionnaires will gain further importance in eliciting and 
quantifying disability caused by NTDs. Hence, further development and validation of such 
tools, for instance by using mixed methods triangulation approaches, is warranted. 
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9.1. Abstract 
Background: Burden of disease estimates are widely used for priority setting in public health 
and disability-adjusted life years are a powerful ‘‘currency’’ nowadays. However, disability 
weights, which capture the disability incurred by a typical patient of a certain condition, are 
fundamental to such burden calculation and their determination remains a widely debated 
issue. 
Methodology: A cross-sectional epidemiological survey was conducted in the recently 
established Taabo health demographic surveillance system (HDSS) in south-central Côte 
d’Ivoire, to provide new, population-based evidence on the disability caused by 
schistosomiasis and soil-transmitted helminthiasis. Parasitological results from stool, urine, 
and blood examinations were juxtaposed to quality of life (QoL) questionnaire results from 
187 adults. A multivariable linear regression model with stepwise backward elimination was 
used to identify significant associations, considering also socio-demographic characteristics 
obtained from the Taabo HDSS database. 
Principal findings: Prevalences for hookworm, Plasmodium spp., Trichuris trichiura, 
Schistosoma haematobium and Schistosoma mansoni were 39.0%, 18.2%, 2.7%, 2.1% and 
2.1%, respectively. S. mansoni and T. trichiura infections of any intensity reduced the 
participants’ self-rated QoL by 16 points (95% confidence interval (CI): 4-29 points) and 13 
points (95% CI: 1-24 points), respectively, on a scale from 0 (worst QoL) to 100 points (best 
QoL). The only other statistically significant effect was a 1-point (95% CI: 0.1-2 points) 
increase on the QoL scale per one unit increase in a calculated wealth index. 
Conclusions/Significance: We found consistent and significant results on the negative effects 
of schistosomiasis and soil-transmitted helminthiasis on adults’ self-rated QoL, also when 
taking socio-demographic characteristics into account. Our results warrant further 
investigation on the disability incurred by helmintic infections and the usefulness of generic 
QoL questionnaires in this endeavor. 
Keywords: Schistosomiasis, soil-transmitted helminthiasis, Plasmodium spp., quality of life, 
questionnaire, Côte d’Ivoire. 
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9.2. Author summary 
In public health, ‘‘burden’’ estimates should capture the human suffering caused by certain 
health states, and the estimates are often used for priority setting. However, such ‘‘burden’’ 
estimates need to assess not only the number of affected people by certain conditions, but also 
the disability incurred by the average patient, and the determination of the degree of disability 
remains a widely debated issue. In order to provide new, population-based evidence on the 
disability caused by infections with parasitic worms, we administered a quality of life (QoL) 
questionnaire to 187 adults in rural Côte d’Ivoire and concurrently examined them for 
parasitic worm infections. We also considered socio-demographic characteristics in our 
analysis. In comparison with their non-infected counterparts, infected people reported a 13-16 
points lower QoL on a scale from 0 (worst QoL) to 100 points (best QoL). At the same time, a 
one unit increase in a calculated wealth index revealed a 1-point increase in the participants’ 
QoL. The results are consistent and warrant further investigation on the disability induced by 
parasitic worm infections and the usefulness of QoL questionnaires in this endeavor. 
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9.3. Introduction 
Efforts are underway for a comprehensive revision of the global burden due to major diseases, 
injuries, and risk factors.
1
 The initial global burden of diseases, injuries, and risk factors study, 
commissioned by the World Bank more than 20 years ago, introduced the disability-adjusted 
life year (DALY) metrics.
2
 DALY is a time-based measure, which combines years of life lost 
(YLL) due to premature death, and years of life lived with disability (YLD) due to a certain 
condition.
2
 Results from the initial global burden of disease study have been widely used for 
priority setting in research, policy, and practice, and the DALY became a powerful 
‘‘currency’’ in public health (see for example reference 3). 
An undeniable merit of the global burden of disease concept is the renewed interest in 
descriptive epidemiology and population health measurement. Not surprisingly though, the 
concept also stimulated considerable controversies. Amongst other issues, criticism about the 
disability weights, which should measure the disability caused by a certain condition on a 
continuous scale from 0 (perfect health) to 1 (death), was raised as the original disability 
weights were solely based on expert opinion.
2,4,5
 In order to respond to such shortcomings, the 
disability weights will be adapted in the current revisions of the global burden of diseases, 
injuries, and risk factors. According to the operations manual on the project’s homepage,6 the 
revised disability weights will be elicited not only by expert opinion, but also by an 
Internetsupported, multi-method study among qualified respondents and, for selected sequelae, 
by population-based discrete choice assessments. 
In order to provide new, setting-specific, population-based evidence on the disability 
caused by schistosomiasis and soil-transmitted helminth infections, we conducted a cross-
sectional survey among adults in the Taabo health demographic surveillance system (HDSS), 
in south-central Côte d’Ivoire. Generic quality of life (QoL) questionnaires and standardized, 
qualitycontrolled parasitological methods were applied and the results juxtaposed, taking into 
consideration readily available socio-demographic data from the Taabo HDSS database as 
potential confounders. To our knowledge, only few studies employed generic QoL 
questionnaires to assess disability attributable to helminth infections.
7-10
 However, these 
studies focused on school-aged children
8,9
 and other narrowly defined population subgroups 
(e.g., patients with advanced, chronic infections).
7,10
 The present study provides new insight 
regarding the usefulness and applicability of generic QoL questionnaires to elicit disabilities 
due to helminthiases in the general public. 
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9.4. Materials and methods 
9.4.1. Ethics statement 
The study protocol was approved by the institutional research commissions of the Swiss 
Tropical and Public Health Institute (Swiss TPH; Basel, Switzerland) and the Centre Suisse 
de Recherches Scientifiques en Côte d’Ivoire (CSRS; Abidjan, Côte d’Ivoire). Ethical 
clearance was provided by the ethics committee of Basel (EKBB; reference no. 316/08) and 
the Comité National d’Ethique et de la Recherche (CNER) in Côte d’Ivoire (reference no. 
1086 MSHP/CNER). 
The Taabo HDSS was set-up in mid-2008, located in the Taabo area in the south-central 
part of Côte d’Ivoire. While establishing the Taabo HDSS, district and village authorities and 
the general public were informed about its purpose, operational procedures, potential risks, 
and benefits. The present study was carried out in June 2010, readily embedded in the second 
crosssectional epidemiological survey pursued once every year. Written informed consent was 
obtained from all participants. It was emphasized that participation was voluntary, and hence 
people could withdraw anytime without further obligation. All results were coded and kept 
confidential. At the end of the study, all people living in the Taabo HDSS were invited for 
deworming with albendazole (400 mg single oral dose) and ivermectin (~200 µg/kg using a 
dose pole) irrespective of participants’ infection status.11,12 Additionally, a physician was 
present during our study and treated acute cases of infections, other diseases and injuries, or 
referred people to the district hospital in Taabo Cité if need be. Preventive chemotherapy 
against schistosomiasis, using praziquantel (~40 mg/kg according to a dose pole), was 
administered 6 months later. 
 
9.4.2. Study area and population 
The Taabo HDSS covers most of the rural Sous-Préfecture Taabo. Its main office is located in 
Taabo Cité, 160 km north-west of Abidjan. The region’s tropical climate follows a seasonal 
pattern with a long dry season between November and April and two rainy seasons, a long 
one between April and July and a shorter one in September and October.
13,14
 The area is at the 
interface of tropical rainforest in the south and the savannah in the north with the Bandama 
River running through from north to south. In 1979, construction of a large hydroelectric dam 
was completed (Figure 19).
15
 Malaria
16
 and neglected tropical diseases (e.g., 
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schistosomiasis
13,15,17 
and soil-transmitted helminthiasis
13,18
) are endemic and rapid re-
infection of Schistosoma haematobium has been observed after praziquantel administration.
17
 
Vital statistics (i.e., pregnancy, birth, death, in-migration, and out-migration) and the 
health of some 38,500 individuals registered in the Taabo HDSS are monitored longitudinally. 
People are mainly engaged in subsistence farming of manioc, yams, and banana, while cacao 
and coffee are farmed as cash crops.
13,14
 There are also some fishermen around Lake Taabo, 
some artisans, and – particularly in Taabo Cité – some shopkeepers and businessmen. 
 
 
Figure 19. Map of the Taabo health demographic surveillance system (HDSS) and predefined survey 
locations. The study was carried out in June 2010, readily embedded in the second annual cross-sectional 
epidemiological survey of the Taabo HDSS. 
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9.4.3. Individual and household data compilation 
For the present study, socio-demographic data on individual and household level were 
obtained from the Taabo HDSS database. Individual data included sex, age, relationship with 
the head of household, education, and main occupation. Household-level data contained 
information on the households’ location, the number of household members, housing 
construction material, availability of certain facilities, and the possession of equipment. 
 
9.4.4. Field and laboratory procedures 
All collaborators, including local health personnel, were trained and informed about the 
purpose, procedures, potential risks, and benefits of the cross-sectional survey and the 
deworming. Subsequently, key informants, field enumerators, and supervisors of the Taabo 
HDSS and the local health personnel informed all heads of households to visit, together with 
their families, a predefined, nearby survey location on a specified date and time to receive 
anthelmintic treatment. In addition, approximately 7% of all households in the Taabo HDSS 
were selected by stratified random sampling. These households were visited the day before 
the treatment and two plastic containers were distributed to all household members for 
collection of a lemon-sized fresh morning stool and a urine sample the next day. 
On the day of treatment, people not selected for in-depth clinical and parasitological 
examinations received albendazole and ivermectin and they could continue with their daily 
chores (Figure 20). People who suffered clinical episodes (e.g., infants with an axillary 
temperature ≥37.5°C and a history of fever) were seen by a physician and provided 
antimalarial treatment or other specific interventions if need be. Families selected for clinical 
and parasitological examinations were sent to a first post to provide written informed consent 
and collection of stool and urine samples. At a second post, qualified technicians measured 
participants’ weight and height and took a finger prick blood sample. One drop of blood was 
taken for a rapid diagnostic test (RDT) for malaria (ICT ML01 malaria Pf kit, ICT 
Diagnostics; Cape Town, South Africa), another drop for the analysis of hemoglobin 
(HemoCue Hb 301 System, HemoCue; Ängelholm, Sweden), and another two drops for thin 
and thick blood film preparation on microscope slides. At post three, trained field enumerators 
invited the heads of households and, if possible, a second adult household member of the 
opposite sex to independently fill out a questionnaire. At the next post, participants were 
clinically examined by a physician and, if need be, given specific treatment according to 
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national guidelines. In a last step, participants were sent to the albendazole and ivermectin 
treatment post. 
 
 
Figure 20. Flow chart of the study procedure in the field. The study was carried out in June 2010, readily 
embedded in the second annual cross-sectional epidemiological survey of the Taabo health demographic 
surveillance system (HDSS). In the frame of this second annual cross-sectional epidemiological survey, the 
whole population of the Taabo HDSS was offered anthelmintic treatment with albendazole and ivermectin. At 
the same time, people selected for an in-depth clinical and parasitological examination were invited to visit a 
series of different posts, including a quality of life (QoL) questionnaire for heads of households and a second 
adult household member of the opposing sex. 
 
Blood, stool, and urine samples were transferred to the laboratory of the hospital in Taabo 
Cité and worked up the same day using standardized, quality-controlled techniques as 
described elsewhere.
13,14,19-21
 In short, duplicate 41.7 mg Kato-Katz thick smears were 
prepared from each stool sample. After a clearing time of 30-45 min, the thick smears were 
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examined under a microscope for soil-transmitted helminths (Ascaris lumbricoides, Trichuris 
trichiura, and hookworm) and Schistosoma mansoni. The sum of the helminth-specific egg 
counts of the two Kato-Katz thick smears were multiplied by a factor 12 to obtain infection 
intensities, as expressed in eggs per gram of stool (EPG). Urine samples were vigorously 
shaken, 10 ml drawn up into a syringe and pressed through a meshed nylon filter with a pore 
size of 20 mm (Sefar AG; Heiden, Switzerland). Next, filters were placed on a microscope 
slide and, after adding a drop of Lugol, examined for S. haematobium eggs under a light 
microscope. All parasitological examinations were performed by experienced laboratory 
technicians. For quality control, ~5% of all microscope slides were re-examined by a senior 
technician. In case of disagreement, slides were read a third time and the result discussed 
among the technicians until agreement was reached. Thin and thick blood films were stained 
with Giemsa and examined for Plasmodium parasitemia. 
 
9.4.5. Questionnaire survey 
We used previously employed questionnaires in Côte d’Ivoire22-25 and developed them further 
so that they allowed us to assess risk factors, signs, and symptoms related to neglected 
tropical diseases and malaria, and added one section pertaining to the respondent’s QoL. The 
World Health Organization (WHO) Quality of Life-BREF (WHOQOL-BREF) 
questionnaire
26
 served as template for the section on QoL, as previous studies with other 
generic questionnaire tools revealed ambiguous results in the People’s Republic of China7,8,10 
and also in a first pre-testing in the frame of another study in the Taabo HDSS
13
 (data on pre-
testing of QoL questionnaires not shown). 
The initial version of the questionnaire after translation into French was discussed with 
the field enumerators and supervisors of the Taabo HDSS. These field enumerators and 
supervisors are locals, who live in the different communities of the Taabo HDSS, are able to 
read, write, and speak French as well as the local languages Baoulé, Dioula, or Senufo. The 
questionnaire was further adapted based on their comments, then pre-tested in a nearby 
village and again refined in order to obtain the finally applied version (Appendix 13.5.2. and 
13.5.3.). During the survey, the same field enumerators and supervisors of the Taabo HDSS 
conducted the interviews, either in French or any of the aforementioned local languages. 
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9.4.6. Statistical analysis 
Data were double-entered and cross-checked in EpiInfo version 3.5.1 (Centers for Disease 
Control and Prevention; Atlanta, United States of America) and analyzed in STATA version 
10.1 (STATA Corp.; College Station, United States of America). For convenience, the myriad 
of main occupations obtained from the Taabo HDSS database were categorized into primary 
economic sector (i.e., making direct use of natural resources, such as farming), secondary 
economic sector (i.e., producing manufactured and other processed goods), and tertiary 
economic sector (i.e., producing services, such as education and health care), with housewives 
included in the primary sector as they are usually involved in (subsistence) farming. Socio-
economic household data were used to calculate an assetbased wealth index and deduce the 
inhabitants’ socio-economic status, according to an approach put forth in a World Bank 
publication.
27
 The results on soil-transmitted helminth infections and schistosomiasis were 
classified into infection intensities (light, moderate, and heavy) according to WHO 
guidelines.
11
 Malaria results from RDTs could only be considered as binary variables 
(positive/negative). Information on QoL was analyzed and summarized according to the 
WHOQOL user manual.
28
 Questionnaire answers on QoL were coded as 1, 2, 3, or 4 with 
higher scores indicating elevated QoL (Appendix 13.5.2. and 13.5.3.). The individual scores 
from questions 11, 12, 16, 17, 18, and 24 were summed up to form the score on domain 1 
about the environmental well-being; the individual scores from questions 19, 21, 22, 23, and 
25 were added and formed the score on domain 2 about the psychological well-being; the 
individual scores from questions 10, 13, 20, 26, 27, 28, and 29 were summed up to form the 
score on domain 3 about the physical well-being; and the individual scores from questions 14 
and 15 were added and formed the score on domain 4 about the social well-being. All 
individual scores from questions 9 to 29 were summed up to form each participant’s overall 
score on QoL. All scores were transformed to values between 0 and 100 (i.e., percentages) 
according to equation (1): 
 
 
100*




 

rangescorerawpossible
scorerawpossiblelowestscorerawactual
scoredtransforme   (1) 
 
A Kruskal-Wallis test was performed to check for statistically significant (p < 0.05) 
variations in the mean QoL scores assessed by the different interviewers (i.e., check for inter-
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observer variation). Furthermore, to assess the internal consistency and validity of the 
resulting QoL scores, we used Cronbach’s alpha and a univariable linear regression model 
with the calculated overall QoL scores as outcome and the QoL ratings directly expressed by 
the participants in the final question of the questionnaire as explanatory variable (Appendix 
13.5.2. and 13.5.3., see question 30: ‘‘How would you rate your quality of life in general? 
Very good? Good? Bad? Very bad?’’). 
Wilcoxon rank sum and Kruskal-Wallis test, χ2 and Fisher’s exact test were employed, as 
appropriate, to check for statistically significant univariable associations between the different 
socio-demographic, parasitological, and Qol indicators. The outcome on QoL was further 
scrutinized in a multivariable linear regression analysis with socio-demographic data (i.e., age, 
sex, education, occupation, and socio-economic status) and parasitological findings (i.e., 
schistosomiasis, soil-transmitted helminth infections, and malaria) as explanatory variables, 
considering also potential clustering of the results in interviewers and residential areas. A 
stepwise backward elimination procedure of non-significant explanatory factors was adopted 
to identify those variables most significantly influencing the participants’ scores on QoL. In 
each iteration, the explanatory variable with the highest p-value was eliminated as long as the 
Akaike information criterion (AIC) was decreasing and the likelihood ratio test indicated no 
statistically significant association between the eliminated explanatory variable and the QoL 
scores. Categories of the same explanatory variable were combined, based on expert 
knowledge and logical deduction, before eventually eliminating the respective variable. 
Only participants with signed written informed consent and complete data records (i.e., 
responses to all questions, duplicate Kato-Katz thick smears, urine filtration, and RDT for 
malaria) were included in the final analysis. Participants with completed written informed 
consent and questionnaire, but incomplete parasitological results were included in an attrition 
analysis. 
 
9.5. Results 
9.5.1. Operational results and socio-demographic characteristics 
Overall, 255 adults were invited to participate in the study (Figure 21). Seven did not provide 
written informed consent or were unwilling to participate in the questionnaire survey, mostly 
because they were pressed for time. Moreover, 36 adults had no valid results from stool 
examination, as they failed to provide sufficiently large stool samples for duplicate Kato-Katz 
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thick smear examination. Another 17 individuals had no valid results from the urine 
examination and eight were excluded as they did not have any malaria RDT results. Hence, 
the final study sample consisted of 187 adults; 98 males and 89 females. The median age was 
45 years for both males (range: 18-87 years) and females (range: 21-83 years) (p = 0.926). 
About half (n = 92, 49.2%) of the participants were heads of household. 
 
 
Figure 21. Flow chart of the participation and compliance in the present study. The study was carried out in 
June 2010, readily embedded in the second annual cross-sectional epidemiological survey of the Taabo health 
demographic surveillance system. 
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The educational level and the main sector of occupation are summarized in Table 25. The 
data on education reveal that a substantial number of participants have never attended school 
and, whereas the differences between age groups were not statistically significant (p = 0.663), 
women reported a significantly lower educational level than men (p = 0.046). Differences in 
occupational sector categorization showed no statistically significant difference between sex 
(p = 0.295) and age groups (p = 0.218) with most participants working in the primary sector 
(mainly subsistence farming) and only very few in the secondary sector. Not surprisingly, 
higher educated people were more often working in the tertiary rather than in the primary or 
secondary sectors (p < 0.001). 
Results from the socio-economic analysis are shown in Table 26. According to the wealth 
quintiles, participants’ socio-economic status were not significantly related to sex (p = 0.377) 
or age group (p = 0.060), but positively associated with the educational level and working in 
the tertiary sector (both p < 0.001). 
 
Table 25. Educational level and main sector of occupation among 187 adults in rural Côte d’Ivoire. 
Age Sex Number Educational level  Main sector of occupation 
(years)  asked None Primary Secondary Higher  Primary
a
 Secondary
b
 Tertiary
c
 
    school school education     
18-40 Male 37 15 11 9 2  31 1 5 
 Female 29 19 5 4 1  23 0 6 
41-60 Male 36 12 10 13 1  26 1 9 
 Female 48 30 8 8 2  29 4 15 
60+ Male 25 17 1 7 0  19 1 5 
 Female 12 7 4 1 0  8 1 3 
All Male 98 44 22 29 3  76 3 19 
All Female 89 56 17 13 3  60 5 24 
All Both 187 100 39 42 6  136 8 43 
Educational level and main sector of occupation among 187 adults interviewed in the Taabo health demographic 
surveillance system, south-central Côte d’Ivoire, in June 2010. Results are stratified by age and sex. aParticipants 
being farmer, fisher, hunter, or housewife. 
b
Participants being builder or artisan. 
c
Participants being driver, 
housekeeper, watchman, merchant, trader, hairdresser, gastronome, healer, nurse, teacher, student, office worker, 
or policeman. 
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Table 26. Overview of asset possession and the calculated socio-economic status among 187 adults in rural 
Côte d’Ivoire. 
Asset Percentage of participants possessing the asset 
  Total Wealth quintiles 
   Most Very Poor Less Least 
   poor poor (n = 38) poor poor 
   (n = 39) (n = 36)  (n = 37) (n = 37) 
Type of housing             
 Traditional hut 31.0 66.7 63.9 18.4 5.4 0.0 
 Barrack 1.1 5.1 0.0 0.0 0.0 0.0 
 Collective dwelling 1.1 0.0 0.0 0.0 2.7 2.7 
 Simple house 7.0 0.0 0.0 2.6 8.1 24.3 
 Row house 18.7 0.0 2.8 5.3 40.5 46.0 
 Modern house 22.5 0.0 11.1 42.1 32.4 27.0 
 Other housing 18.7 28.2 22.2 31.6 10.8 0.0 
People per sleeping room
a
 2.1 2.3 1.9 1.8 2.5 2.2 
Main lighting at home       
 Lantern 29.4 87.2 58.3 0.0 0.0 0.0 
 Fix electric lighting 65.8 0.0 30.6 100.0 100.0 100.0 
 Other lighting 4.8 12.8 11.1 0.0 0.0 0.0 
Energy source for cooking      
 Wood 80.8 100.0 94.4 100.0 81.1 27.0 
 Wood + coal 10.7 0.0 0.0 0.0 13.5 40.5 
 Coal 3.7 0.0 0.0 0.0 5.4 13.5 
 Gas + coal 1.6 0.0 5.6 0.0 0.0 2.7 
 Gas 3.2 0.0 0.0 0.0 0.0 16.2 
Equipment       
 Hand barrow 9.6 0.0 11.1 5.3 13.5 18.9 
 Cistern 32.6 30.8 22.2 50.0 29.7 29.7 
 Mobile phone 67.4 20.5 80.6 65.8 78.4 94.6 
 Radio 64.2 46.2 69.4 55.3 64.9 86.5 
 TV 33.2 0.0 0.0 23.7 54.1 89.2 
 Pirogue 6.4 2.6 8.3 10.5 8.1 2.7 
 Bicycle 73.8 76.9 72.2 79.0 73.0 67.6 
 Moped 13.9 0.0 0.0 13.2 13.5 43.2 
 Ventilator 27.8 0.0 0.0 13.2 46.0 81.1 
 Fridge 5.9 0.0 0.0 0.0 2.7 27.0 
  Freezer 5.9 0.0 0.0 0.0 0.0 29.7 
Overview of asset possession and the calculated socio-economic status among 187 adults interviewed in the 
Taabo health demographic surveillance system, south-central Côte d’Ivoire, in June 2010. aReports the average 
number of people per sleeping room in the respective wealth quintile. 
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9.5.2. Parasitological results 
Sex- and age-specific prevalence and intensity of helminth infection and Plasmodium 
infection are summarized in Table 27. We found hookworm, Plasmodium spp., T. trichiura, 
S. haematobium and S. mansoni prevalences of 39.0%, 18.2%, 2.7%, 2.1% and 2.1%, 
respectively. Most helminth infections were of light intensity and no heavy infections were 
diagnosed at all. With the exception of a higher prevalence of Plasmodium spp. infection in 
people aged 60 years and above (p = 0.028), no significant differences occurred in the 
prevalence and intensity of helminth and Plasmodium infection with regard to sex, age group, 
educational level, and occupational sector. Regarding participants’ socio-economic status, 
hookworm prevalence (p < 0.001) and infection intensity (p = 0.002) as well as T. trichiura 
prevalence (p = 0.025) were significantly lower in wealthier participants. 
 
9.5.3. Self-reported QoL 
Thirteen different field enumerators and supervisors of the Taabo HDSS were involved in 
interviewing the study participants, with no statistically significant inter-observer variation in 
reported mean QoL scores (p = 0.104). The mean summary score on QoL was 63.9 (range: 
21.2-93.9) and Cronbach’s alpha (0.805) indicated a good internal consistency of the QoL 
scores. The univariable linear regression model with the calculated QoL summary scores as 
outcome, and the QoL ratings directly expressed by the participants as explanatory variable, 
indicated a statistically significant positive correlation (p < 0.001). The calculated scores on 
the four different domains and the summary score on QoL are illustrated in Figure 22. 
Generally lower scores were obtained for the domains comprising the participants’ 
environment and psychological well-being, and higher scores for the physical and social well-
being. 
The mean domain and overall QoL scores in relation to socio-demographic and 
parasitological variables are shown in Table 28. The only statistically significant differences 
in the univariable analysis were an increased score in the environmental well-being of higher 
educated people (p = 0.043), those belonging to the wealthiest quintile (p = 0.006), and people 
with no hookworm infection (p = 0.002). 
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Figure 22. Box plots illustrating the different domain and overall quality of life scores as revealed in the 
present study. The study was carried out in June 2010, readily embedded in the second annual cross-sectional 
epidemiological survey of the Taabo health demographic surveillance system. The different domain and overall 
quality of life (QoL) scores were obtained through questionnaire-based QoL interviews with the study 
participants. The participants’ scores were measured on a scale from 0 to 100, as detailed on the y-axis of the 
figure, with higher scores indicating higher well-being. Domain 1 = environmental well-being. Domain 2 = 
psychological well-being. Domain 3 = physical well-being. Domain 4 = social well-being. Box plot: the ends of 
the box represent the 25
th
 and 75
th
 percentile of the scores; the middle line represents the median; the lower 
whisker represents the lowest value between the lower quartile and the lower quartile - 1.5 * (interquartile 
range); the upper whisker represents the highest value between the upper quartile and the upper 
quartile + 1.5 * (interquartile range); the small squares, triangles, and crosses indicate outliers. 
 
The wealth index (p = 0.034) and S. mansoni and T. trichiura infections of any intensity 
(p = 0.011 and p = 0.035, respectively) remained as the only three statistically significant 
explanatory variables for the overall QoL scores in the multivariable linear regression model 
with backward elimination (Table 29 and Appendix 13.5.4.). The other three remaining 
variables after backward elimination were sex (p = 0.067), working in the secondary or 
tertiary sectors (p = 0.094), and hookworm infection of any intensity (p = 0.061). Whether age 
and wealth were used as continuous variables (e.g., age in years and wealth as wealth index as 
in the presented model) or as categorical variables (e.g., age as age categories and/or wealth 
as wealth quintiles; details on these models are not shown) influenced these findings only 
insofar as the individuals’ occupation was also eliminated in the latter models. 
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Table 29. Associations remaining in the multivariable linear regression model after stepwise backward 
elimination. 
Explanatory variable Coeff. 95% CI p-value 
Sex
a
 -3.5 (-7.3, 0.2) 0.067 
Working in secondary or tertiary sectors
b
 3.8 (-0.7, 8.3) 0.094 
Wealth index
c
 1.2 (0.1, 2.3) 0.034* 
S. mansoni infection of any intensity
d
 -16.4 (-29.2, -3.7) 0.011* 
Hookworm infection of any intensity
e
 -3.9 (-8.0, 0.2) 0.061 
T. trichiura infection of any intensity
f
 -12.6 (-24.4, -0.9) 0.035* 
A multivariable linear regression model with a stepwise backward elimination procedure was adopted in order to 
identify those explanatory variables, which most significantly influence the study participants’ quality of life 
(QoL) scores. The explanatory variables and indicators of the multivariable linear regression model at each step 
of the backward elimination procedure are shown in the supporting information (Appendix 13.5.4.). The data on 
socio-demographic factors, parasitology, and QoL of the 187 study participants were collected in the Taabo 
health demographic surveillance system, south-central Côte d’Ivoire, in June 2010. CI = confidence interval. 
a
Reference category: male. 
b
Reference category: primary sector. 
c
Continuous variable. 
d
Reference category: no 
S. mansoni infection. 
e
Reference category: no hookworm infection. 
f
Reference category: no T. trichiura 
infection. *Statistically significant (p < 0.05). 
 
 
9.5.4. Attrition analysis 
Comparison of participants who were included in the final analysis and participants who gave 
written informed consent and completed the questionnaire, but dropped out due to incomplete 
parasitological data, revealed no statistically significant differences in socio-demographic 
characteristics (Table 30) or mean domain and overall QoL scores (Table 31). Moreover, our 
attrition analysis revealed no significant difference between included and excluded people in 
terms of mean domain and overall QoL scores. 
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Table 30. Attrition analysis comparing socio-demographic determinants between included and excluded 
individuals. 
Socio-demographic factor Included Excluded p-value
a
 
 (n = 187) (n = 61)  
Sex: male 98 25  
Sex: female 89 36 0.121 
Age: 18-40 years 66 27  
Age: 41-60 years 84 28  
Age: over 60 years 37 6 0.163 
Education: no 100 34  
Education: primary school 39 18  
Education: secondary school 42 8  
Education: higher education 6 1 0.277 
Occupation: primary sector 136 50  
Occupation: secondary sector 8 0  
Occupation: tertiary sector 43 11 0.164 
Socio-economic status: most poor 33 18  
Socio-economic status: very poor 35 14  
Socio-economic status: poor 42 8  
Socio-economic status: less poor 39 10  
Socio-economic status: least poor 38 11 0.189 
The socio-demographic determinants of the 248 individuals who participated in the questionnaire survey were 
collected in the Taabo health demographic surveillance system, south-central Côte d’Ivoire, in June 2010. ap-
values from comparing the number of included individuals vs. the number of excluded individuals with a specific 
socio-demographic determinant by using χ² and Fisher’s exact test, as appropriate. 
 
 
Table 31. Attrition analysis comparing mean domain and overall quality of life scores between included 
and excluded individuals. 
Quality of life indicator Included Excluded p-value
a 
 (n = 187) (n = 61)  
Domain 1: environmental well-being 50.6 49.6 0.770 
Domain 2: psychological well-being 62.6 60.9 0.464 
Domain 3: physical well-being 71.3 68.0 0.213 
Domain 4: social well-being 85.3 83.3 0.632 
Overall quality of life 63.9 62.3 0.468 
The domain and overall quality of life (QoL) scores of the 248 individuals who participated in the questionnaire 
survey were collected in the Taabo health demographic surveillance system, south-central Côte d’Ivoire, in June 
2010. 
a
p-values from comparing the mean domain and overall QoL scores between included and excluded 
individuals by using Wilcoxon rank sum test. 
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9.6. Discussion 
We present an analysis from a QoL questionnaire survey conducted alongside the 2010 cross-
sectional epidemiological survey and deworming campaign in the Taabo HDSS in south-
central Côte d’Ivoire. Results of a multivariable linear logistic regression model revealed that 
adults’ QoL is reduced considerably among those infected with different species of helminths, 
regardless of the intensity of infection. Indeed, we found that the perceived QoL among adults 
infected with S. mansoni and T. trichiura was 16 points (95% confidence interval (CI): 4-29 
points) and 13 points (95% CI: 1-24 points) lower on a scale from 0 to 100 than the reported 
QoL of non-infected individuals. The only other statistically significant effect was a 1-point 
(95% CI: 0.1-2 points) increase in QoL per one unit increase in the wealth index. Other 
important explanatory variables that remained in our multivariable linear regression model 
after applying a stepwise backward elimination procedure were sex, indicating a 4 points 
(95% CI: 27-0.2 points) decrease in QoL of females; occupation, indicating a 4 points 
(95% CI: 20.7-8 points) increase in QoL of those working mainly in the secondary or tertiary 
sectors; and hookworm infections, indicating a 4 points (95% CI: 28-0.2 points) decrease in 
QoL of those infected. 
Our results have to be interpreted with caution, but raise many interesting issues. As a 
first critical point, it has to be considered that the sampling of the current study depended on a 
stratified random sampling. Starting in mid-2009, our team pursued a yearly cross-sectional 
epidemiological survey among approximately 7% of the people who were under demographic 
and health surveillance in the Taabo HDSS. The present study was linked to the June 2010 
cross-sectional survey, using a sub-sample (i.e., all head of households plus a second 
randomly selected person of the same household but the opposite sex to maintain gender 
balance). Given our sampling approach and in view of operational and financial 
considerations, no formal sample size calculation was made for the present study. 
Second, our final sample size of 187 individuals was relatively small and the compliance 
rate of 73.3% suboptimal. However, somewhat higher drop-out rates had to be expected as the 
participants were adults, many of whom were illiterate. Compared to school-aged children, 
adults seemed to be somewhat reluctant or ashamed to provide any stool or urine samples. 
Importantly though, the attrition analysis revealed no statistically significant differences in the 
available indicators between the included and excluded adults, and hence no selection bias 
seems to have been introduced by the drop-outs. 
Third, the absence of a statistically significant inter-observer variation suggests that our 
questionnaire results are reliable. Cronbach’s alpha as well as the highly significant positive 
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correlation between the calculated summary scores on QoL based on all questions and the 
QoL ratings directly expressed by the participants in the final question of the questionnaire 
indicate internal consistency and validity of the QoL scores. 
Fourth, the parasitological diagnosis was based on single stool and urine samples with 
duplicate Kato-Katz thick smear examinations and single urine filtration, respectively. There 
is a large body of work demonstrating that multiple sampling or a combination of diagnostic 
methods result in more accurate diagnosis.
29,30
 It follows that we missed some helminth 
infections, particularly those of light intensity. At this stage, it is difficult to say how these 
false negative results might have influenced our findings. However, assuming that helminth 
infections have no beneficial impact on patients’ QoL, one hypothesis would be that the false 
negative results mistakenly lowered the QoL of the uninfected comparison group in our study. 
Furthermore, assuming that most individuals with false negative results suffered from light 
infections (like most of those effectively diagnosed as infected), a next hypothesis is that false 
negative results do not systematically distort the QoL of the infected comparison group. This 
hypothesis would even hold true when expecting a correlation between infection intensity and 
QoL. One could therefore argue that the false negative results may have mistakenly reduced 
the measured QoL difference between the uninfected and infected comparison group in our 
study. 
Fifth, the mean domain and overall QoL scores displayed in Table 28 were consistently 
lower in participants with helminth infections compared to their helminth-free counterparts. 
For instance, participants tested positive for S. mansoni reported a statistically non-significant, 
but consistent decrease in the mean environmental (p = 0.251), psychological, physical, and 
social well-being (all p < 0.2). This remarkable consistency increases the plausibility of the 
presented findings. However, with regard to Plasmodium spp. infections the picture was less 
clear. Participants with positive malaria RDTs reported higher mean scores on environmental 
and physical well-being and had higher overall QoL score. These counterintuitive findings 
might at least partially be explained by false positive results of the RDTs because of delayed 
clearance of the circulating antigen
31
 and by the acquired semi-immunity of probably all 
examined adults leading to usually uncomplicated malaria with mild symptoms.
32
 
Sixth, the effects of the socio-demographic determinants on the mean domain and overall 
QoL scores were somewhat less clear in the univariable comparison as summarized in Table 
28. However, the statistically significantly higher scores in environmental well-being of 
higher educated adults and the wealthiest participants demonstrate also the unsurprising 
importance of socio-demographic determinants. This statement is supported by the fact that 
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sex, the sector of occupation, and the wealth index also remained in the multivariable linear 
regression model after the stepwise backward elimination. 
Seventh, there were only a few people infected with S. haematobium, S. mansoni, and 
T. trichiura in our study sample and even though the probably most obvious confounders (e.g., 
age, sex, educational attainment, occupation, and socio-economic status) were included in our 
analyses, we cannot rule out an effect of other potential confounders (e.g., lack of access to 
clean water and sanitation). Furthermore, we did not consider infection intensities or explore 
interaction terms for combined infections in our multivariable linear regression model as more 
complex modeling was not possible due to the comparatively small numbers. 
Eighth, the here presented decrease of 16 points on the 0 to 100 QoL scale due to 
S. mansoni infections can be interpreted as a disability of 16%. This disability estimate is 
slightly below previously presented results from QoL surveys on advanced, chronic 
S. japonicum in the People’s Republic of China, which revealed a mean disability of 19%7 
and up to even 45%
10
. However, our results are considerably higher than current WHO 
estimates, which indicate a disability of only 1% for any Schistosoma infection and 10% for 
advanced renal or hepatic infection.
33
 Unfortunately, no QoL surveys for comparison could be 
identified with regard to soil-transmitted helminth infections. However, if the 13 points 
reduction for T. trichiura infections and the 4 points reduction for hookworm infections are 
also considered as disabilities of 13% and 4%, they are in the range of the disability weights 
listed by WHO (trichuriasis-associated high intensity infection 0%, contemporaneous 
cognitive deficit 1%, massive dysentery syndrome 12%, and cognitive impairment 2%; 
hookworm-associated high intensity infection 1%, anemia 2%, and cognitive impairment 
2%).
33
 
In conclusion, we found consistent and significant results on the effect of schistosomiasis, 
soil-transmitted helminthiasis, and socio-demographic determinants on adults’ QoL in rural 
Côte d’Ivoire. It is conceivable that helminth-infected adults in the present study suffered 
from advanced chronic infections and therefore reported notable losses in QoL. Our results 
warrant further investigation on the disability induced by helmintic infections and further 
probing of the usefulness and applicability of generic QoL questionnaires in this regard. 
Future studies should adhere to a more rigorous sampling strategy and sample size calculation, 
optimally in a randomized trial design, which allows for an improved control of potential 
confounders and the assessment of interactions due to combined infections. Furthermore, they 
should consider additional qualitative research to further explore the local residents’ concept 
about QoL, additional verification of the QoL questionnaire’s reliability and validity (e.g., 
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test-retest comparison, comparison of questionnaire results with objectively measurable 
indicators
9
), more intensive parasitological diagnosis (e.g., repeated stool, urine, and blood 
sampling, multiple testing, and concurrent use of different diagnostic methods), further 
analyses regarding the effects of differing infection intensities, and clinical examinations (e.g., 
stethoscopy and ultrasound) to confirm chronic sequelae and other medical complaints. 
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10.1. Abstract 
Background: Schistosomiasis and soil-transmitted helminthiasis are two high-burden 
neglected tropical diseases. In highly endemic areas, control efforts emphasize preventive 
chemotherapy. However, as morbidity, infection, and transmission begin to decrease, more 
targeted treatment is likely to become more cost-effective, provided that comparatively cheap 
diagnostic methods with reasonable accuracy are available. 
Methodology: Adults were administered an anamnestic questionnaire in mid-2010 during a 
cross-sectional epidemiological survey in the Taabo health demographic surveillance system 
in south-central Côte d’Ivoire. Questions pertaining to risk factors and signs and symptoms 
for schistosomiasis and soil-transmitted helminthiasis were included. The individuals’ 
helminth infection status and their belonging to three different anthelmintic treatment groups 
were compared with the questionnaire results (i) to inform the local health authorities about 
the epidemiological and clinical footprint of locally prevailing helminthiases, and (ii) to 
explore the scope and limits of an anamnestic questionnaire as monitoring tool, which 
eventually could help guiding the control of neglected tropical diseases in control-induced 
low-endemicity settings. 
Principal findings: Our study sample consisted of 195 adults (101 males, 94 females). We 
found prevalences of hookworm, Trichuris trichiura, Schistosoma haematobium, and 
Schistosoma mansoni of 39.0%, 2.7%, 2.1%, and 2.1%, respectively. No Ascaris lumbricoides 
infection was found. Helminth infection intensities were generally very low. Seven, 74 and 79 
participants belonged to three different treatment groups. Multivariable logistic regression 
models revealed statistically significant (p < 0.05) associations between some risk factors, 
signs, and symptoms, and the different helminth infections and treatment groups. However, 
the risk factors, signs, and symptoms showed weak diagnostic properties. 
Conclusions/Significance: The generally low prevalence and intensity of helminth infection 
in this part of south-central Côte d’Ivoire indicates that recent control efforts have turned our 
study area into a low endemicity setting. Our anamnestic questionnaire had low sensitivity 
and specificity to identify infected individuals or treatment groups. 
Keywords: Schistosomiasis, soil-transmitted helminthiasis, anamnestic questionnaire, 
helminthiasis control, Côte d’Ivoire. 
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10.2. Introduction 
Schistosomiasis and soil-transmitted helminthiasis are two high burden neglected tropical 
diseases.
1
 Burden estimates, as expressed in disability-adjusted life years (DALYs), range 
from 1.7 to 70 million DALYs for schistosomiasis,
1-8
 and from 2.9 to 39 million DALYs for 
soil-transmitted helminthiasis.
1,3,4,8,9
 The awareness for these high disease burdens have 
increased in the past few years, but despite the fact that control efforts are going to scale, a 
variety of high and low endemicity zones remain around the globe.
10,11
 
The main strategy to combat the diseases in highly endemic areas is morbidity control. 
Once morbidity has decreased, the control strategies foresee a progressive shift toward 
infection and transmission control, surveillance and case detection and, ultimately, local 
elimination.
12-14
 Consequently, the diagnosis, treatment, and control strategies have to be 
adapted.
13,15,16
 For instance, in high endemicity areas, preventive chemotherapy (i.e., regular 
treatment of high-risk groups without prior diagnosis
17
) using available, safe, and efficacious 
drugs that are inexpensive or donated by pharmaceutical companies, is the most widely used 
strategy.
17,18
 However, as morbidity, infection, and transmission begin to decrease, more 
targeted treatment might become more cost-effective,
19
 provided that comparatively cheap 
diagnostic methods with reasonable accuracy are available.
13
 Such diagnostics have to 
consider the changes in parasite ecology that increasingly occur due to the scale-up of 
preventive chemotherapy and the expansion of more integrated control strategies, which 
tackle multiple helminth species simultaneously
18,20
 and also on non-drug-based routes (e.g., 
providing clean water and improved sanitation).
21,22
 Hence, control-induced low-endemicity 
settings have become the new reality of helminth epidemiology in many areas. 
Simple, rapid, inexpensive, and culturally adapted questionnaires have been considered as 
useful diagnostic tools to screen communities and guiding control interventions over the past 
years.
23
 Regarding schistosomiasis, for example, school-based questionnaires proved useful 
for identification of high-risk communities of Schistosoma haematobium.
24
 Indeed, school 
prevalence of self-reported blood in urine correlates well with the prevalence of 
S. haematobium.
24
 A simple anamnestic questionnaire, including questions on signs, 
symptoms, and water contact patterns, allowed individual diagnosis of S. japonicum.
25
 
However, adaptation for S. mansoni and other helminth infections proved to be more 
difficult
13,24,26
 and the usefulness of anamnestic questionnaires seems to be restrained in 
regions with naturally low helminth endemicity as noticeable signs and symptoms are rare. 
Further research is therefore needed to determine the scope and limits of anamnestic 
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questionnaires when they are employed over the course of control programs, which are 
characterized by declining morbidity and prevalence rates.
13,23,27
 
In this paper, we report our experience from a cross-sectional survey carried out in mid-
2010 as part of a prospective longitudinal monitoring of people’s malaria and neglected 
tropical diseases status in the Taabo health demographic surveillance system (HDSS) in 
south-central Côte d’Ivoire. The study area represents an epidemiological situation, which is 
influenced by helminth control activities.
28
 The two objectives of the survey were (i) to assess 
risk factors, signs, and symptoms related to schistosomiasis and soil-transmitted helminthiasis 
in order to inform the local health authorities about the epidemiological and clinical footprint 
of these two helminthiasis, and (ii) to explore the scope and limits of an anamnestic 
questionnaire as monitoring tool, which eventually could help guiding the control of 
neglected tropical diseases in control-induced low-endemicity settings. 
 
10.3. Methods 
10.3.1. Ethics statement 
The study protocol was cleared by the institutional research commissions of the Centre Suisse 
de Recherches Scientifiques en Côte d’Ivoire (CSRS; Abidjan, Côte d’Ivoire) and the Swiss 
Tropical and Public Health Institute (Swiss TPH; Basel, Switzerland). Ethical clearance was 
obtained from the Comité National d’Ethique et de la Recherche (CNER) in Côte d’Ivoire 
(reference no. 1086 MSHP/CNER) and the ethics committee in Basel (EKBB; reference 
no. 316/08). 
The study was integrated in the second annual parasitological survey and preventive 
chemotherapy campaign in the Taabo HDSS in June 2010. District and village authorities and 
the general public were informed about the purpose, procedures, potential risks and benefits 
of the annual survey, treatment, and the current questionnaire study. Written informed consent 
was obtained from all participants of the present study. Everybody living in the area of the 
Taabo HDSS was invited for a free anthelmintic treatment with ivermectin (~200 μg/kg using 
a dose pole) and albendazole (400 mg single oral dose), irrespective of the infection status or 
participation in the present study.
29,30
 Praziquantel (40 mg/kg using a dose pole), was 
administered half a year later for individuals aged 5 years and above in the course of a 
preventive chemotherapy campaign against schistosomiasis.
29
 Medical staff accompanied the 
survey, anthelmintic treatment, and follow-up. 
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10.3.2. Study area and population 
The study area and population have been described elsewhere.
31
 In brief, the Taabo HDSS 
was established in 2008 around Lake Taabo in south-central Côte d’Ivoire. It covers most of 
the rural sub-district of Taabo with a surface area of approximately 1,000 km
2
. Since 2012, 
the Taabo HDSS is a member center of the INDEPTH Network (see http://www.indepth-
network.org). The main station of the Taabo HDSS is located in Taabo Cité, the only small 
urban settlement in the Taabo HDSS, 160 km north-west of Abidjan. Most people in the 
region cultivate yams, manioc, and banana mainly for subsistence. Coffee and cacao are 
farmed as cash crops. Furthermore, there is a minority of fishermen, artisans, shopkeepers, 
and businessmen. 
Lake Taabo is a man-made impoundment resulting from damming up the Bandama River 
in the late 1970s for hydroelectric power generation.
32
 Hence, the study area underwent major 
ecologic and demographic transformation, which favored the spread of schistosomiasis
32,33
 
and might have influenced patterns of other helminth infections
34,35
 and malaria.
36
 Before the 
establishment of the Taabo HDSS, different studies provided sporadic anthelmintic treatment 
to some village communities. Therefore, the development of more systematic and integrated 
disease control measures, particularly annual preventive chemotherapy campaigns against 
helminthiases and a strengthening of the health system became specific objectives of the 
Taabo HDSS. 
 
10.3.3. Data collection 
The parasitological data for the present study were obtained in the frame of the second cross-
sectional survey and preventive chemotherapy campaign (carried out once every year) in the 
Taabo HDSS. While everybody living in the area of the Taabo HDSS was invited to 
participate in the preventive chemotherapy campaign, the members of approximately 7% of 
all registered households were selected for the epidemiological survey based on a stratified 
random sampling procedure. They were asked to provide fresh morning stool and urine 
samples. The samples were transferred to the laboratory of the general hospital in Taabo Cité 
and analyzed the same day by experienced laboratory technicians using standardized, quality-
controlled techniques.
37,38
 In short, duplicate Kato-Katz thick smears were prepared with 
41.7 mg of stool and microscopically examined for S. mansoni and soil-transmitted helminths 
(Ascaris lumbricoides, Trichuris trichiura, and hookworm). In order to obtain infection 
intensities as expressed in eggs per gram of stool (EPG), the sum of the helminth-specific egg 
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counts from the two Kato-Katz thick smears were multiplied by a factor 12.
29
 Urine samples 
were vigorously shaken, 10 ml subjected to a filtration, and the filters, after adding a drop of 
iodine Lugol, microscopically examined for S. haematobium. Five percent of the Kato-Katz 
thick smears and the urine filters were re-examined by a senior technician. In case of 
disagreement, the slides were read a third time and the results discussed among the 
technicians until agreement was reached. 
All heads of households and, if possible, a second adult household member of the 
opposite sex were eligible for the present study. On the day of the epidemiological survey, all 
eligible individuals were invited to complete a questionnaire on risk factors, signs, and 
symptoms pertaining to different neglected tropical diseases (Appendix 13.6.1.) with the 
assistance of a trained field enumerator or supervisor of the Taabo HDSS. Questions were 
either asked in French or translated and explained in any of the local languages (Baoulé, 
Dioula, or Senoufo). Our questionnaire was carefully developed from previously employed 
questionnaires in Côte d’Ivoire,39-42 further adapted during discussions with health personnel 
and Taabo HDSS staff and pre-tested in a nearby village. 
Additional socio-demographic data on the individual and household level, including 
information on sex, age, education, main occupation, relationship with the respective head of 
household, type of housing, and availability of facilities were readily available from the Taabo 
HDSS database. For further details on the field and laboratory procedures, the reader is 
referred to Fürst et al. (2012).
31
 All data from the present study can be obtained from the 
authors upon request. 
 
10.3.4. Statistical analysis 
Data were double-entered and cross-checked in EpiInfo version 3.5.1 (Centers for Disease 
Control and Prevention; Atlanta, United States of America), and analyzed in STATA version 
10.1 (STATA Corp.; College Station, United States of America). Participants for the present 
study were purposefully sampled, as described in the previous section, with no formal sample 
size calculation. Only individuals with complete datasets were included in our final analysis. 
Age was stratified into three groups, namely (i) 18-40 years, (ii) 41-60 years, and 
(iii) > 60 years. Educational levels were classified as (i) none, (ii) primary, and (iii) secondary 
or higher. Occupation was grouped into farmer, fisherman and hunter, housewife, builder and 
artisan, and being employed in the tertiary sector (includes driver, housekeeper, watchman, 
merchant, trader, hairdresser, gastronome, healer, nurse, teacher, student, office worker, and 
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policeman). The parasitological results were classified according to infection intensities as 
expressed in EPG (for S. mansoni and soil-transmitted helminths) and eggs/10 ml of urine (for 
S. haematobium), according to World Health Organization (WHO) guidelines.
29
 Furthermore, 
treatment groups were established, relying on the parasitological results and current WHO 
recommendations,
18
 i.e., S. haematobium and S. mansoni infections in the praziquantel 
treatment group (Tx1), A. lumbricoides, T. trichiura, and hookworm infections in the 
benzimidazole treatment group (Tx2), and all single or multiple infections with 
S. haematobium, S. mansoni, A. lumbricoides, T. trichiura, and hookworm in the overarching 
praziquantel and benzimidazole treatment group (Tx3). 
Initially, χ2 test statistics and Fisher’s exact test, as appropriate, were used to identify 
univariable associations between helminth infections and treatment groups, respectively, and 
reported risk factors, signs, and symptoms. Risk factors, signs, and symptoms significantly 
associated (p < 0.05) were then included as explanatories in a multivariable logistic 
regression, again with the outcomes helminth infections and treatment groups. A stepwise 
backward elimination procedure was performed, removing the explanatory variable with the 
highest p-value one after the other, as long as the Akaike information criterion (AIC) was 
decreasing. Associations between anamnestic questions and treatment groups were considered 
as the correct treatment may be more important than exact species identification for control 
program managers. 
Either each of the remaining and significantly associated (p < 0.05) explanatories on their 
own or all of them combined were used as diagnostic variables to predict helminth infections 
and treatment group specific classifications of individuals. In case of combining diagnostic 
variables, a scoring approach was adopted. All significantly associated risk factors, signs, and 
symptoms were coded 0 or 1 with the higher score indicating elevated odds for being infected 
with the respective helminth or belonging to a certain treatment group. The scores from all 
significantly associated risk factors, signs, and symptoms were then summed up to obtain 
each participant’s combined score. Sensitivity (i.e., proportion of true-positives recognized as 
positives), specificity (i.e., proportion of true-negatives recognized as negatives), positive 
predictive value (PPV; i.e., probability that a positively tested individual is a true-positive), 
and negative predictive value (NPV; i.e., probability that a negatively tested individual is a 
true-negative) were used to assess the diagnostic performance of each significantly associated 
risk factor, sign, and symptom on its own and of the combined score at different cut-off 
levels. 
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10.4. Results 
10.4.1. Study cohort and compliance 
Details of our study cohort have been described elsewhere.
31
 Overall, 255 adults were invited 
(128 males and 127 females; Figure 23). Sixty individuals were excluded (27 males and 33 
females); seven had no written informed consent or failed to have complete questionnaire 
results, whereas 53 had no valid results from the parasitological examination, mainly because 
they lacked sufficiently large stool and/or urine samples for diagnostic workup. Our final 
study sample consisted of 195 adults (101 males and 94 females) with details of the socio-
demographic characteristics summarized in Table 32. 
 
 
Figure 23. Study participation and compliance. The study was carried out in June 2010 in the Taabo health 
demographic surveillance system, south-central Côte d’Ivoire. 
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Table 32. Socio-demographic characteristics among the 195 study participants with complete 
questionnaire and parasitological data. 
Socio-demographic characteristics Number of people (%) 
Sex Male 101 (51.8) 
 Female 94 (48.2) 
Age (years) 18-40 107 (54.9) 
 41-60 66 (33.9) 
 >60 22 (11.3) 
Education None 106 (54.4) 
 Primary 41 (21.0) 
 Secondary or higher 48 (24.6) 
Main occupation Farmer 123 (63.1) 
 Tertiary sector
a
 49 (25.1) 
 Housewife 13 (6.7) 
 Builder and artisan 8 (4.1) 
 Fisherman and hunter 2 (1.0) 
The study was carried out in June 2010 in the Taabo health demographic surveillance system, south-central Côte 
d’Ivoire. aIncluding driver, housekeeper, watchman, merchant, trader, hairdresser, gastronome, healer, nurse, 
teacher, student, office worker, and policeman. 
 
10.4.2. Parasitological results 
Table 33 shows the parasitological results. We found very low prevalence for S. haematobium 
and S. mansoni (2.1% for each schistosome species). The prevalence for hookworm and 
T. trichiura were 38.5% and 2.6%, whereas no A. lumbricoides were found. Most helminth 
infections were of low intensity. Seven, 76 and 81 participants belonged to Tx1, Tx2, and 
Tx3, respectively. 
 
10.4.3. Results from univariable analysis 
Based on univariable χ2 test statistics and Fisher’s exact test, we identified one risk factor and 
one symptom that were significantly associated with S. haematobium infection, three risk 
factors that were significantly associated with S. mansoni, 18 risk factors that were 
significantly associated with hookworm infection, and two risk factors that were significantly 
associated with T. trichiura infections (Table 34). Four risk factors and two symptoms were 
significantly associated with Tx1, 18 risk factors with Tx2, and 11 risk factors with Tx3, as 
shown in Table 35. 
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Table 33. Prevalence and intensity of helminth infections among the 195 study participants. 
Parasite Infection intensity
a
 Number of people (%) 
Schistosoma haematobium Negative 191 (97.9) 
 Light 4 (2.1) 
 Heavy 0 
Schistosoma mansoni Negative 191 (97.9) 
 Light 3 (1.6) 
 Moderate 1 (0.5) 
 Heavy 0 
Tx1 (Sh + Sm) Negative 188 (96.4) 
 Positive 7 (3.6) 
Hookworm Negative 120 (61.5) 
 Light 72 (36.9) 
 Moderate 3 (1.6) 
 Heavy 0 
Trichuris trichiura Negative 190 (97.4) 
 Light 4 (2.1) 
 Moderate 1 (0.5) 
 Heavy 0 
Ascaris lumbricoides Negative 195 (100.0) 
 Light 0 
 Moderate 0 
 Heavy 0 
Tx2 (Hw + Tt + Al) Negative 119 (61.0) 
 Positive 76 (39.0) 
Tx3 (Sh + Sm + Hw + Tt + Al) Negative 114 (58.5) 
  Positive 81 (41.5) 
The study was carried out in June 2010 in the Taabo health demographic surveillance system, south-central Côte 
d’Ivoire. Al = A. lumbricoides. Hw = hookworm. Sh = S. haematobium. Sm = S. mansoni. Tt = T. trichiura. 
Tx1 = treatment group 1 (i.e., praziquantel against schistosomiasis). Tx2 = treatment group 2 (i.e., 
benzimidazole against soil-transmitted helminthiasis). Tx3 = treatment group 3 (i.e., praziquantel and 
benzimidazole against schistosomiasis and soil-transmitted helminthiasis, respectively). 
a
Infection intensities 
according to WHO guidelines.
29
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Table 34. Risk factors, signs, and symptoms significantly (p < 0.05) associated with helminth infections, as 
determined by univariable analysis. 
Parasite Risk factor, sign, and symptom p-value
a
 
Schistosoma haematobium Vertigo 0.026 
 Worm infections considered frequent in household 0.027 
Schistosoma mansoni Occupation: farmer 0.018 
 Occupation: housewife 0.023 
 Drinking water: rain 0.011 
Hookworm Occupation: farmer 0.022 
 Occupation: tertiary sector 0.027 
 Tile or carpet flooring 0.011 
 Type of toilet: WC 0.048 
 Open defecation 0.014 
 Natural water contact: washing oneself 0.010 
 Natural water contact: cooking 0.014 
 Natural water contact: washing children 0.033 
 Natural water contact: cultivating rice 0.019 
 Natural water contact: religious worship 0.045 
 Drinking water: natural water body 0.001 
 Drinking water: rain 0.042 
 Drinking water: fountain 0.011 
 Using soap for washing clothes 0.015 
 Using soap for washing dishes 0.024 
 Washing hands after defecation 0.003 
 Washing hands when returning from work 0.004 
 Worm infections considered frequent in household 0.003 
Trichuris trichiura Using soap for washing oneself 0.018 
 Having a cat 0.048 
The study was carried out in June 2010 in the Taabo health demographic surveillance system, south-central Côte 
d’Ivoire. aUnivariable analysis, using χ² test statistics and Fisher’s exact test, as appropriate. 
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Table 35. Risk factors, signs, and symptoms significantly (p < 0.05) associated with treatment groups, as 
determined by univariable analysis. 
Treatment group Risk factor, sign, and symptom p-valuea 
Tx1 Occupation: farmer 0.011 
 Occupation: builder and artisan 0.028 
 Drinking water: rain 0.005 
 Headache 0.049 
 Vertigo 0.018 
 Worm infections considered frequent in household 0.020 
Tx2 Occupation: farmer 0.015 
 Occupation: tertiary sector 0.018 
 Tile or carpet flooring 0.010 
 Type of toilet: WC 0.047 
 Open defecation 0.022 
 Natural water contact: washing oneself 0.010 
 Natural water contact: cooking 0.022 
 Natural water contact: washing children 0.035 
 Natural water contact: cultivating rice 0.010 
 Drinking water: natural water body 0.001 
 Drinking water: rain 0.042 
 Drinking water: fountain 0.017 
 Using soap for washing clothes 0.015 
 Using soap for washing dishes 0.025 
 Washing hands after defecation 0.005 
 Washing hands when returning from work 0.004 
 Having poultry 0.043 
 Worm infections considered frequent in household 0.004 
Tx3 Occupation: tertiary sector 0.044 
 Tile or carpet flooring 0.009 
 Uncemented latrine 0.028 
 Natural water contact: washing oneself 0.011 
 Natural water contact: cultivating rice 0.011 
 Drinking water: natural water body 0.003 
 Drinking water: fountain 0.018 
 Using soap for washing clothes 0.018 
 Washing hands after defecation 0.005 
 Washing hands when returning from work 0.002 
  Worm infections considered frequent in household 0.002 
The study was carried out in June 2010 in the Taabo health demographic surveillance system, south-central Côte 
d’Ivoire. Tx1 = treatment group 1 (i.e., praziquantel against schistosomiasis). Tx2 = treatment group 2 (i.e., 
benzimidazole against soil-transmitted helminthiasis). Tx3 = treatment group 3 (i.e., praziquantel and 
benzimidazole against schistosomiasis and soil-transmitted helminthiasis, respectively). 
a
Univariable analysis, 
using χ² test statistics and Fisher’s exact test, as appropriate. 
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10.4.4. Results from multivariable analysis 
Many of the univariably significantly associated risk factors, signs, and symptoms presented 
in Tables 34 and 35 dropped out when subjecting them to multivariable logistic regression 
with a stepwise backward elimination procedure, as shown in Table 36. The only remaining 
significant explanatory variable for S. mansoni infection was being a housewife (odds ratio 
(OR) = 10.3, 95% confidence interval (CI): 1.1-102.1), whereas all explanatories for 
S. haematobium were eliminated. People belonging to the praziquantel treatment group (Tx1) 
had an increased risk for vertigo (OR = 16.9, 95% CI: 1.2-34.6). 
People cultivating rice (OR = 2.6, 95% CI: 1.2-5.7) and considering worm infections as 
something that occurs frequently in their household (OR = 4.6, 95% CI: 1.4-14.6) were at a 
higher risk for hookworm infection. On the other hand, people who use fountains as a primary 
source of drinking water (OR = 0.4, 95% CI: 0.2-0.8) and those who use soap for washing 
clothes (OR = 0.1, 95% CI: 0.02-0.6) had low odds of hookworm infection. Regarding 
T. trichiura, having a cat as domestic animal was associated with a high odds of infection 
(OR = 10.6, 95% CI: 1.3-85.8), whereas using soap for washing oneself showed a low odds of 
infection (OR = 0.05, 95% CI: 0.01-0.4). People cultivating rice (OR = 2.9, 95% CI: 1.3-6.4) 
and considering worm infections as something that occurs frequently in their household 
(OR = 4.4, 95% CI: 1.4-14.1) showed higher odds and people reporting fountains as an 
important source of drinking water (OR = 0.4, 95% CI: 0.2-0.9), using soap for washing 
clothes (OR = 0.1, 95% CI: 0.02-0.6), and washing their hands when returning from work 
(OR = 0.5, 95% CI: 0.2-0.9) had lower odds to belonging to the benzimidazole treatment 
group (Tx2). 
Cultivating rice (OR = 2.8, 95% CI: 1.3-6.2) or considering worm infections as frequent 
in the household (OR = 5.4, 95% CI: 1.7-17.9) were associated with high odds, whereas 
fountains as an important source of drinking water (OR = 0.4, 95% CI: 0.2-0.8), using soap 
for washing clothes (OR = 0.1, 95% CI: 0.02-0.8), or washing hands when returning from 
work (OR = 0.4, 95% CI: 0.2-0.8) were associated with low odds of schistosomiasis and soil-
transmitted helminthiasis, and therefore belonging to the treatment group Tx3. 
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10.4.5. Diagnostic properties of risk factors, signs, and symptoms 
If each of the significant risk factors, signs, and symptoms revealed from the multivariable 
analysis was considered as diagnostic variable on its own, estimated sensitivity and specificity 
showed that at least one of the two diagnostic indicators was ≤50% with the exception of 
vertigo and belonging to Tx1 (sensitivity = 85.7%, 95% CI: 80.8-90.6%; specificity = 61.2%, 
95% CI: 54.3-68.0%) (Table 36). However, when calculating the respective specificity for 
vertigo as a diagnostic indicator for Tx1, a high number of false-positives was masked by the 
high number of correctly identified negatives in the studied low schistosomiasis prevalence 
sample, as revealed by the inferior corresponding PPV of 7.6% (95% CI: 3.9-11.3%). 
When considering the combined score, the only combinations that achieved values >50% 
for sensitivity, specificity, and the predictive values occurred for Tx2 and Tx3 at the cut-off 
level >1 (Table 37). By increasing the cut-off levels for predicting positive cases, the number 
of false-positives decreased and the number of false-negatives increased, consequentially 
leading to lower sensitivities and higher specificities. 
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10.5. Discussion 
In the present study, we juxtaposed quality-controlled parasitological data pertaining to 
schistosome and soil-transmitted helminth infections to socio-demographic data and detailed 
information on risk factors, signs, and symptoms. Data were obtained during a cross-sectional 
epidemiological survey conducted in mid-2010 in the Taabo HDSS in south-central Côte 
d’Ivoire. The intention of this study was twofold. First, we wanted to inform the local health 
authorities in the study area about risk factors, signs, and symptoms associated with 
schistosomiasis and soil-transmitted helminthiasis. Second, we were interested in the 
performance of an anamnestic questionnaire to predict helminth infection in an area subjected 
to preventive chemotherapy and a strengthened health system. Our study area might therefore 
represent a typical setting of low-endemicity helminthiasis due to sustained control 
interventions. Disappointingly, not a single risk factor, sign, or symptom, or combinations of 
them, revealed promising statistical associations and diagnostic properties in this ‘new 
parasitic landscape’ of control-induced low endemicity. 
Nevertheless, some issues warrant further discussion. First, the sample size of our study 
was relatively small (n = 195 adults with complete parasitological and questionnaire data) 
and, with the exception of hookworm infection (39%), helminth prevalences were indeed very 
low (<5%). The heads of households and, if possible, a second adult household member of the 
opposite sex were purposefully sampled from over 1,100 participants who were enrolled 
during the cross-sectional epidemiological survey in the Taabo HDSS. Importantly, the 
prevalences of helminth infections in the cross-sectional epidemiological survey were similar 
to those in our study sample. In the overall survey, the prevalence of hookworm, 
S. haematobium, S. mansoni, T. trichiura, and A. lumbricoides were 31.3%, 3.7%, 2.1%, 
1.6%, and 0.8%, respectively (E. K. N’Goran and colleagues, unpublished results). 
Second, the low prevalence and intensity of helminth infection are the likely result of 
recent control efforts (i.e., annual deworming, health education, improved sanitation, and 
strengthened health system), which turned the previously polyparasitic study area into an area, 
where mainly hookworm infections remain. Indeed, N’Goran and colleagues reported a 
S. haematobium prevalence among school children in selected villages of 70% and above in 
the early and mid-1990s, and still in 2001,
32,33,43
 whereas surveys conducted in 2008 and 2009 
prior to Taabo HDSS-related deworming activities and other control interventions revealed 
hookworm prevalences of 51-89%.
34,35
 We can expect similar helminth prevalences in other 
communities where preventive chemotherapy campaigns are underway. The relative 
Chapter 10 – Scope and limits of anamnestic questionnaires for helminthiasis control 
208 
importance of hookworm versus the roundworm A. lumbricoides will likely be higher now as 
single-dose albendazole has a considerably lower efficacy in eliminating hookworm 
compared to A. lumbricoides infection.
44
 For example, a recent study in Yunnan province, 
People’s Republic of China demonstrated a 67.1% prevalence of hookworm prior to single-
dose albendazole, and a prevalence of 20.7% 3-4 weeks after treatment. In the same study, the 
prevalence of A. lumbricoides dropped from 95.1% to 3.7%.
45
 With the scale up of preventive 
chemotherapy against helminthiases, it is likely that hookworm (and T. trichiura) infections 
will predominate in areas which were once highly endemic for schistosomiasis and soil-
transmitted helminthiasis. Although our study area can now be considered a low endemicity 
region for schistosomiasis and a moderate endemicity area for soil-transmitted 
helminthiasis,
29
 it is a consequence of local helminth control efforts, and might therefore 
differ to other naturally occurring low or moderate endemic settings. 
Third, as efforts are underway to integrate different control programs targeting multiple 
neglected tropical diseases,
46,47
 questions arise as to how one might identify treatment-specific 
groups most efficiently. Hence, we did not only consider helminth-specific groups, but also 
treatment-specific groups. This is in line with recent WHO policies, which state that 
‘‘preventive chemotherapy interventions should be conceived as drug-based rather than 
disease-based: emphasis should be on the best, coordinated use of the available drugs rather 
than on specific forms of helminthiasis’’.18 However, due to the low prevalence Schistosoma 
infection, our praziquantel treatment group (Tx1) also became comparatively small and due to 
the several fold higher prevalence of hookworm infection, our benzimidazole treatment group 
(Tx2), and our combined treatment group (Tx3) were clearly driven by the hookworm cases. 
Therefore, it is difficult to draw firm conclusions and further verification is needed to assess 
whether anamnestic questionnaires targeting at specific treatment groups may constitute a 
potential way forward in settings with higher levels of helminth co-endemicity. Also of note 
when further following a treatment group design, there are other intestinal parasites such as 
Strongyloides stercoralis,
34,35,48,49
 which should be included in future considerations, and their 
rapid assessment and treatment within treatment groups of existing, efficacious, safe, often 
donated, or low-cost drug combinations
50,51
 may further enhance the usefulness of the 
approach. 
Fourth, people reporting that worm infections are frequent in their household when 
directly asked showed higher odds of hookworm infection, and hence they were more likely 
to belong to two of the treatment groups considered here (Tx2 and Tx3). People may have 
some knowledge about helminth infections, possibly acquired during previous research and 
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interventions in the region. If this hypothesis could be confirmed in future studies, the local 
control efforts should implicitly draw on this knowledge.
52
 
Fifth, we applied comparatively simple statistical models to analyze the data, including 
univariable and multivariable models and a scoring method, which is similar to approaches 
frequently applied in other health-related tests.
53-56
 Interestingly, an approach using a scoring 
method and associated flexible score thresholds to predict positive cases may allow for the 
adaptation of the questionnaire’s sensitivity, specificity, and predictive values. However, 
better methods to elicit potentially useful anamnestic questions and their optimal combination 
would be needed. 
Sixth, our anamnestic questionnaire did not perform well for predicting schistosomiasis 
and soil-transmitted helminth infections in the Taabo HDSS area where control interventions 
against helminthiases, other neglected tropical diseases, and malaria are underway. The lack 
of a clear and readily assessable epidemiological and clinical footprint in control-induced 
low-endemicity settings makes it difficult to inform local health workers and village 
authorities about the disease and to motivate them to keep up the disease control efforts. Such 
difficulties are inherent to control-induced low-endemicity settings and have also been noted 
on the ‘‘last mile’’ of dracunculiasis eradication.57 Adapting a surveillance-response 
mechanism (i.e., surveillance for detection of new cases, followed by setting-specific health 
intervention in response to the cases picked up in the surveillance) should be considered as the 
way forward. 
In conclusion, we recommend further studies in the Taabo HDSS, but also in other areas 
with currently still higher prevalences and intensities of helminth infections, to shed 
additional light on the scope and limits of anamnestic questionnaires as monitoring and 
guidance tool for neglected tropical disease control programs. Certainly, other clinical factors 
such as physical exam features and rapid diagnostic tests should be further evaluated as well. 
Likewise, improvements of alternative helminth diagnostics should be kept in mind in order 
to continuously appraise the optimal combination of the different diagnostic and monitoring 
tools. For instance, the Schistosomiasis Consortium for Operational Research and Evaluation 
(SCORE; http://score.uga.edu) conducted a multi-country study to assess the diagnostic 
accuracy of a commercially available point-of-care urine circulating cathodic antigen (POC-
CCA) assay for the rapid detection of S. mansoni infection, which showed that POC-CCA 
urine tests are more sensitive than routine Kato-Katz thick smears.
58
 Combining features of 
the different diagnostic and monitoring tools in consideration of the setting-specific levels of 
endemicity of the different parasites will become more important as prevalence rates and 
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infection intensities decline due to successful morbidity and infection control and such 
combinations will likely result in the most efficient care at the point-of-contact. Of note, the 
European research network NIDIAG is currently aiming at the development of improved, 
simple, integrated, and cost-effective diagnosis and treatment algorithms for clinical 
syndromes related to neglected tropical diseases (NIDIAG; http://www.nidiag.org) and such 
more comprehensive approaches may also provide the necessary framework for the additional 
evaluation and potential application of anamnestic questionnaires. 
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11. Discussion 
The main purpose of this PhD thesis was to develop, validate, and apply tools for assessing 
the morbidity and burden caused by different neglected tropical diseases (NTDs) at different 
geographical scales. This overarching goal was subdivided into the three main objectives: 
(i) to assess the global burden of food-borne trematodiasis in terms of DALYs; 
(ii) to develop, validate, and apply tools for the assessment of the average disability 
incurred by an individual infected with schistosomes and/or soil-transmitted 
helminths; and  
(iii) to further explore the potential of anamnestic questionnaire tools for guiding 
schistosomiasis and soil-transmitted helminthiasis control efforts. 
As indicated in the overarching goal, the thesis adhered to the strategic nexus of Swiss 
TPH, which emphasizes the cycle of innovation, validation, and application of tools, 
approaches and strategies in public health (Table 38). Consequently, the following discussion 
focuses on each of the three main objectives and their potential progression from innovation 
to validation and application. 
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11.1. Assessing the global burden of food-borne trematodiasis 
Based on a systematic review, we summarized the current knowledge about the manifestation, 
diagnosis and management of food-borne trematodiasis in a clinical review (Chapter 5).
1
 We 
then used this knowledge to assess – for the first time – the global burden of food-borne 
trematodiasis in terms of DALYs (Chapter 6).
2
 We find that, in 2005, an estimated 56.2 
million people were infected with food-borne trematodes worldwide, 7.9 million suffered 
from severe sequelae and 7,158 died mainly due to cholangiocarcinoma (caused by 
Clonorchis sinensis and Opisthorchis viverrini) and cerebral infection (caused by 
Paragonimus spp.). These figures result in a global burden of 665,352 DALYs for the year 
2005.
2
 
Considerable simplifications are revealed in our disease models used for the burden 
estimation, when they are compared with the natural history as described in the clinical 
review.
1,2
 This divergence mainly reflects the gap between qualitative statements based on 
biomedical observations and the availability of reliable quantitative population level data. For 
instance, it is widely accepted that liver fluke infections induce cholangiocarcinoma,
3,4
 even 
though the exact mechanism of the carcinogenesis remains to be determined.
5-8
 
Cholangiocarcinoma is one of the most fatal cancers
9
 and estimates of attributable deaths 
were as high as 28,000 in 2004 for Thailand alone.
10
 However, the crucial question for 
assessing the burden of food-borne trematodiasis is how many of these cholangiocarcinoma 
cases are due to food-borne trematode infections. For our global burden estimates, we had to 
rely on just five studies, which reported on the odds ratio between C. sinensis infections and 
cholangiocarcinoma, and three studies, which reported on the odds ratio between O. viverrini 
infections and cholangiocarcinoma.
2
 Based on these odds ratios, we calculated that 1,323 
people died due to O. viverrini-induced cholangiocarcinoma throughout Southeast Asia in 
2005, for instance.
2
 These figures implicate that far less than every 20
th
 death due to 
cholangiocarcinoma is caused by liver flukes in Thailand, which we, as well as others, 
consider as a conservative estimate.
2,10
 
A second shortcoming of our burden estimates has been revealed in a recently finalized 
manuscript. By simply juxtaposing countries which were included in our global burden 
estimates to all countries with reported autochthonous cases of human food-borne trematodes 
infections, we demonstrated that many countries were not considered in our burden estimates 
due to missing reliable prevalence data on the national level.
11
 
Chapter 11 – Discussion 
220 
Despite these shortcomings, we and others consider our global burden estimates as a 
valuable benchmark and stimulus for future investigations.
2,10
 In order to further improve and 
validate our estimates, the frequency and progression of signs and symptoms attributable to 
food-borne trematode infections as listed in Table 7 should be quantified to unravel the 
disease models from simple egg count dependency. Furthermore, if not yet existing, disability 
weights have to be assigned to well-defined signs and symptoms (see also Chapter 11.2). First 
efforts to determine disability weights due to clonorchiasis have been made recently and 
resulted in a summary disability weight of 0.075 for all infection intensities.
12
 For 
comparison, we used disability weights of 0.104, but only for the 8.2% of all cases modeled 
as heavy infections in our burden estimate (Appendix 13.2.5.).
2
 Hence, by applying this newly 
established disability weight (~3/4 of the disability weight currently used in our model) on all 
infected instead of only those 8% modeled with heavy infections, the YLD part of the 
clonorchiasis burden estimates would roughly increase by a factor 9. As a result, our estimates 
for the total global burden due to C. sinensis infections would more than double and result in 
over half a million DALYs for clonorchiasis alone. 
Regarding the many countries, which report cases of food-borne trematodiasis but are not 
included in the presented burden estimates, emphasis should be placed on the realization of 
additional, carefully designed national surveys. Often, information is missing at the very 
basic, i.e., individual and local level, leading to ‘guesstimates’ at the national level and global 
summary measures, which have to be interpreted very carefully. Optimally, new national 
surveys would trigger local studies, which in turn rely on individual level data and avoid 
frequent problems such as “preferential sampling”.13 Reliable individual, local, national and 
global morbidity and mortality information would be most useful for decision making and the 
design of control efforts at each of the respective levels. Hence, morbidity and mortality 
assessments have their justification at all geographical scales and different scales should be 
seen as complementary rather than exclusionary to each other. However, as simple as this 
sounds as far away are we currently from achieving such optimal information in many 
countries. 
Of note, advanced modeling approaches are in the end only as good as the quality and 
quantity of the underlying localized data points permit. For instance, with regard to spatial 
modeling approaches of food-borne trematodiasis, it is noteworthy that transmission may 
involve an even stronger behavioral component as schistosomiasis or soil-transmitted 
helminthiasis due to the implicit need for the consumption of undercooked, mainly aquatic 
products. However, compared to spatially explicit environmental indicators, such behavioral 
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covariates are more complex to obtain and include in spatial models and this ambiguity about 
human behavior may seriously complicate the prediction of human infections.
14
 
In the current global burden of diseases study, DisMod 3 is used to compute disease 
specific, internally consistent and complete sets of the five epidemiological key indicators 
prevalence, incidence, remission, mortality and duration. As initial input, the software needs a 
minimum of three of these indicators. To the best of my knowledge, DisMod 3 draws then on 
pre-programmed large-scale demographic background data (e.g., age and sex distributions and 
life tables), but allows only for the interpolation of estimates by world regions (see Chapters 6 
and 13) or – probably with some additional configurations – by countries.15 In order to 
become an even more useful tool, future DisMod versions should include options to upload 
additional, smaller scale demographic background data in combination with associated 
epidemiological key indicators and to interpolate these information also at local levels. 
Realizing the importance of well-designed national surveys, WHO’s Food-borne Disease 
Burden Epidemiology Reference Group (FERG) initiated efforts to strengthen the capacity of 
countries to undertake such surveys and also supported local pilot studies.
16
 Additional good 
examples should set precedents for increasingly bridging not only the work at different 
geographical scales, but also the gap between basic burden research and urgently needed 
practical control efforts. Thereby, the objection that DALYs and burden of disease studies are 
not worth the bother and only withdraw scarce resources from more urgently needed practical 
public health interventions
17
 could be invalidated. Nevertheless, it is important to keep in 
mind that burden of disease assessments need considerable resources during their innovation 
and validation phase and only if the results are turned into action, they may provide real 
benefits by assisting in the most efficient (re-)allocation of scarce resources and the actual 
reduction of human suffering. 
An immediate application of our own global burden of food-borne trematodiasis 
assessment is the more prominent placement of this widely neglected infectious disease 
cluster on the radar screen of organizations, donors and scientists. Next logical applications 
include costing and cost- effectiveness studies to further assess the potential of food-borne 
trematodiasis control programs. For instance, according to often used WHO criteria, 
interventions are considered as highly cost-effective if the incremental cost-effectiveness ratio 
(ICER) per DALY averted is less than the per capita gross domestic product (GDP) and as 
still cost-effective if the ICER per DALY averted is below three times the per capita GDP.
18
 
Such criteria could be used to calculate thresholds at which interventions are still cost-
effective and to evaluate different scenarios of food-borne trematodiasis control. 
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Of particular interest with regard to such health economic evaluations, first, the burden 
due to food-borne trematodiasis is highly aggregated in some endemic areas (e.g., O. viverrini 
infections in northern and eastern Thailand and neighboring Lao PDR
19
). Hence, even though 
the respective burden estimates may not reach the most alarming levels of other conditions at 
the global scale, they may constitute an important public health problem in endemic areas and 
consequentially represent a cost-effective target for control in these regions. The “First WHO 
Report on Neglected Tropical Diseases” may provide good benchmarks for estimated number 
of DALYs, economic costs and costs per DALY averted of other NTDs, stratified by WHO 
regions.
20
 Second, cost estimates for lost wages and medical care due to opisthorchiasis and 
cholangiocarcinoma in Thailand have been substantial, totaling US$ 85-120 million 
annually.
21,22
 Third, besides the costs on human health, food-borne trematodes also negatively 
impact on livestock and aquaculture production. For example, the annual economic loss in 
livestock production due to fascioliasis has been estimated at US$ 50 million in Peru.
23
 
Fourth, the potential for piggybacking on, and integration with other helminth control 
programs, has hardly been exploited,
24
 even though integrated approaches have recently been 
shown to be successful in many countries.
25,26
 However, additional reflections about novel, 
multi-disease, and intersectoral approaches to harness the respective synergies have been 
initiated.
27
 Fifth, the repeated call for more integrated and intersectoral approaches instead of 
only preventive chemotherapy may become unmistakable with regard to clonorchiasis and 
opisthorchiasis as first indications point towards an increased risk for cholangiocarcinoma 
among people who were repeatedly treated and re-infected with these liver flukes (Peter 
Odermatt, personal communication). This last point underscores the need for continued 
monitoring of implemented interventions and the associated effects on the targeted disease 
burden.
20
 
 
11.2. Generating evidence on disability due to schistosomiasis and soil-transmitted 
helminthiasis 
In order to generate new, patient-based evidence on the disability incurred by individuals 
infected with schistosomes and soil-transmitted helminths, we conducted cross-sectional 
surveys with schoolchildren and adults in Côte d’Ivoire. We could not identify any effect of 
schistosomiasis and soil-transmitted helminthiasis on children’s physical fitness as objectively 
measured in a maximal multistage 20 m shuttle run test (Chapter 7)
28
 and as self-reported in a 
questionnaire, which was based on a quality of life questionnaire pertaining to physical fitness 
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(Chapter 8).
29
 However, we found statistically significant correlations between objectively 
measured and self-reported physical fitness. We therefore concluded that the quality of life 
questionnaire proofed valid to assess children’s physical fitness, which is promising for the 
more general use of quality of life questionnaires (Chapter 8).
29
 Finally, we could indeed 
identify significant negative effects of S. mansoni and T. trichiura infections on adults’ 
quality of life as self-reported in such questionnaires (Chapter 9).
30
 
Potential explanations for the rather unexpected findings that schistosomiasis and soil-
transmitted helminthiasis had no effect on children’s physical fitness, but negatively impacted 
adults’ quality of life were already discussed in the respective chapters. However, three points 
are worth highlighting. First, in our initial study, it is conceivable that we excluded exactly 
those children from the physical fitness test due to medical concerns who suffered the most 
from their parasitic infections. At least, these children could be included in the questionnaire 
survey, but supposedly due to relative small sample sizes even their inclusion led to no 
significant difference.
28,29
 Second, children are at highest risk of helminth infections, but most 
severe complications may only occur after years of advanced chronic infection and therefore 
in adolescents and adults (Chapter 1). This peculiarity may explain why we could identify an 
effect in adults, but not in children. Third, all our studies were cross-sectional surveys, which 
is probably not the optimal study design. 
As mentioned in Chapter 1.7.3, the initial disability weights applied in burden estimates 
were solely based on expert opinion. It is only in the past years that more systematic and 
field-supported epidemiological surveys to assess the disability incurred by individuals 
suffering from certain conditions gained increased attention. Hence, most efforts – and 
particularly those targeted at NTDs such as ours – are still in rather early innovation and 
validation stages.
31-33
 Particularly with regard to disability assessments due to parasitic 
helminths, it is important to note that infections may take years to resolve without treatment, 
that super-infections and re-infections are likely in endemic communities, and that the worms 
cause a diversity of contemporaneous pathology and disability during active infection, but 
also irreversible chronic morbidity, which may persist even after parasite clearance.
31
 
Nevertheless, based on the WHO’s definition that health is a “state of complete physical, 
mental, and societal well-being and not merely the absence of disease or infirmity”,34 every 
deviation from this ideal, which is attributable to a certain condition, should be measured. 
Hence, innovative, systematic, and holistic approaches to more precisely assess and validate 
disability elicited by helminthiasis are essential. 
Chapter 11 – Discussion 
224 
Drawing from generic health-related quality of life concepts,
35-37
 a potential conceptual 
framework for future studies may consider the four basic domains physical health, 
psychological health, social well-being and environmental quality (Figure 24). The first three 
domains may be uncontested, whereas the inclusion of an environmental domain (e.g., 
physical environment such as housing, pollution and noise, but also access to infrastructure 
and resources, safety and security) may be more controversial. However, besides being an 
important risk factor, the environment is also an important effect modifier of ill-health.
38,39
 In 
addition, health-related quality of life questionnaires occasionally include also separate 
domains for pain, spirituality/religion and the level of independence (e.g., mobility, daily life 
activities, medical and non-medical substances).
35-37
 
More systematic approaches may help to better define variables that should or should not 
be included in disability assessments and to better interpret results and identify knowledge 
gaps. For instance, Figure 24 indicates that our own work based on a maximal multistage 20 
m shuttle run test (Chapters 7 and 8) provides mainly information on aerobic endurance, 
which is only one facet of physical fitness. Moreover, physical fitness is only one component 
of physical health and physical health is only one of four domains of health-related quality of 
life. Hence results from testing a single facet should not be over-interpreted. At the same time, 
Figure 24 may help to identify quality of life facets, which could be omitted as the respective 
condition under investigation may only marginally influence them, or facets which could be 
assessed simultaneously. For instance, there are different series of approximately 6-10 simple 
and quick tests, which are adaptable to all ages of participants and allow the assessment of 
physical fitness in all its facets.
40-44
 Likewise, other test series are available or could be 
adapted/developed for other health-related quality of life domains (e.g., psychometric tests, 
cognitive tests, social network analysis, environmental assessments, etc.). As also indicated in 
Chapter 8, the combination of different test series and different methodologies (e.g., different 
tests to measure the same facet, more specific vs. more generic tools, mixed methods 
research) will provide exciting opportunities to further compare and validate tools as well as 
the resulting disability outcomes. 
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Figure 24. Proposed conceptual framework for future disability assessments based on individual health-
related quality of life, exemplified for physical fitness. Individual health-related quality of life is primarily 
based on the four domains physical health, psychological health, social well-being and environmental quality. 
Each of these domains can be further sub-divided into different components and each component may be further 
sub-divided into different facets. This figure has been further developed based on references 
35-37,40
. 
 
Optimally, future attempts to assess or validate disability rely on series of tests rather than 
a single test. The study design should be as rigorous as possible and particularly in case of 
treatment or other interventions carefully consider periods for remission, which may range 
from extremely short to endlessly long. In case of quickly curable, contemporaneous 
pathologies and disabilities (e.g., unadvanced, active helminth infections) randomised 
controlled trials should be feasible and set the standard. However, in case of slowly resolving 
chronic effects or even irreversible pathology and disability, randomised controlled trials may 
not be feasible and carefully designed case-control and longitudinal studies in the frame of 
long-term control programs may represent the best options. Irrespective of the detailed study 
design, special attention should also be paid to co-morbidity and age-specific effects. 
Of note, first considerations have also been made about the assessment of the more 
indirect, societal (e.g., emotional, socio-economic) burden born by persons close to the 
directly affected and disabled individuals. However, while intuitively comprehensible, such 
an amendment would probably push the limits too far and constitute a hardly feasible task 
(e.g., the number of more or less severely affected persons may be highly variable not only 
between, but also within societies). Hence, it might be advisable to first improve the figures 
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on the direct burden before opening the Pandora’s Box of indirect burden evaluation. As 
aforementioned, adhering to a more systematic conceptual framework for future disability 
assessments is essential for the clarification of what exactly should be reflected by the 
disability measurements. Questions such as what should be directly included and what are 
potentially important adjustments to consider (e.g., indirect, societal burden? environmental 
quality? local levels of poverty?) need to be answered. 
The ultimate application of well-defined, revised disability measurements in burden 
estimates may correct important flaws of previous burden of disease studies and has the 
potential to markedly change the figures and deduced priority setting in public health. As 
indicated in Chapters 1 and 11, the global burden of schistosomiasis may rise from 1.7-4.5 
million DALYs
45,46
 to 70 million DALYs
32,47,48
 and also the burden of clonorchiasis may 
more than double
2,12
 just because of revised disability weights. Finally, and without further 
delving into the discussion about which burden measure may be best for future use, it is 
important to realize that both major types of health-adjusted life years (HALYs; measures that 
combine mortality and morbidity in a single measure), namely DALYs and quality-adjusted 
life years (QALYs), need an indicator to measure disability or – synonymously – health-
related quality of life.
49
 
 
11.3. Exploring anamnestic questionnaire tools for guiding schistosomiasis and soil-
transmitted helminthiasis control 
Realizing the need for reliable, simple, rapid, inexpensive and culturally adapted diagnostic 
methods for the guidance of schistosomiasis and soil-transmitted helminthiasis control at all 
levels of endemicity, we conducted a study in the Taabo HDSS, south-central Côte d’Ivoire, 
in mid-2010 (Chapter 10). The main objectives were to assess risk factors, signs and 
symptoms associated with the respective helminthic infections in a control-induced low-
endemicity setting and to explore their potential in anamnestic rapid screening questionnaire 
tools. At first sight, we could not identify promising candidates among the considered risk 
factors, signs and symptoms in our pilot study. However, important issues, which future 
studies may wish to consider, were further discussed. 
In order to further develop and validate the initial findings, a second study was carried out 
in the frame of the third annual parasitological survey and preventive chemotherapy campaign 
in the Taabo HDSS in summer 2011. This second study included 585 participants of all ages, 
who were subjected to parasitological diagnosis and a revised questionnaire. The 
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questionnaire included again questions on the individual and the household level as clustering 
of helminth infections in certain individuals
50-53
 and households
54,55
 may exist. Furthermore, 
individuals and households were again directly approached in order to circumvent low school 
enrolment and high school absenteeism, an admitted shortcoming of school-based 
questionnaires.
56-59
 In-depth analyses of these data are still ongoing. 
Importantly, future evaluations should not only carefully consider whom to ask, but also 
who asks. For instance, a well-accepted and fully integrated female anthropologist identified 
much higher numbers of miscarriages and stillbirths among nomadic women than an also very 
empathetic male clinician.
60
 Similarly, during our own study, we made the observation that a 
woman reported no complaints when asked by a male clinician, but mentioned a swollen leg 
(“jambe enflée”) when subsequently interviewed by one of the male field enumerators. 
Indeed, the woman was suffering from severe elephantiasis, most likely caused by lymphatic 
filariasis (Figure 25). 
 
 
Figure 25. Female case of elephantiasis most likely caused by lymphatic filariasis. The case was observed 
during the survey carried out in June 2010 in the Taabo HDSS, south-central Côte d’Ivoire. The woman did not 
report any complaints when explicitly asked by a male clinician, but mentioned a swollen leg (“jambe enflée”) 
when subsequently interviewed by one of the male field enumerators. 
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Besides anamnestic questionnaires, there are alternative and also constantly advanced 
approaches for the rapid screening of helminthic infections. Examples are the currently 
evaluated point-of-contact (POC) circulating cathiodic antigen (CCA) urine assays for 
S. mansoni infections,
61,62
 but also lot quality assurance sampling (LQAS),
63
 grid sampling
64
 
and spatial modeling,
65,66
 which increasingly allow for guiding helminth control efforts even 
at smaller scale. These approaches should be continuously reviewed in order to identify 
potential synergies between the methods and to decide whether further efforts should be made 
in the development of anamnestic questionnaires or rather in the alternatives. 
All aforementioned screening techniques are employed in the hope to better target control 
efforts, and hence to further improve the cost-effectiveness of interventions. For instance, a 
study from Uganda indicates that some rapid screening is superior to preventive 
chemotherapy in most settings because prevalence rates do not ubiquitously reach very high 
levels and treatment and delivery costs are still relevant.
63
 Hence, current estimates that 
concurrent preventive chemotherapy against seven NTDs (including schistosomiasis and soil-
transmitted helminthiasis) would cost US$ 0.40 per person per year and result in an economic 
rate of return of 15-30%
67
 could even be surpassed. However, besides this purely economic 
argument, to end this thesis discussion, it should be re-emphasized that the control of NTDs 
contributes to at least five of the eight broader millennium development goals (MDGs). First, 
by tackling the intimate link between poverty and NTDs, removing infections helps to 
eradicate extreme poverty and hunger. Second, it helps reducing child morbidity and thereby 
supports primary education. Third, it directly helps to reduce child mortality. Fourth, it 
improves maternal health. Fifth, epidemiological evidence strongly suggests that it will 
improve the outcome of concurrent HIV/AIDS, malaria and tuberculosis and thereby also 
promote the fight against these “big three”.68 
Chapter 11 – Discussion 
229 
11.4. References 
1. Fürst T, Sayasone S, Odermatt P, Keiser J, Utzinger J. Manifestation, diagnosis, and 
management of food-borne trematodiasis. BMJ 2012;344:e4093. 
2. Fürst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a 
systematic review and meta-analysis. Lancet Infect Dis 2012;12:210-221. 
3. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, et 
al. A review of human carcinogens. Part B: biological agents. Lancet Oncol 
2009;10:321-322. 
4. IARC. Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and 
Clonorchis sinensis). IARC Monogr Eval Carcinog Risks Hum 1994;61:121-175. 
5. Shimonishi T, Sasaki M, Nakanuma Y. Precancerous lesions of intrahepatic 
cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2000;7:542-550. 
6. Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, Smout M, Pairojkul C, et al. 
Liver fluke induces cholangiocarcinoma. PLoS Med 2007;4:e201. 
7. Choi BI, Han JK, Hong ST, Lee KH. Clonorchiasis and cholangiocarcinoma: etiologic 
relationship and imaging diagnosis. Clin Microbiol Rev 2004;17:540-552. 
8. Vatanasapt V, Sripa B, Sithithaworn P, Mairiang P. Liver flukes and liver cancer. Cancer 
Surveys 1999;33:313-343. 
9. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and 
prevalence across five continents: defining priorities to reduce cancer disparities in 
different geographic regions of the world. J Clin Oncol 2006;24:2137-2150. 
10. Sripa B. Global burden of food-borne trematodiasis. Lancet Infect Dis 2012;12:171-172. 
11. Fürst T, Duthaler U, Sripa B, Utzinger J, Keiser J. Trematode infections: liver and lung 
flukes. Infect Dis Clin North Am 2012;26:399-419. 
12. Qian MB, Chen YD, Fang YY, Xu LQ, Zhu TJ, Tan T, Zhou CH, et al. Disability weight 
of Clonorchis sinensis infection: captured from community study and model 
simulation. PLoS Negl Trop Dis 2011;5:e1377. 
13. Diggle PJ, Menezes R, Su TL. Geostatistical inference under preferential sampling. J R 
Stat Soc Ser C Appl Stat 2010;59:191-232. 
14. Forrer A, Sayasone S, Vounatsou P, Vonghachack Y, Bouakhasith D, Vogt S, Glaser R, et 
al. Spatial distribution of, and risk factors for, Opisthorchis viverrini infection in 
southern Lao PDR. PLoS Negl Trop Dis 2012;6:e1481. 
Chapter 11 – Discussion 
230 
15. Institute for Health Metrics and Evaluation. Welcome to DisMod III's documentation, 
2009. http://winthrop.ihme.washington.edu/public/ (accessed Feb 26, 2012). 
16. WHO. Initiative to estimate the global burden of food-borne diseases. Country studies, 
2012. http://www.who.int/foodsafety/food-borne_disease/ferg/en/index4.html 
(accessed Feb 24, 2012). 
17. Barker C, Green A. Opening the debate on DALYs. Health Policy Plan 1996;11:179-183. 
18. WHO. Macroeconomics and health: investing in health for economic development. Report 
of the Commission on Macroeconomics and Health. Geneva, Switzerland: WHO, 
2001. 
19. Sithithaworn P, Andrews RH, Nguyen VD, Wongsaroj T, Sinuon M, Odermatt P, Nawa 
Y, et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. 
Parasitol Int 2011;61:10-16. 
20. WHO. Working to overcome the global impact of neglected tropical diseases. First WHO 
report on neglected tropical diseases. Geneva, Switzerland: WHO, 2010. 
21. Andrews RH, Sithithaworn P, Petney TN. Opisthorchis viverrini: an underestimated 
parasite in world health. Trends Parasitol 2008;24:497-501. 
22. Loaharanu P, Sornmani S. Preliminary estimates of economic impact of liver fluke 
infection in Thailand and the feasibility of irradiation as a control measure. Southeast 
Asian J Trop Med Public Health 1991;22:384-390. 
23. Espinoza JR, Terashima A, Herrera-Velit P, Marcos LA. [Human and animal fascioliasis 
in Peru: impact in the economy of endemic zones]. Rev Peru Med Exp Salud Publica 
2010;27:604-612 (in Spanish). 
24. Montresor A, Cong DT, Sinuon M, Tsuyuoka R, Chanthavisouk C, Strandgaard H, 
Velayudhan R, et al. Large-scale preventive chemotherapy for the control of helminth 
infection in Western Pacific countries: six years later. PLoS Negl Trop Dis 
2008;2:e278. 
25. Linehan M, Hanson C, Weaver A, Baker M, Kabore A, Zoerhoff KL, Sankara D, et al. 
Integrated implementation of programs targeting neglected tropical diseases through 
preventive chemotherapy: proving the feasibility at national scale. Am J Trop Med 
Hyg 2011;84:5-14. 
26. Kabatereine NB, Malecela M, Lado M, Zaramba S, Amiel O, Kolaczinski JH. How to (or 
not to) integrate vertical programmes for the control of major neglected tropical 
diseases in sub-Saharan Africa. PLoS Negl Trop Dis 2010;4:e755. 
Chapter 11 – Discussion 
231 
27. WHO. Informal consultation on novel approaches in the prevention and control of 
neglected tropical diseases in the Western Pacific region. Manila, Philippines: WHO 
Western Pacific Regional Office, 2011. 
28. Müller I, Coulibaly JT, Fürst T, Knopp S, Hattendorf J, Krauth SJ, Stete K, et al. Effect of 
schistosomiasis and soil-transmitted helminth infections on physical fitness of school 
children in Côte d'Ivoire. PLoS Negl Trop Dis 2011;5:e1239. 
29. Fürst T, Müller I, Coulibaly JT, Yao AK, Utzinger J, N'Goran EK. Questionnaire-based 
approach to assess schoolchildren's physical fitness and its potential role in exploring 
the putative impact of helminth and Plasmodium spp. infections in Côte d'Ivoire. 
Parasit Vectors 2011;4:116. 
30. Fürst T, Silué KD, Ouattara M, N'Goran DN, Adiossan L, N'Guessan Y, Zouzou F, et al. 
Schistosomiasis, soil-transmitted helminthiasis, and socio-demographic factors 
influence quality of life of adults in Côte d'Ivoire. PLoS Negl Trop Dis 2012;6:e1855. 
31. King CH. Health metrics for helminthic infections. Adv Parasitol 2010;73:51-69. 
32. King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: 
a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 
2005;365:1561-1569. 
33. Guyatt H. Do intestinal nematodes affect productivity in adulthood? Parasitol Today 
2000;16:153-158. 
34. WHO. Constitution of the World Health Organization, 2012. 
http://apps.who.int/gb/bd/PDF/bd47/EN/constitution-en.pdf (accessed Feb 27, 2012). 
35. EuroQol Group. EQ-5D. A standardised instrument for use as a measure of health 
outcome, 2012. http://www.euroqol.org (accessed Feb 27, 2012). 
36. WHO. WHOQOL user manual, 1998. http://www.who.int/mental_health/evidence/ 
who_qol_user_manual_98.pdf (accessed Feb 27, 2012). 
37. QualityMetric. SF-36.org. A community for measuring health outcomes using SF tools, 
2012. http://www.sf-36.org (accessed Feb 27, 2012). 
38. King CH, Bertino AM. Asymmetries of poverty: why global burden of disease valuations 
underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis 
2008;2:e209. 
39. Reidpath DD, Allotey PA, Kouame A, Cummins RA. Measuring health in a vacuum: 
examining the disability weight of the DALY. Health Policy Plan 2003;18:351-356. 
Chapter 11 – Discussion 
232 
40. Bös K. [Handbuch motorische Tests. Sportmotorische Tests, motorische Funktionstests, 
Fragebogen zur körperlich-sportlichen Aktivität und sportpsychologische 
Diagnoseverfahren]. Göttingen, Germany: Hogrefe Verlag, 2001 (in German). 
41. American College of Sports Medicine. ACSM's resource manual for guidelines for 
exercise testing and prescription. Baltimore, USA: Lippincott Williams & Wilkins, 
2010. 
42. Reiman MP, Manske RC. Functional testing in human performance. 139 tests for sport, 
fitness, and occupational settings. Champaign, USA: Human Kinetics, 2009. 
43. Bös K, Schlenker L, Büsch D, Lämmle L, Müller H, Oberger J, Seidel I, et al. [Deutscher 
Motorik Test 6-18 (DMT 6-18)]. Hamburg, Germany: Czwalina, 2009 (in German). 
44. ETH Zürich. [Wir bewegen Zürich], 2012 (in German). http://www.wirbewegen 
zuerich.ch/forschung/smba-laeuft-wieder-in-winterthur (accessed Feb 28, 2012). 
45. Brooker S, Utzinger J. Integrated disease mapping in a polyparasitic world. Geospat 
Health 2007;1:141-146. 
46. Lammie PJ, Fenwick A, Utzinger J. A blueprint for success: integration of neglected 
tropical disease control programmes. Trends Parasitol 2006;22:313-321. 
47. Gray DJ, Ross AG, Li YS, McManus DP. Diagnosis and management of schistosomiasis. 
BMJ 2011;342:d2651. 
48. King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. 
Chronic Illn 2008;4:65-79. 
49. Gold MR, Stevenson D, Fryback DG. HALYS and QALYS and DALYS, oh my: 
similarities and differences in summary measures of population health. Annu Rev 
Public Health 2002;23:115-134. 
50. Schad GA, Anderson RM. Predisposition to hookworm infection in humans. Science 
1985;228:1537-1540. 
51. Bundy DAP, Cooper ES, Thompson DE, Didier JM, Anderson RM, Simmons I. 
Predisposition to Trichuris trichiura infection in humans. Epidemiol Infect 
1987;98:65-71. 
52. Anderson RM. The population dynamics and epidemiology of intestinal nematode 
infections. Trans R Soc Trop Med Hyg 1986;80:686-696. 
53. Crompton DWT. Ascaris and ascariasis. Adv Parasitol 2001;48:285-375. 
54. Forrester JE, Scott ME, Bundy DAP, Golden MH. Clustering of Ascaris lumbricoides and 
Trichuris trichiura infections within households. Trans R Soc Trop Med Hyg 
1988;82:282-288. 
Chapter 11 – Discussion 
233 
55. Brooker S, Alexander N, Geiger S, Moyeed RA, Stander J, Fleming F, Hotez PJ, et al. 
Contrasting patterns in the small-scale heterogeneity of human helminth infections in 
urban and rural environments in Brazil. Int J Parasitol 2006;36:1143-1151. 
56. Lengeler C, Utzinger J, Tanner M. Screening for schistosomiasis with questionnaires. 
Trends Parasitol 2002;18:375-377. 
57. Lengeler C, Kilima P, Mshinda H, Morona D, Hatz C, Tanner M. Rapid, low-cost, two-
step method to screen for urinary schistosomiasis at the district level: the Kilosa 
experience. Bull World Health Organ 1991;69:179-189. 
58. Lengeler C, de Savigny D, Mshinda H, Mayombana C, Tayari S, Hatz C, Degremont A, et 
al. Community-based questionnaires and health statistics as tools for the cost-efficient 
identification of communities at risk of urinary schistosomiasis. Int J Epidemiol 
1991;20:796-807. 
59. Raso G, Utzinger J, Silué KD, Ouattara M, Yapi A, Toty A, Matthys B, et al. Disparities 
in parasitic infections, perceived ill health and access to health care among poorer and 
less poor schoolchildren of rural Côte d'Ivoire. Trop Med Int Health 2005;10:42-57. 
60. Münch AK. Nomadic women’s health practice: islamic belief and medical care among 
Kel Alhafra Tuareg in Mali. Basel, Switzerland: Schwabe Verlag, 2012. 
61. Coulibaly JT, Knopp S, N'Guessan NA, Silué KD, Fürst T, Lohourignon LK, Brou JK, et 
al. Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni 
diagnosis in different settings of Côte d'Ivoire. PLoS Negl Trop Dis 2011;5:e1384. 
62. SCORE. Schistosomiasis consortium for operational research and evaluation, 2012. 
http://score.uga.edu (accessed Feb 28, 2012). 
63. Brooker S, Kabatereine NB, Myatt M, Stothard RJ, Fenwick A. Rapid assessment of 
Schistosoma mansoni: the validity, applicability and cost-effectiveness of the lot 
quality assurance sampling method in Uganda. Trop Med Int Health 2005;10:647-658. 
64. Sturrock HJ, Gething PW, Clements AC, Brooker S. Optimal survey designs for targeting 
chemotherapy against soil-transmitted helminths: effect of spatial heterogeneity and 
cost-efficiency of sampling. Am J Trop Med Hyg 2010;82:1079-1087. 
65. Schur N, Ndir O, Utzinger J, Vounatsou P. Bayesian modeling of anisotropic 
geostatistical data: an application in mapping urinary schistosomiasis in Senegal. Stat 
Med:under review. 
66. Schur N, Gosoniu L, Raso G, Utzinger J, Vounatsou P. Modelling the geographical 
distribution of co-infection risk from single-disease surveys. Stat Med 2011;30:1761-
1776. 
Chapter 11 – Discussion 
234 
67. Molyneux DH, Hotez PJ, Fenwick A. "Rapid-impact interventions": how a policy of 
integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS 
Med 2005;2:e336. 
68. WHO. Preventive chemotherapy in human helminthiasis. Coordinated use of 
anthelminthic drugs in control interventions: a manual for health professionals and 
programme managers. Geneva, Switzerland: WHO, 2006. 
 
Chapter 11 – Discussion 
235 
 
 
 
 236 
 
Chapter 12 – Conclusion 
 
237 
12. Conclusion 
Probably the most important finding of the most recent global burden of disease endeavor will 
be the renewed realization of how little is still known about the distribution and epidemiology 
of many diseases. This vagueness will be most pronounced for diseases, which primarily 
occur in developing countries (e.g., tropical diseases), but will also include diseases, which 
are very well documented in some countries, but not in others (e.g., cancer). However, besides 
the endless need for more and better data, more systematic concepts are imperative for future 
burden assessments. For instance, concepts have to clarify what disability weights – and 
therefore the resulting burden estimates – should exactly measure. Further clarification would 
help to prevent from exhausting, nebulous discussions. 
As DALYs have become a frequently used measure to evaluate public health needs, it is 
of utmost importance to get the figures right and consider a complete list of conditions. 
Hence, we made an effort to assess, for the first time, the global burden of food-borne 
trematodiasis. Nevertheless, many other conditions are still missing (e.g., strongyloidiasis, 
taeniasis, toxoplasmosis, brucellosis). 
Additionally, questions about the leadership, coordination, accessibility of data and 
transparency of methods of global burden of disease studies have to be addressed. To the best 
of my knowledge, WHO was partner in the latest global burden of disease endeavor, but – 
while welcoming all efforts pertaining to better knowledge – recently decided to not 
automatically endorse the results without further review because of the aforementioned 
organizational constraints. Clearly, as long as all these shortcomings exist, the global burden 
of disease study’s initial objective to further decouple epidemiological assessments from 
advocacy will not be accomplished and advocacy will just reach a next, more abstract level 
instead. 
With regard to individual morbidity and disability assessments, this PhD thesis tried to 
emphasize the importance of truly interdisciplinary work. The currently observable change of 
perspective from expert opinion towards field-based epidemiological survey data in the 
elicitation of disability weights may indeed correct some important flaws of previous burden 
of disease studies. To further support this highly welcome development, a potential way 
forward has been suggested in the discussion of this thesis. 
At the current stage, it is too early to say anything about the potential of further refined 
anamnestic questionnaires to guide schistosomiasis and soil-transmitted helminthiasis control 
efforts. However, of note, if it may become possible to elicit effects of NTDs with carefully 
adapted and applied quality of life questionnaires, it is also conceivable that disease-
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associated risk factors, signs and symptoms allow for the development of anamnestic 
questionnaires for rapid screening. Certainly, it will be no easy task, but the potential benefits 
warrant further efforts. 
Finally, this thesis was governed by the idea that work on different geographical scales is 
complementary rather than exclusionary to each other and that basic research and practical 
control efforts should be as fruitfully combined as possible. 
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13. Appendix 
13.1. Clinical review: manifestation, diagnosis and management of food-borne 
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13.2.5. Webappendix 5. Forest plots of the meta-analysis on proportions of heavy food-
borne trematode infections among all food-borne trematode infections 
References are sorted according to the year of publication with newer ones closer to the 
bottom. Respective references are provided with a ‘W’ at the beginning to distinguish them 
from the other references given in the main text. Bibliographic details on the references of the 
quantitative datasets included are provided in Appendix 13.2.4. 
 
Clonorchiasis 
Proportion meta-analysis plot [random effects]
0.0 0.2 0.4 0.6
combined 0.0819 (0.0590, 0.1082)
W3 0.0000 (0.0000, 0.0061)
W2 0.0350 (0.0309, 0.0394)
W153 0.0633 (0.0391, 0.0961)
W44 0.1161 (0.0891, 0.1478)
W34 0.0083 (0.0031, 0.0180)
W12 0.0099 (0.0003, 0.0539)
W30 0.0872 (0.0516, 0.1359)
W29 0.0166 (0.0072, 0.0324)
W150 0.2967 (0.2055, 0.4016)
W41 0.0437 (0.0365, 0.0518)
W27 0.1092 (0.0899, 0.1310)
W21 0.1692 (0.0876, 0.2827)
W14 0.0842 (0.0371, 0.1592)
W43 0.0211 (0.0129, 0.0324)
W151 0.1049 (0.0950, 0.1155)
W9 0.1553 (0.1349, 0.1775)
W16 0.0000 (0.0000, 0.0348)
W15 0.1615 (0.1388, 0.1862)
W24 0.1092 (0.0835, 0.1394)
W152 0.0377 (0.0046, 0.1298)
W18 0.0700 (0.0600, 0.0810)
W58 0.2216 (0.1611, 0.2922)
W57 0.2000 (0.1003, 0.3372)
W13 0.3268 (0.2532, 0.4072)
proportion (95% confidence interval)
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13.2.5. Webappendix 5. Continued 
Opisthorchiasis 
Proportion meta-analysis plot [random effects]
0.0 0.2 0.4 0.6
combined 0.0485 (0.0135, 0.1035)
W156 0.0021 (5.32E-05, 0.0116)
W155 0.0000 (0.0000, 0.0180)
W61 0.0745 (0.0667, 0.0829)
W157 0.0101 (0.0070, 0.0142)
W161 0.0099 (0.0045, 0.0186)
W159 0.0462 (0.0096, 0.1290)
W73 0.0150 (0.0096, 0.0222)
W154 0.0109 (0.0074, 0.0154)
W158 0.0102 (0.0057, 0.0167)
W76 0.1349 (0.0953, 0.1834)
W59 0.4202 (0.3948, 0.4458)
W67 0.2992 (0.2446, 0.3584)
W160 0.0078 (0.0021, 0.0198)
proportion (95% confidence interval)  
 
 
Fascioliasis 
Proportion meta-analysis plot [random effects]
0.0 0.2 0.4 0.6
combined 0.14 (0.06, 0.24)
W162 0.00 (0.00, 0.46)
W83 0.07 (0.03, 0.15)
W148 0.31 (0.16, 0.50)
W81 0.12 (0.07, 0.19)
proportion (95% confidence interval)  
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13.2.5. Webappendix 5. Continued 
Intestinal fluke infections 
Proportion meta-analysis plot [random effects]
0.0 0.2 0.4 0.6 0.8
combined 0.154 (0.088, 0.234)
W164 0.054 (0.011, 0.149)
W12 0.102 (0.038, 0.208)
W163 0.254 (0.153, 0.379)
W165 0.286 (0.037, 0.710)
W14 0.184 (0.113, 0.275)
W109 0.077 (0.009, 0.251)
W104 0.086 (0.035, 0.170)
W116 0.102 (0.052, 0.175)
W18 0.303 (0.264, 0.344)
proportion (95% confidence interval)  
 
 
Paragonimiasis 
Proportion meta-analysis plot [random effects]
0.0 0.2 0.4 0.6 0.8
combined 0.26 (0.08, 0.51)
W167 0.07 (0.04, 0.10)
W166 0.59 (0.52, 0.66)
W133 0.06 (0.02, 0.12)
W125 0.33 (0.28, 0.38)
W132 0.44 (0.14, 0.79)
proportion (95% confidence interval)  
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13.2.6. Webappendix 6. Forest plots of the meta-analysis on odds ratios between CCA 
and clonorchiasis and CCA and opisthorchiasis, respectively 
References are sorted according to the year of publication with newer ones closer to the 
bottom. Respective references are provided with a ‘W’ at the beginning to distinguish them 
from the other references given in the main text. Bibliographic details on the references of the 
quantitative datasets included are provided in Appendix 13.2.4. 
 
Clonorchiasis 
Odds ratio meta-analysis plot [random effects]
1 2 5 10 100
W171 9.38 (5.20, 17.47)
W172 3.48 (1.47, 7.82)
W169 5.67 (2.43, 13.11)
W174 6.51 (3.40, 12.30)
W170 4.81 (1.64, 14.99)
combined [random] 6.12 (4.35, 8.59)
odds ratio (95% confidence interval)  
 
Opisthorchiasis 
Odds ratio meta-analysis plot [random effects]
0.2 0.5 1 2 5 10 100
W177 15.85 (6.92, 40.30)
W176 4.78 (2.14, 11.68)
W175 0.94 (0.26, 4.22)
combined [random] 4.39 (1.04, 18.55)
odds ratio (95% confidence interval)  
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13.2.7. Webappendix 7. Forest plot of the meta-analysis on the proportions of cerebral 
paragonimiasis cases who die 
References are sorted according to the year of publication with newer ones closer to the 
bottom. Respective references are provided with a ‘W’ at the beginning to distinguish them 
from the other references given in the main text. Bibliographic details on the references of the 
quantitative datasets included are provided in Appendix 13.2.4. 
 
Proportion meta-analysis plot [random effects]
0.0 0.2 0.4 0.6 0.8
combined 0.10 (0.06, 0.14)
W178 0.20 (0.03, 0.56)
W181 0.05 (0.01, 0.13)
W180 0.09 (0.02, 0.21)
W179 0.11 (0.05, 0.21)
proportion (95% confidence interval)  
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13.2.8. Webappendix 8. Parasite group-specific, region-specific, and sex-specific 
analytical graphs of the DisMod 3 outputs for the relevant sequelae 
If provided, initial model input data are represented as unconnected horizontal lines for the 
respective age groups with vertical error bars. Final model output data are represented as 
continuous steplike lines at the respective ages with estimation errors displayed as 
surrounding gray-shaded areas. Prevalence rates are defined as number of people in the 
respective age group who had the condition at time t divided by the total number of people in 
the respective age group at time t. Incidence rates are defined as number of people in the 
respective age group who did not have the condition at time t-1 and got it before time t 
divided by the person years of people in the respective age group who did not have the 
condition during the period t-1 to t. Remission rates are defined as number of people in the 
respective age group who had the condition at time t-1 and remitted before time t divided by 
the person years of people in the respective age group who had the condition during the 
period t-1 to t. Excess mortality rates are defined as with condition mortality rates of people 
in the respective age group during the period t-1 to t minus without condition mortality rates 
of people in the respective age group during the period t-1 to t. With condition mortality rates 
are defined as number of people in the respective age group who had the condition at time t-1 
and died before time t divided by person years of people in the respective age group who had 
the condition during the period t-1 to t. Relative risks are defined as with condition mortality 
rates of people in the respective age group during the period t-1 to t divided by without 
condition mortality rates of people in the respective age group during the period t-1 to t. 
Durations are defined as average time period in years until remission or death for someone 
who gets the disease at the respective age. Incidence_x_duration is defined as the product of 
these two variables, which is crucial for estimating the years lifed with disability. 
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13.2.8. Webappendix 8. Continued 
Heavy clonorchiasis: Asia, east 
 
Appendix 
274 
13.2.8. Webappendix 8. Continued 
Heavy clonorchiasis: Asia, southeast 
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13.2.8. Webappendix 8. Continued 
Heavy clonorchiasis: Asia Pacific, high income 
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13.2.8. Webappendix 8. Continued 
Heavy clonorchiasis: Europe, eastern 
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13.2.8. Webappendix 8. Continued 
Heavy opisthorchiasis: Asia, southeast (O. viverrini) 
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13.2.8. Webappendix 8. Continued 
Heavy opisthorchiasis: Europe, eastern (O. felineus) 
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13.2.8. Webappendix 8. Continued 
Heavy opisthorchiasis: Asia, central (O. felineus) 
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13.2.8. Webappendix 8. Continued 
Heavy fasioliasis: Latin America, Andean 
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13.2.8. Webappendix 8. Continued 
Heavy fasioliasis: North Africa or Middle East 
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13.2.8. Webappendix 8. Continued 
Heavy fasioliasis: Asia, east 
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13.2.8. Webappendix 8. Continued 
Heavy fasioliasis: Europe, western 
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13.2.8. Webappendix 8. Continued 
Heavy intestinal fluke infections: Asia, southeast 
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13.2.8. Webappendix 8. Continued 
Heavy intestinal fluke infections: Asia, east 
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13.2.8. Webappendix 8. Continued 
Heavy intestinal fluke infections: Asia Pacific, high income 
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13.2.8. Webappendix 8. Continued 
Heavy intestinal fluke infections: Europe, eastern 
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13.2.8. Webappendix 8. Continued 
Heavy intestinal fluke infections: North Africa or Middle East 
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13.2.8. Webappendix 8. Continued 
Heavy paragonimiasis: Asia, east 
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13.2.8. Webappendix 8. Continued 
Heavy paragonimiasis: Latin America, Andean 
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13.2.8. Webappendix 8. Continued 
Heavy paragonimiasis: Asia, southeast 
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13.2.8. Webappendix 8. Continued 
Heavy paragonimiasis: Asia Pacific, high income 
 
Appendix 
293 
13.2.8. Webappendix 8. Continued 
Cerebral paragonimiasis: Asia, east 
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13.2.8. Webappendix 8. Continued 
Cerebral paragonimiasis: Latin America, Andean 
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13.2.8. Webappendix 8. Continued 
Cerebral paragonimiasis: Asia, southeast 
 
Appendix 
296 
13.2.8. Webappendix 8. Continued 
Cerebral paragonimiasis: Asia Pacific, high income 
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13.2.9. Webappendix 9. Summary of parasite-specific and region-specific modelled 
lower and upper estimates for human food-borne trematodiasis in 2005, based on GBD 
2010 study regions 
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13.2.9. Webappendix 9. Continued 
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13.3. Effect of schistosomiasis and soil-transmitted helminth infections on physical 
fitness of schoolchildren in Côte d’Ivoire 
13.3.1. Supporting information. Table S1. Total numbers and intensities of helminth and 
Plasmodium spp. infections among 156 schoolchildren in Côte d’Ivoire 
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13.4. Questionnaire-based approach to assess schoolchildren’s physical fitness and its 
potential role in exploring the putative impact of helminth and Plasmodium spp. 
infections in Côte d’Ivoire 
13.4.1. Additional material. Additional file 1. Questionnaire employed to assess self-
reported physical fitness in the present study 
Two sections about physical functioning and physical role from the widely used SF-36v2 
questionnaire (Medical Outcome Trust, Boston, MA, USA; Health Assessment Lab, Boston, 
MA, USA; QualityMetric, Lincoln,, RI, USA; references 
14,18
 from the main text) were used 
as templates, adapted to the specific study setting, pre-tested and further revised. 
 
Appendix 
301 
Cher élève, chère élève, 
 
Nous avons rédigé 14 brèves questions concernant ton avis sur ta forme physique. Ce n’est pas un 
test avec des bonnes ou des fausses réponses. Pour nous, il est plus important d’apprendre comment 
tu vas et c’est seulement ton honnête opinion qui est importante. Alors, nous te prions de remplir le 
questionnaire suivant complètement. 
 
1. Pour commencer, lis chaque question. 
2. Assure toi que tu comprends toutes les questions. Si tu n’es pas sûr(e), tu peux toujours poser 
des questions à l’équipe ou à l’instituteur. 
3. Contrôle toutes les réponses données, choisis la réponse qui est la plus vraie pour ta situation 
et puis marque le box correspondant □ avec une croix. 
4. Choisis seulement une réponse par question. 
 
Tout d’abord, nous avons besoin de ton nom. 
 
Ecris ton nom ici: __________________________________________________ 
 
Tu trouves en suivant les 14 brèves questions concernant ton avis sur ta forme physique. Chaque 
question décrit les activités quotidiennes au cours desquelles tu peux rencontrer des problèmes 
comme l'essoufflement, une fatigue ou d'épuisement à cause de ta forme physique. Maintenant c’est à 
toi de choisir la réponse qui est la plus vraie pour ta situation. 
 
1) As-tu des problèmes pour faire des activités très fatigantes, comme par exemple courir très vite, 
soulever des choses très lourdes ou jouer au foot sans arrêter? 
□ Oui, beaucoup de problèmes. □ Oui, quelques problèmes. □ Non, pas de problème. 
 
2) As-tu des problèmes de faire des activités moyennement fatigantes, comme par exemple courir 
lentement, bouger une table ou jouer à cache-cache? 
□ Oui, beaucoup de problèmes. □ Oui, quelques problèmes. □ Non, pas de problème. 
 
3) As-tu des problèmes pour soulever ou porter ton sac à dos ou sac de riz de 5 kilogramme? 
□ Oui, beaucoup de problèmes. □ Oui, quelques problèmes. □ Non, pas de problème. 
 
4) As-tu des problèmes pour monter brièvement sur une colline basse? 
□ Oui, beaucoup de problèmes. □ Oui, quelques problèmes. □ Non, pas de problème. 
 
5) As-tu des problèmes pour monter sur une colline raide pendant un temps prolongé? 
□ Oui, beaucoup de problèmes. □ Oui, quelques problèmes. □ Non, pas de problème. 
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6) As-tu des problèmes pour te pencher en avant, te baisser ou t’agenouiller? 
□ Oui, beaucoup de problèmes. □ Oui, quelques problèmes. □ Non, pas de problème. 
 
7) As-tu des problèmes pour aller à pied de l’école de Moutcho jusqu’au marché de Moutcho (environs 
100 mètres)? 
□ Oui, beaucoup de problèmes. □ Oui, quelques problèmes. □ Non, pas de problème. 
 
8) As-tu des problèmes pour aller à pied de l’école de Moutcho jusqu’au bout de village Moutcho 
(environs 400 - 600 mètres)? 
□ Oui, beaucoup de problèmes. □ Oui, quelques problèmes. □ Non, pas de problème. 
 
9) As-tu des problèmes pour aller à pied de l’école de Moutcho jusqu’ à l’école Nakoi (environs 1’000 
mètres)? 
□ Oui, beaucoup de problèmes. □ Oui, quelques problèmes. □ Non, pas de problème. 
 
10) As-tu des problèmes pour te baigner, te laver ou t’habiller? 
□ Oui, beaucoup de problèmes. □ Oui, quelques problèmes. □ Non, pas de problème. 
 
11) As-tu eu des problèmes pour apprendre tes leçons, aider quelqu’un de ta famille ou jouer avec tes 
amis aussi long temps que d’habitude à cause de ta forme physique pendant le dernier mois? 
□ Oui, toujours. □ Oui, souvent. □ Oui, mais rarement. □ Non, jamais. 
 
12) As-tu eu des problèmes à faire la même quantité de devoirs à l’école ou à la maison comme 
d’habitude à cause de ta forme physique pendant le dernier mois? 
□ Oui, toujours. □ Oui, souvent. □ Oui, mais rarement. □ Non, jamais. 
 
13) Pouvais-tu seulement faire certaines activités quotidiennes (comme apprendre pour l’école, aider 
quelqu’un de ta famille ou jouer) mais pas toutes à cause de ta forme physique pendant le dernier 
mois? 
□ Oui, toujours. □ Oui, souvent. □ Oui, mais rarement. □ Non, jamais. 
 
14) As-tu eu besoin de faire plus d’effort que d’habitude pour apprendre tes leçons, aider quelqu’un de 
ta famille ou jouer avec tes amis à cause de ta forme physique pendant le dernier mois? 
□ Oui, toujours. □ Oui, souvent. □ Oui, mais rarement. □ Non, jamais. 
 
Et voilà, c’est déjà fini. Merci beaucoup pour ta merveilleuse collaboration. 
☺ 
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13.5. Schistosomiasis, soil-transmitted helminthiasis, and socio-demographic factors 
influence quality of life of adults in Côte d’Ivoire 
13.5.1. Supporting information. Alternative language abstract S1 in French. 
Schistosomiase, géohelminthiases et facteurs socio-démographiques influencent la 
qualité de vie des adultes en Côte d’Ivoire 
 
Contexte: Les estimations du fardeau attribué aux différentes maladies sont aujourd’hui 
largement utilisées en santé publique pour établir les priorités. Parmi ces indicateurs, le 
nombre d’années de vie corrigées du facteur d’invalidité (AVCI) est le plus couramment 
employé. Cependant, cet indicateur fait l’objet d’une critique continue du fait que pour le 
calculer, l’estimation de l’invalidité subie par un patient est essentielle et cette dernière 
représente un sujet encore largement débattu. 
Méthodologie: Une enquête épidémiologique transversale a été conduite dans le site de 
surveillance démographique et de santé (SSDS) établi en 2008 à Taabo, au centre sud de la 
Côte d’Ivoire. Cette enquête avait pour objet à partir de données collectées au niveau de la 
population, de rechercher de nouvelles preuves sur le handicap causé par la schistosomiase et 
les géohelminthiases. Les résultats des examens parasitologiques de selles, d’urine et de sang 
ont été associés aux résultats d’un questionnaire sur la qualité de vie de 187 adultes. Un 
modèle de régression linéaire multiple a été utilisé pour identifier les associations 
significatives, en considérant aussi des caractéristiques socio-démographiques obtenues à 
partir de la base de données du SSDS de Taabo. 
Principaux Résultats: Les prévalences des ankylostomes, Plasmodium spp., Trichuris 
trichiura, Schistosoma haematobium et Schistosoma mansoni ont été de 39,0 %, 18,2 %, 
2,7 %, 2,1 % et 2,1 %, respectivement. Les infestations par S. mansoni et T. trichiura de toute 
intensité, réduisent l’auto-évaluation de la qualité de vie des participants de 16 points 
(intervalle de confidence (IC) à 95 %: 4-29 points) et 13 points (IC 95 %: 1-24 points) 
respectivement sur une échelle de 0 (la plus mauvaise qualité de vie) à 100 points (la mieux 
qualité de vie). Le seul autre effet statistiquement significatif était une augmentation de 1 
point (IC 95 %: 0.1-2 points) sur l’échelle, qui mesure la qualité de vie, si un indice de 
richesse calculé par nous-même augmentait d’une unité. 
Conclusion: En considérant aussi des caractéristiques socio-démographiques, nous avons 
montré sur la base d’associations statistiquement et significatives, l’impact négatif de la 
schistosomiase et des géohelminthiases sur l’auto-évaluation de la qualité de vie chez les 
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adultes. Ces résultats démontrent la pertinence d’un questionnaire générique sur la qualité de 
la vie dans un tel contexte et incitent à une enquête plus approfondie sur le handicap induit par 
helminthiases. 
Traduction: Kigbafori D. Silué et Eliézer K. N’Goran. 
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13.5.2. Supporting information. Text S2. Questionnaire for evaluating the health state of 
individuals (in French) 
 
Enquête pour évaluer l’état de santé 
Questionnaire pour les participents à l’enquête transversal au SSD de Taabo en Juin 2010. 
 
Cher(e) participant(e), 
 
Nous avons rédigé quelques questions concernant votre avis sur votre état de santé et vos activités 
quotidiennes. Ces questions ne sont pas un test avec des bonnes et des mauvaises réponses. Pour 
nous, il est plus important de savoir comment vous allez et seule votre opinion personnelle et honnête 
nous intéresse. Nous vous prions donc de nous aider à remplir le questionnaire complètement. 
 
 
Village/Campement : 
 
Date : 
 
Nom de l’enquêteur : 
 
Numéro d’identification du participant        
 
 
Facteur de risque (6) 
Indiquez le numéro correct (1, 2 ou 9) pour chaque réponse prévue à la gauche. 
1) Quelles activités liées à l’eau (de rivières, lacs, 
marigot etc.) avez-vous pratiqué durant ces 4 dernières 
semaines ? 
(1=oui / 2=non / 9=ne sait pas) 
faire la lessive 
faire la vaisselle 
se laver 
nager 
cuisiner 
laver les enfants 
traverser les rivières 
pêcher au filet 
pêcher à l’hameçon 
cultiver du riz 
pratiques religieuses  
autres :……………………….. 
 
 
 
 
 
 
 
 
 
 
 
 
 
2) Quelle eau buvez-vous ? 
(1=oui / 2=non / 9=ne sait pas) 
 
eau de marigot, ruisseau, 
rivière 
eau de pluie 
eau courrant / robinet 
eau en bouteille / eau 
minérale / awa 
autres :……………………….. 
 
 
 
 
 
 
 
 
3) Ces 4 dernières semaines, avez-vous utilisé… 
(1=oui / 2=non / 9=ne sait pas) 
 
une moustiquaire 
des insecticides (p. ex. timor) 
moustico 
autres :……………………….. 
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4) Est-ce que vous utilisez du savon pour… 
(1=oui / 2=non / 9=ne sait pas) 
faire la lessive 
faire la vaisselle 
vous laver 
vous laver les mains avant de 
manger 
vous laver les mains après les 
selles 
laver les mains au retour du 
travail 
 
 
 
 
 
 
 
 
 
 
5) De temps en temps, mangez-vous… 
(1=oui / 2=non / 9=ne sait pas) 
 
de la viande crue 
des poisons crus 
des fruits crus 
des légumes crus 
 
 
 
 
 
6) Quels animaux possédez-vous ? 
(1=oui / 2=non / 9=ne sait pas) 
 
chien 
poule / volaille 
lapin 
cobaye 
cochon 
cabri 
mouton 
vache / buffle 
autres :………………………… 
 
 
 
 
 
 
 
 
 
 
 
 
Signes & Symptômes (2) 
7) Avez-vous expérimenté un ou plusieurs signes ou 
symptômes suivants durant ces 4 dernières semaines? 
(1=oui / 2=non / 9=ne sait pas) 
sang dans les selles 
sang dans l’urine 
mal de ventre 
ballonnement du ventre 
perte de l’appétit 
mal de tête 
troubles visuels 
problème pour articuler/ 
parler 
fièvre/ corps qui chauffe 
faiblesse/ fatigue 
vomissement 
vertige 
diarrhée 
douleur en pissant 
perte de poids 
boutons ou tache sur la 
peau 
mal à la poitrine 
problème pour respirer 
toux 
corps qui gratte 
partie du corps enflée 
mal de rein 
autres :…………………. 
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8) Quelles sont les maladies fréquentes dans votre 
ménage ? 
(1=oui / 2=non / 9= ne sait pas) 
Bilharziose ou 
schistosomiase 
Tuberculose 
Diarrhée 
Onchocercose 
VIH / SIDA 
Méningite 
Filariose / éléphantiasis 
Paludisme 
Ulcère de buruli 
Vers intestinaux 
Lèpre 
Je ne connais pas ces 
maladies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Qualité de vie (adultes : WHOQOL bref (24)) 
Marquez la réponse qui est la plus vraie pour chaque question. 
9) Vous sentez-vous en bonne santé ? 
Non, pas 
du tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
10) Avez vous eu assez d’énergie durant 
ces 4 dernières semaines pour mener 
votre vie quotidienne ? 
Non, pas 
du tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
11) Avez-vous eu assez d’argent pour 
acheter tout ce dont vous aviez besoin 
durant ces 4 dernières semaines ? 
Non, pas 
du tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
12) Avez-vous eu assez de temps libre 
durant ces 4 dernières semaines ? 
Non, pas 
du tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
13) Êtes-vous satisfait de votre capacité 
de travail ? 
Non, pas 
du tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
14) Êtes-vous satisfait de vos relations 
personnelles (par exemple avec vos 
amis ou votre famille) ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
15) Êtes-vous satisfait du support de vos 
amis ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
16) Êtes-vous satisfait de votre 
logement ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
17) Êtes-vous satisfait de votre accès au 
centre de santé le plus proche ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
18) Êtes-vous satisfait de vos 
possibilités de transport ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
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19) Êtes-vous content avec vous et votre 
situation en générale ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
 
 
20) Combien de fois avez-vous pris des 
médicaments durant ces 4 dernières 
semaines ? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
21) Combien de fois vous êtes-vous 
réjouit de votre vie durant ces 4 
dernières semaines? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
22) Combien de fois avez-vous pensé 
que votre vie avait un sens durant ces 4 
dernières semaines? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
23) Combien de fois avez-vous eu des 
problèmes pour vous concentrer durant 
ces 4 dernières semaines ? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
24) Combien de fois ne vous êtes vous 
pas sentis en sécurité durant ces 4 
dernières semaines? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
25) Combien de fois avez-vous eu des 
sentiments négatifs, comme par 
exemple la peur, le désespoir, la 
tristesse ou la dépression ? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
 
 
26) Avez vous souffert de douleurs, 
durant ces 4 dernières semaines, qui 
vous ont handicapées dans vos activités 
quotidiennes ? 
Non, 
jamais 
Oui, mais 
rarement 
 
Oui, 
souvent 
Oui, 
toujours 
27) Avez-vous eu de la peine à marcher 
durant ces 4 dernières semaines? 
Non, 
jamais 
Oui, mais 
rarement 
 
Oui, 
souvent 
Oui, 
toujours 
28) Avez-vous bien dormi durant ces 4 
dernières semaines? 
Non, 
jamais 
Oui, mais 
rarement 
 
Oui, 
souvent 
Oui, 
toujours 
29) Avez-vous eu des problèmes pour 
exécuter vos activités quotidiennes 
durant ces 4 dernières semaines? 
Non, 
jamais 
Oui, mais 
rarement 
 
Oui, 
souvent 
Oui, 
toujours 
 
 
30) Comment jugez-vous votre qualité de 
vie, en général ? 
Très bien 
 
 
Bien 
 
Mal 
 
Très mal 
 
 
Merci beaucoup de votre merveilleuse collaboration!!! 
☺ 
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13.5.3. Supporting information. Text S3. Questionnaire for evaluating the health state of 
individuals (unofficial translation into English) 
 
Survey to evaluate the health status 
Questionnaire for participants of the cross-sectional survey in the Taabo HDSS in June 2010 
 
Dear participant, 
 
We prepared some questions regarding your opinion about your personal health status and daily 
activities. These questions are not a test with right or wrong answers. For us, it is most important to 
know how you feel and we are only interested in your personal and honest opinion. We would 
therefore like to ask you to help us complete the following questionnaire. 
 
 
Name of village/hamlet: 
 
Date: 
 
Name of field enumerator: 
 
ID number of participant        
 
 
Risk Factors (6) 
Note the correct number (1, 2, or 9) for each response indicated on the left. 
1) Which water-related (rivers, lakes, ponds, etc.) 
activities did you do during the last 4 weeks? 
(1=yes / 2=no / 9=don’t know) 
do the laundry 
wash the dishes 
wash yourself 
swimming 
cooking 
wash the children 
cross the rivers 
fishing with net 
fishing with fishing-rod 
cultivate rice 
religious worship 
others:……………………….. 
 
 
 
 
 
 
 
 
 
 
 
 
 
2) Which water do you drink? 
(1=yes / 2=no / 9=don’t know) 
 
water from rivers, lakes, 
ponds 
rain water 
tap water 
bottled water / mineral water / 
awa 
others:……………………….. 
 
 
 
 
 
 
 
 
3) During the last 4 weeks, did you use… 
(1=yes / 2=no / 9=don’t know) 
 
a mosquito net 
insecticides (e.g., Timor) 
moustico 
others:……………………….. 
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4) Do you use soap for… 
(1=yes / 2=no / 9=don’t know) 
 
doing the laundry 
washing the dishes 
washing yourself 
washing your hands before 
eating 
washing your hands after 
defecation 
washing your hands when 
returning from work 
 
 
 
 
 
 
 
 
 
 
5) From time to time, do you eat… 
(1=yes / 2=no / 9=don’t know) 
 
uncooked meat 
uncooked fish 
uncooked fruits 
uncooked vegetables 
 
 
 
 
 
6) What animals do you own? 
(1=yes / 2=no / 9=don’t know) 
 
dog 
chicken / poultry 
rabbit 
guinea pig 
pig 
goat 
sheep 
cow / buffalo 
others:………………………… 
 
 
 
 
 
 
 
 
 
 
 
 
Signs & Symptoms (2) 
7) Did you suffer from one or several of the following 
signs and symptoms during the last 4 weeks? 
(1=yes / 2=no / 9=don’t know) 
blood in the stool 
blood in the urine 
abdominal pain 
flatulence 
loss of appetite 
headache 
impaired vision 
problems to articulate / 
speak 
fever / hot body 
weakness / fatigue 
vomiting 
vertigo 
diarrhea 
pain when urinating 
weight loss 
spots or pimples on the 
skin 
chest pain 
problems to breathe 
cough 
itching body 
part of the body swollen 
kidney pain 
others :…………………. 
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8) What are frequent diseases in your household? 
(1=yes / 2=no / 9=don’t know) 
Bilharzia or 
schistosomiasis 
Tuberculosis 
Diarrhea 
Onchocerciasis 
HIV / AIDS 
Meningitis 
Filariasis/elephantiasis 
Malaria 
Buruli ulcer 
Intestinal helminths 
Leprosy 
I don’t know these 
diseases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quality of life (adults: WHOQOL bref (24)) 
Mark the most appropriate response for each question. 
9) Do you feel that you are in good 
health? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
10) Did you have enough energy to 
complete your daily tasks during the last 
4 weeks? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
11) Did you have enough money to buy 
all things that you needed during the last 
4 weeks? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
12) Did you have enough leisure time 
during the last 4 weeks? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
13) Are you satisfied with your working 
capacity? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
14) Are you satisfied with your personal 
relationships (for instance with your 
friends or family)? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
15) Are you satisfied with the support of 
your friends? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
16) Are you satisfied with your housing? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
17) Are you satisfied with the 
accessibility of the nearest health 
center? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
18) Are you satisfied with the means of 
transportation that are available for you? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
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19) In general, are you satisfied with you 
and your situation? 
No, not 
at all 
More or 
less 
Yes, most of 
the time 
Yes, 
absolutely 
 
 
20) How often did you take drugs during 
the last 4 weeks? 
Never 
 
Rarely 
 
 
Often Always 
21) How often were you happy about / 
did you enjoy your life during the last 4 
weeks? 
Never 
 
Rarely 
 
 
Often Always 
22) How often did you think that your life 
makes sense / is meaningful during the 
last 4 weeks? 
Never 
 
Rarely 
 
 
Often Always 
23) How often did you have problems to 
concentrate yourself during the last 4 
weeks? 
Never 
 
Rarely 
 
 
Often Always 
24) How often did you feel unsafe during 
the last 4 weeks? 
Never 
 
Rarely 
 
 
Often Always 
25) How often did you have negative 
feelings, like anxiety, despair, sadness 
or depression during the last 4 weeks? 
Never 
 
Rarely 
 
 
Often Always 
 
 
26) Did you suffer from physical pain, 
which prevented you from doing what 
you needed or wanted to do during the 
last 4 weeks? 
No, 
never 
Yes, but 
rarely 
 
Yes, 
often 
Yes, 
always 
27) Did you suffer from physical pain 
when walking around during the last 4 
weeks? 
No, 
never 
Yes, but 
rarely 
 
Yes, 
often 
Yes, 
always 
28) Did you sleep well during the last 4 
weeks? 
No, 
never 
Yes, but 
rarely 
 
Yes, 
often 
Yes, 
always 
29) Did you have any problems to 
perform your daily living activities during 
the last 4 weeks? 
No, 
never 
Yes, but 
rarely 
 
Yes, 
often 
Yes, 
always 
 
 
30) How would you rate your quality of 
life in general? 
Very good 
 
 
Good 
 
Bad 
 
Very bad 
 
 
Thank you very much for your wonderful collaboration!!! 
☺ 
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13.5.4. Supporting information. Table S1. Explanatory variables and indicators of the 
multivariable linear regression model at each step of the backward elimination 
procedure 
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13.5.4. Supporting information. Table S1. Continued 
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13.6. Scope and limits of an anamnestic questionnaire in a control-induced low-
endemicity helminthiasis setting in south-central Côte d’Ivoire 
13.6.1. Supporting information. Text S1. Questionnaire for evaluating the health state of 
individuals in June 2010 in the Taabo health demographic surveillance system, south-
central Côte d’Ivoire (in French) 
 
Enquête pour évaluer l’état de santé 
Questionnaire pour les participents à l’enquête transversal au SSD de Taabo en Juin 2010. 
 
Cher(e) participant(e), 
 
Nous avons rédigé quelques questions concernant votre avis sur votre état de santé et vos activités 
quotidiennes. Ces questions ne sont pas un test avec des bonnes et des mauvaises réponses. Pour 
nous, il est plus important de savoir comment vous allez et seule votre opinion personnelle et honnête 
nous intéresse. Nous vous prions donc de nous aider à remplir le questionnaire complètement. 
 
 
Village/Campement : 
 
Date : 
 
Nom de l’enquêteur : 
 
Numéro d’identification du participant        
 
 
Facteur de risque (6) 
Indiquez le numéro correct (1, 2 ou 9) pour chaque réponse prévue à la gauche. 
1) Quelles activités liées à l’eau (de rivières, lacs, 
marigot etc.) avez-vous pratiqué durant ces 4 dernières 
semaines ? 
(1=oui / 2=non / 9=ne sait pas) 
faire la lessive 
faire la vaisselle 
se laver 
nager 
cuisiner 
laver les enfants 
traverser les rivières 
pêcher au filet 
pêcher à l’hameçon 
cultiver du riz 
pratiques religieuses  
autres :……………………….. 
 
 
 
 
 
 
 
 
 
 
 
 
 
2) Quelle eau buvez-vous ? 
(1=oui / 2=non / 9=ne sait pas) 
 
eau de marigot, ruisseau, 
rivière 
eau de pluie 
eau courrant / robinet 
eau en bouteille / eau 
minérale / awa 
autres :……………………….. 
 
 
 
 
 
 
 
 
3) Ces 4 dernières semaines, avez-vous utilisé… 
 
 
 
 
 
Appendix 
316 
(1=oui / 2=non / 9=ne sait pas) 
 
une moustiquaire 
des insecticides (p. ex. timor) 
moustico 
autres :……………………….. 
4) Est-ce que vous utilisez du savon pour… 
(1=oui / 2=non / 9=ne sait pas) 
faire la lessive 
faire la vaisselle 
vous laver 
vous laver les mains avant de 
manger 
vous laver les mains après les 
selles 
laver les mains au retour du 
travail 
 
 
 
 
 
 
 
 
 
 
5) De temps en temps, mangez-vous… 
(1=oui / 2=non / 9=ne sait pas) 
 
de la viande crue 
des poisons crus 
des fruits crus 
des légumes crus 
 
 
 
 
 
6) Quels animaux possédez-vous ? 
(1=oui / 2=non / 9=ne sait pas) 
 
chien 
poule / volaille 
lapin 
cobaye 
cochon 
cabri 
mouton 
vache / buffle 
autres :………………………… 
 
 
 
 
 
 
 
 
 
 
 
 
Signes & Symptômes (2) 
7) Avez-vous expérimenté un ou plusieurs signes ou 
symptômes suivants durant ces 4 dernières semaines? 
(1=oui / 2=non / 9=ne sait pas) 
sang dans les selles 
sang dans l’urine 
mal de ventre 
ballonnement du ventre 
perte de l’appétit 
mal de tête 
troubles visuels 
problème pour articuler/ 
parler 
fièvre/ corps qui chauffe 
faiblesse/ fatigue 
vomissement 
vertige 
diarrhée 
douleur en pissant 
perte de poids 
boutons ou tache sur la 
peau 
mal à la poitrine 
problème pour respirer 
toux 
corps qui gratte 
partie du corps enflée 
mal de rein 
autres :…………………. 
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8) Quelles sont les maladies fréquentes dans votre 
ménage ? 
(1=oui / 2=non / 9= ne sait pas) 
Bilharziose ou 
schistosomiase 
Tuberculose 
Diarrhée 
Onchocercose 
VIH / SIDA 
Méningite 
Filariose / éléphantiasis 
Paludisme 
Ulcère de buruli 
Vers intestinaux 
Lèpre 
Je ne connais pas ces 
maladies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Qualité de vie (adultes : WHOQOL bref (24)) 
Marquez la réponse qui est la plus vraie pour chaque question. 
9) Vous sentez-vous en bonne santé ? 
Non, pas 
du tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
10) Avez vous eu assez d’énergie durant 
ces 4 dernières semaines pour mener 
votre vie quotidienne ? 
Non, pas 
du tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
11) Avez-vous eu assez d’argent pour 
acheter tout ce dont vous aviez besoin 
durant ces 4 dernières semaines ? 
Non, pas 
du tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
12) Avez-vous eu assez de temps libre 
durant ces 4 dernières semaines ? 
Non, pas 
du tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
13) Êtes-vous satisfait de votre capacité 
de travail ? 
Non, pas 
du tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
14) Êtes-vous satisfait de vos relations 
personnelles (par exemple avec vos 
amis ou votre famille) ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
15) Êtes-vous satisfait du support de vos 
amis ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
16) Êtes-vous satisfait de votre 
logement ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
17) Êtes-vous satisfait de votre accès au 
centre de santé le plus proche ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
18) Êtes-vous satisfait de vos 
possibilités de transport ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
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19) Êtes-vous content avec vous et votre 
situation en générale ? 
Non, pas 
de tout 
Plus ou 
moins 
Oui, la plupart 
du temps 
Oui, 
absolument 
 
 
20) Combien de fois avez-vous pris des 
médicaments durant ces 4 dernières 
semaines ? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
21) Combien de fois vous êtes-vous 
réjouit de votre vie durant ces 4 
dernières semaines? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
22) Combien de fois avez-vous pensé 
que votre vie avait un sens durant ces 4 
dernières semaines? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
23) Combien de fois avez-vous eu des 
problèmes pour vous concentrer durant 
ces 4 dernières semaines ? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
24) Combien de fois ne vous êtes vous 
pas sentis en sécurité durant ces 4 
dernières semaines? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
25) Combien de fois avez-vous eu des 
sentiments négatifs, comme par 
exemple la peur, le désespoir, la 
tristesse ou la dépression ? 
Jamais 
 
Rarement 
 
 
Souvent Toujours 
 
 
26) Avez vous souffert de douleurs, 
durant ces 4 dernières semaines, qui 
vous ont handicapées dans vos activités 
quotidiennes ? 
Non, 
jamais 
Oui, mais 
rarement 
 
Oui, 
souvent 
Oui, 
toujours 
27) Avez-vous eu de la peine à marcher 
durant ces 4 dernières semaines? 
Non, 
jamais 
Oui, mais 
rarement 
 
Oui, 
souvent 
Oui, 
toujours 
28) Avez-vous bien dormi durant ces 4 
dernières semaines? 
Non, 
jamais 
Oui, mais 
rarement 
 
Oui, 
souvent 
Oui, 
toujours 
29) Avez-vous eu des problèmes pour 
exécuter vos activités quotidiennes 
durant ces 4 dernières semaines? 
Non, 
jamais 
Oui, mais 
rarement 
 
Oui, 
souvent 
Oui, 
toujours 
 
 
30) Comment jugez-vous votre qualité de 
vie, en général ? 
Très bien 
 
 
Bien 
 
Mal 
 
Très mal 
 
 
Merci beaucoup de votre merveilleuse collaboration!!! 
☺ 
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